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ABSTRACT
Detector Photon Response and Absorbed Dose and Their Applications to Rapid Triage
Techniques.
(August 2008)
Shannon Prentice Voss, B.S., Oregon State University;
M.S., San Diego State University
Chair of Advisory Committee: Dr. John W. Poston, Sr.
As radiation specialists, one of our primary objectives in the Navy is protecting
people and the environment from the effects of ionizing and non-ionizing radiation.
Focusing on radiological dispersal devices (RDD) will provide increased personnel
protection as well as optimize emergency response assets for the general public. An
attack involving an RDD has been of particular concern because it is intended to spread
contamination over a wide area and cause massive panic within the general population.
A rapid method of triage will be necessary to segregate the unexposed and slightly
exposed from those needing immediate medical treatment. Because of the aerosol
dispersal of the radioactive material, inhalation of the radioactive material may be the
primary exposure route. The primary radionuclides likely to be used in a RDD attack
are Co-60, Cs-137, Ir-192, Sr-90 and Am-241. Through the use of a MAX phantom
along with a few Simulink MATLAB programs, a good anthropomorphic phantom was
created for use in MCNPX simulations that would provide organ doses from internally
deposited radionuclides. Ludlum model 44-9 and 44-2 detectors were used to verify the
simulated dose from the MCNPX code. Based on the results, acute dose rate limits were
developed for emergency response personnel that would assist in patient triage.
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1CHAPTER I
INTRODUCTION: RADIOLOGICAL DISPERSAL DEVICES
As radiation specialists, our primary objectives in the Navy is protecting people
and the environment from the effects of ionizing and non-ionizing radiation, advancing
radiological techniques through research and development and providing radiological
expertise and intelligence in the War on Terrorism. Focusing on radiological dispersal
devices (RDD) will accomplish the Navy’s objectives as well as providing protection
and of the general public. RDDs are a potential threat to local, state and federal
government agencies. They are the most likely nuclear component that can be accessed
by terrorist organizations and formed into a radiological weapon. An attack involving an
RDD has been of particular concern because of the widespread use of radioactive
materials in the United States and abroad by industry, hospitals, and academic
institutions (DOE/NRC 2003). Such a device is intended to spread radioactive
contamination over a wide area, and causing a panic within the general population.
RDDs typically involve the use of explosives as the mechanism for dispersal, resulting
in an aerosol plume of radioactive material with a potential for wide-scale contamination
of a population. Because of the aerosol dispersal of the radioactive material, inhalation
of the material may be the primary exposure route. It is anticipated that large numbers
of the general population could have intakes of radioactive materials. In addition, a
large portion of the population, who are unexposed (the “worried well”), will go to
hospital emergency rooms and other medical facilities seeking treatment and/or
assurance that they have not been exposed. In these cases, a rapid method of triage will
be necessary to segregate the unexposed and slightly exposed from those needing
immediate medical treatment.
____________
This dissertation follows the style of Health Physics.
2CHAPTER II
RADIOLOGICAL DISPERSAL DEVICE BACKGROUND
One of the main goals of the Department of Energy (DOE) is nuclear
nonproliferation. They define their job as it relates to Nuclear Nonproliferation by
providing technical leadership to limit or prevent the spread of materials, technology,
and expertise relating to weapons of mass destruction; advance the technologies to detect
the proliferation of weapons of mass destruction worldwide; and eliminate or secure
inventories of surplus materials and infrastructure usable for nuclear weapons (Abraham
2003). Over the past seven and one-half years, the DOE has significantly improved its
ability to prevent and reverse the proliferation of weapons of mass destruction (WMD)
but they admit that nuclear material must be made more physically secure. While border
monitoring and export controls help to ensure nuclear material remains outside of our
borders, nuclear material can and should be consolidated. Reducing the number of sites
storing material coincides with reducing the vulnerability to threat or sabotage. Down-
blending and burning excess material is another way to prevent the material from falling
into the wrong hands. The DOE is working to enhance the international framework to
reduce the threat of a radiological attack against the United States (US) and its interests
abroad (Abraham 2003). According to the DOE, September 11th made these concerns
more immediate. There are any number of states and non-state actors interested in
acquiring nuclear or radiological materials. The International Atomic Energy Agency
(IAEA) has reported some 200 attempts at the illicit smuggling of nuclear materials in
the past decade alone (Abraham 2003). Dirty bombs are much simpler to make and use
than nuclear weapons. While dirty bombs are not comparable to nuclear weapons in
destructiveness, they are far easier to assemble and deploy. The materials that might be
used in a dirty bomb exist in many everyday forms, including medical nuclides,
radiography sources, large sources at scientific research facilities, and sources that
provide electric power. Such material can be found in virtually every country. While
the physical destruction an RDD would cause is comparable to conventional explosives,
3the disruption and panic caused by widespread contamination is far greater. And it is
disruption and panic that terrorists seek. All it takes is one small successful smuggling
attempt to ignite a catastrophic chain of events that can significantly impact our people
and targeted infrastructures. Over the last 20 years, our main concern has been rogue
states seeking to acquire illicit radioactive material. Now terrorist networks are seeking
such weapons and materials. The greatest threat according to the DOE is under secured
radiological sources that would be used in a radiological dispersion attack (Abraham
2003).
Sandia National Laboratories have conducted experiments on the aerosolization
on RDDs. They have conducted over 500 explosive experiments with more than 20
materials and 85 device geometries to determine the aerosol physics that are
representative of what might occur from the detonation of an actual device. Their
experimental chambers are large enough so that almost all of the aerosol generated
remains in the air and is not deposited on the walls of the chamber but small enough so
that detectable quantities of the aerosol can be collected (Harper 2006). These
experiments provide the basic information needed to evaluate exposure to individuals in
the vicinity of an RDD event.
4CHAPTER III
METHODS FOR SIMULATING MCNP PHANTOM
The basic dosimetric quantity related to the probability of the appearance of
stochastic radiation effects, as defined by the International Commission on Radiological
Protection (ICRP), is the effective dose, which is 'the sum of the weighted equivalent
doses in all tissues and organs of the body'. The ICRP Publication 60 effective dose is
given in Equation 3.1 by (ICRP 1991):
(3.1)
where HT is the equivalent dose in tissue or organ T and wT is the stochastic tissue
weighting factor for tissue T (ICRP 1991).
Effective dose is the most important quantity of the protection philosophy of
ICRP Publication 60 (ICRP 1991), and as a consequence dose limits for stochastic
effects recommended by the Commission are expressed in terms of effective dose for
routine occupational exposures. In a radiological attack, the initial focus will be on
acute, deterministic effects. Therefore, it becomes the main task of radiation protection
dosimetry to determine organ and tissue absorbed dose in units of gray (Gy).
With respect to the execution of this task, the development of mathematical
heterogeneous human phantoms was a major achievement, because equivalent doses
cannot be measured directly in the human body. In mathematical human phantoms, the
size and form of the body and its organs are described by mathematical expressions
representing combinations and intersections of planes, circular and elliptical cylinders,
spheres, cones, tori, etc. Fisher and Snyder (1967, 1968) introduced this type of
phantom for an adult male, which also contains ovaries and a uterus. Since 1979 it has
been known as ‘MIRD5 phantom’ (Medical Internal Radiation Dose Committee). Body
height and weight as well as the organ masses are in accordance with Reference Man
data (ICRP 1975). Most of the recent dosimetric data for adult humans published by the
ICRP were the same as for the MIRD5-type phantoms.
5Now, tomographic or voxel phantoms represent the latest evolutionary step of
exposure models. Tomographic phantoms are based on digital images recorded from
scanning of real persons using computed tomography (CT) or magnetic resonance
imaging (MRI). Compared to the mathematical phantoms, voxel phantoms are true to
nature representations of a human body. But, as hard as we try to justify these voxel
phantoms, they only represent a single human. Reference Man represents an average
over a large population. Tomographic or voxel phantoms were introduced by (Gibbs
1984) and independently also by (Williams 1986).
A tomographic phantom is a three-dimensional matrix of small voxels (volume
pixels), to which, depending on their location, organ volume identification (ID) numbers
have been assigned by segmentation. The media ID number, the elemental composition
and the density, which define the material to fill a voxel, have still to be defined by the
user. Tissue compositions and densities of the materials used for the construction of the
MAX phantom are taken from or are based on the ICRU Report No. 44 (ICRU 1989).
Zubal used segmented CT and MRI data of a patient who was scanned from head
to mid-thigh (Zubal 1994a), (Zubal 1994b) and Dimbylow introduced the voxel phantom
NORMAN based on MRI data of a healthy volunteer (Dimbylow 1995). The voxel
dimensions have been scaled to match the body height and weight of the Reference Man
(ICRP 1975), that is, a body weight of 70 kg and a body height of 170 cm.
Equivalent doses to organs and tissues of human phantoms are usually calculated
with Monte Carlo methods, and the results are normalized to measurable quantities. A
ratio between a quantity of interest and a measurable quantity is called a conversion
coefficient (CC) which, in general, depends on the energy and directional distribution of
the radiation field.
Equivalent dose to air-kerma CCs have been determined by Saito et al (2001) for
the OTOKO voxel phantom, for the VIPMAN voxel phantom for external exposure to
photons by Chao et al (2001a), for the same phantom for external exposure to electrons
by Chao et al (2001b), and by Zankl et al (2002a) for external photon exposure of the
GOLEM and other voxel phantoms. In most of the cited studies incident particle fluence,
6or air-kerma free in air or at the phantom surface were the normalization quantities for
the CCs.
For internal exposures Petoussi-Henss and Zankl (1998) published photon
specific absorbed fractions for the pediatric BABY and CHILD voxel phantoms, as well
as for the adult voxel phantoms GOLEM and VOXELMAN. These studies have been
continued by Smith et al (2000, 2001) and the data have been compared to those of the
MIRD5 system. Voxel data from Zubal et al (1994a, 1994b, 1995) have been used by
Johnson et al (2000) to determine CCs for organ equivalent dose normalized to activity
and by Yoriyaz et al (2000) and by Stabin and Yoriyaz (2002) to calculate specific
absorbed fractions to be used in nuclear medicine.
Yale University created three voxel phantoms VOXELMAN, MANTISSUE3-6,
and VOXTISS8 with the same data base, namely 78 CT images acquired from neck to
mid-thigh with 1 cm slice thickness, 55 CT images of the head and neck region with 0.5
cm slice thickness, and 124 high-resolution transverse MRI images with 0.15 cm slice
thickness from a patient, who was scheduled for head, thorax, abdomen and pelvic scans
for diagnosis of diffuse melanoma. His height was 175 cm and the weight was 70 kg
(Kramer 2003).
VOXELMAN represents the combination of the segmented head and body CT
images with a 4-mm cubic voxel size. Later arms and legs, segmented from the Visible
Man’s red color cross-sections (Spitzer andWhitlock 1998), were added by Stuchly
(1996) to the torso phantom, which was called MANTISSUE3-6. This phantom was
resampled to achieve a 3.6-mm cubic voxel size (Kramer 2003).
Finally, the arms of the MANTISSUE3-6 phantom have been straightened along
the sides of the body by Sjogreen (1998), maintaining the 3.6-mm cubic voxels. This
version has been called VOXTISS8, and consisted of 487 segmented body cross-
sections, each of which expanded into a 192 × 96 pixel matrix. About 40 organs and
tissues were segmented in the trunk, arms and legs and about 56 organs and tissues in the
head. The VOXTISS8 phantom had a body height of 175.3 cm, and it was this voxel
7model which has been chosen as the database for the construction of the MAX phantom
(Kramer 2003).
To represent the skin by a 1.5-mm thick surface layer as established based on
data given in ICRP Publication 89 (ICRP 2003); no effort has been made to change the
segmentation of the 3.6-mm skin of the VOXTISS8 phantom. Instead a dosimetric
method was developed to separate the deposition of energy in the 1.5-mm surface layer
from the absorption of energy in the 2.1-mm layer underneath. Depending on the
location on the surface of the body, every cubic skin voxel has at least one surface
bordering on an air voxel. This criterion already helps to eliminate voxels falsely
segmented as skin below the first surface layer. Once an interaction has been identified
as having taken place in a skin voxel, the algorithm checks to determine if the point of
interaction lies within the first 1.5-mm. In this case, the energy loss will be deposited in
skin, otherwise in adipose tissue. The method takes into account the specific location of
a skin voxel, the number of bordering air voxels and the direction of radiation incidence.
A slightly modified technique was used to determine the mass of the new 1.5 mm skin.
This method allows the skin depth to be chosen for any depth below the voxel thickness
(Kramer 2003).
8CHAPTER IV
METHODS FOR MCNP ORGAN DOSE CALCULATIONS
Introduction
MCNPX is a general purpose Monte Carlo radiation transport code that tracks
continuous energy using a coupled neutron, photon and electron transport code. It is the
next generation in the series of Monte Carlo transport codes that began at Los Alamos
National Laboratory fifty years ago. MCNPX 2.4.0 is a superset of MCNP4C3 and
MCNPX 2.3.0, LAHET 2.8 and CEM (RSICC 2002).
The MCNPX program began in 1994 as an extension of MCNP and LAHET in
support of the Accelerator Production of Tritium Project (APT). The work involved a
formal extension of MCNP to all emissions and all energies, improvement of physics
simulation models, extension of neutron, photon and photonuclear libraries to 150 MeV,
and the formulation of new variance reduction and data analysis techniques. The
program also included cross section measurements, benchmark experiments,
deterministic code development, and improvements in transmutation code and library
tools through the CINDER ’90 project (RSICC 2002).
Description
MCNP has built-in flexibility and can be used for single transport or coupled
transport of photons, neutrons and electrons. The neutron/photon transport code has the
capability to track photons produced by neutron interactions. The range of neutron
energies is from 10-11 MeV to 20 MeV for all nuclides and for a select few, the energy
extends to 150 MeV. For photons, the energy range is from 1 keV to 100 GeV. The
electron energy range is from 1 keV to 1 GeV (RSICC 2002).
Independent input files are created by the user. The input file should include the
following basic subsections: geometry specification, material description with cross-
9section evaluations, source specifications and tally or answer specifications. The more
detailed each area can be described, the more accurate answers MCNP will deliver. The
general rules of thumb are defining and sampling the geometry and source well and
always questioning the stability and reliability of results (RSICC 2002).
Method comparisons
There are two basic methods for analyzing a transport code, the Monte Carlo
method and deterministic transport methods. The Monte Carlo method and deterministic
methods solve problems in very different ways. Deterministic methods provide fairly
complete information throughout each step of the problem. Monte Carlo only supplies
information specifically requested by the user. The most common deterministic method
is the discrete ordinates method that solves the transport equation for the average particle
behavior. The Monte Carlo method simulates individual particles and records different
aspects of their average behavior and places the answers in defined bins. The central
limit theorem is used to deduce the average behavior of simulated particles within the
system (RSICC 2002).
Monte Carlo and discrete ordinates methods solve the transport equation in two
different ways. The Monte Carlo method solves the integral transport equation while the
discrete ordinates methods solve the integro-differential transport equation. Monte Carlo
uses simulated particle histories to solve the transport problem without solving the
equation. From the solution, an equation can be derived that describes the probability
density of particles (RSICC 2002).
The discrete ordinates methods breaks down the phase space into many small
boxes. As particles move from one box to another, the boxes become consecutively
smaller and the particles take a differential amount of time to cross a differential amount
of space. This method has two different derivatives in space and time. On the other
hand, the Monte Carlo method tracks particles between interaction events that are
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separated by time and distance. In the Monte Carlo method, the integral equation does
not contain terms involving time or space derivatives (Center 2002).
The Monte Carlo method is specifically designed for solving complicated, three-
dimensional, time-dependent problems. There are no averaging approximations required
in space, energy, and time. This allows all aspects of physical data to be represented
(RSICC 2002).
The Monte Carlo method
Theoretically, statistical processes that cannot be modeled by computer codes
using deterministic methods can be described by using Monte Carlo methods. The
Monte Carlo codes use sequential simulation to comprise individual probabilistic events
that make up a process. The totality of the event can be described by statistically
sampling the probability distributions that control the event. Since it usually takes a
large number of events, simulations are usually performed on a digital computer. A
selection of random numbers is used to perform the statistical sampling. The basis of
this process is tracking individual particles from their source to some predefined
stopping point. Probability distributions are randomly sampled to determine the
outcome at each step (LANL 2003).
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CHAPTER V
METHODS FOR BUILDING AND TRANSFORMING THE INTERNAL DOSE
MODEL INTO A READABLE LANGUAGE USABLE BY MCNPX
Introduction
Developing the input for MCNPX requires a specific set of instructions that must
follow a logical sequence. The MAX/FAX phantom requires the use of Scion Image
software to interpret the electronic image of the phantom (Vieira 2005). The phantom is
saved as a tagged image file format (tiff) file. The Scion Image program is used to
upload the file by changing the default width, height and slice parameters to match
values of the matrix. The matrix values for the MAX phantom are 158, a width or x-
axis, 74, a height or y-axis and 487, and a slice or z-axis. Each slice contains an x- and
y-component as a two-dimensional matrix that has a value corresponding to a particular
material in the body. Each value is unique and defined in a Microsoft Excel spreadsheet
(Kramer 2003). The Excel spreadsheet contains 61 unique identifiers ranging from 1 to
160, the corresponding name of the material located in the body along with the number
of voxels that contain the unique identifier number. Each voxel represents a volume of
0.36 cm3.
Method description
Once the image is opened, each slice is loaded into a matrix that is displayed as a
3-dimensional image of the human body. Tools within the Scion program allow
manipulation of the image in various ways such as enlarging, cropping or changing the
image from black and white to a color format. The image originally appears in
grayscale. The image was converted into a color format to differentiate between the
various materials within the body. Under the options, color table menu, the system
button was selected and the image on the computer screen appears as a color conversion
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of the matrix for each slice starting with top of the head. The first slice corresponds to
z=1. Each corresponding slice can be toggled by using the < and > keys. Figure 5.1 is
an example of slice 121 of the MAX phantom that illustrates the various body tissues
using color to correspond to the unique number identifier (Kramer 2003). In this figure,
the purple represents the lung and the light blue represents the heart. The entire MAX
tiff image is saved in appendix A.
Once the file is uploaded into the Scion Image program, each slice must be saved
as an individual two-dimensional matrix. The DAT file contains a matrix of unique
number identifiers that correspond to each type of tissue located within the body. Any
voxel within the 74 x 158 matrix, that is not part of the body, is designated with the
number 0. Figure 5.2 represents a portion of the 74 x 158 matrix delineated in number
patterns. Each number represents a voxel with a unique x-, y- and z-position.
Each slice of the MAX phantom must be individually saved as a DAT file and
stored in the same folder. For the MAX phantom, 487 DAT files were created and
stored in an exported matrix folder.
As part of the MCNPX input deck, the matrix must be in a specific sequence
which corresponds to the geometry of the universe that will be created. The program
MATLAB was used to read the individual DAT files and convert them into a single
DAT file that could be read into the MCNPX input deck. Appendix B provides a copy
of the MATLAB code that was used to read the 487 individual DAT files and create a
single voxmap that contained the MAX phantom data (MathWorks 2007). Figures 5.3
and 5.4 provide a 55% opaque image of the MAX phantom for both the anterior and
posterior views illustrating the z-axis slice grid along with a color chart associated with
different body tissues. The color scale to the right of each figure represents the tissue or
organ number. Each number is assigned a unique color. The colors range from dark
blue to dark red.
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Fig. 5.2. A portion of the Matrix number representation of MAX phantom slice 121.
Fig. 5.1. A color representation of MAX phantom slice 121 showing various body
tissues (MathWorks 2007).
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Fig 5.4. Rear view Scion MAX
Phantom
Fig. 5.3. Front view Scion MAX
Phantom
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The phantom images can be manipulated in any 360-degree orientation. Internal
organs can be viewed by adjusting the opacity of the image. An opacity of 55% was
chosen as the best representation for the phantom. The dose profile can be viewed in a
similar manner.
The program creates a voxel map with a three-dimensional, x-, y- and z-matrix
that correctly corresponds to the 74 x 158 x 487 matrix. Each data file is opened and
read into the corresponding slice of the voxmap. Once the voxmap is built, another
program is used to transform the voxmap into a single file that can be directly copied
into the MCNPX input file.
In the MAX phantom, all of the voxels outside of the phantom correspond to air
and are given the unique identifier of zero. The MCNPX basic geometry code, that
builds the universes to be used, does not allow a universe coded as zero. In MCNPX,
zero constitutes a vacuum. Therefore, in the code used in this research all of the values
within our voxmap and any value that contains a zero was replaced with the arbitrary
number three. The number three was uniquely identified as air. Once this process is
complete, the program must transform a three dimensional-matrix into a one-
dimensional string.
Three different indices are set up to correspond with each dimension in the
voxmap matrix. The indices are given a maximum value equivalent to the largest value
in each dimension. Due to the rules associated with the MCNPX input code, the string
of values must be printed in a specific format. No line can extend beyond 80 characters
in length, including punctuation and spaces; nor should a character be placed within the
first 5 spaces of the line. The program initially sets each x-, y- and z-index to 1. Since
the z-index, which corresponds to the horizontal slices through the phantom, are the last
values to be read, a loop is set up to increment the z-index. Another loop limits the
length of the print line to less than 70 characters. To maintain the integrity of the
phantom, the voxmap values are read starting in the [1,1,1] position and moving to the
[2,1,1] point. Therefore, the program must index the x-position first until x reaches its
maximum. The next step is to increment the y-index while simultaneously returning the
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x-index to one. The program will proceed in this manner until the y-index reaches its
maximum value. Only then will the program increment the z-index while
simultaneously returning the x- and y-indices to one. This iterative process will continue
until all of the values have been read into a one-dimensional array. Since there are over
5,694,004 values that average 2 characters apiece and have one space between them, this
would require 244,028 lines of code just for the phantom. The program was designed to
reduce the number of lines of code for the phantom down to 26,318 lines by using a
repeat function.
An if-statement is used to compare the current index x, y and z with the next
index x, y and z. If the value located at the current position (1, 1, 1) and the value at the
adjacent position (2, 1, 1) is the same, the program will count the number of repetitive
values while incrementing the next index to the next position and repeating the
evaluation until a different value is found. Once this occurs, the repeat variable will be
reset to zero and the process will continue through the string of values. This step follows
the same order as mentioned above. Finally, the output of this program will begin with
five spaces, the value located at the first position, followed by a space and either the
number of repeats along with the letter r and a space or a new value and a space. This
process will continue until the number of characters on the line reaches 70 and then a
new line with 5 spaces is created and the process continues until all of the values are
printed in the output file labeled MCNP_INPUT. A small snapshot sample of the
MCNP_INPUT file is listed in Figure 5.5.
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3 2082r 1 28r 3 40r 1 35r 3 36r 1 38r 3 33r 1 41r 3 30r 1 46r 3 26r
1 48r 3 23r 1 52r 3 20r 1 53r 3 19r 1 55r 3 17r 1 55r 3 17r 1 55r
3 17r 1 55r 3 18r 1 54r 3 18r 1 53r 3 21r 1 50r 3 23r 1 43r 3 30r
1 39r 3 34r 1 30r 3 45r 1 6r 3 10r 1 1r 3 55r 1 1r 3 4724r 1 14r
3 56r 1 24r 3 47r 1 47r 3 24r 1 52r 3 21r 1 54r 3 18r 1 55r 3 18r
1 55r 3 18r 1 54r 3 19r 1 53r 3 20r 1 52r 3 20r 1 52r 3 21r 1 50r
3 23r 1 48r 3 24r 1 46r 3 27r 1 44r 3 29r 1 42r 3 31r 1 39r 3 39r
1 26r 3 4184r 1 28r 3 40r 1 3r 22 2r 9 8r 22 16r 1 2r 3 36r 1 22 6r
9 8r 22 12r 9 6r 1 1r 3 33r 1 22 7r 9 8r 22 10r 48 4r 9 22 3r 9 1 1r
3 30r 1 22 8r 9 8r 22 6r 48 8r 22 7r 1 3r 3 25r 1 22 9r 9 8r 22 6r
48 8r 22 8r 9 48 1r 1 1r 3 23r 1 22 9r 9 8r 22 6r 48 8r 22 1r 48 2r
22 2r 9 2r 48 2r 1 2r 3 19r 1 22 10r 9 8r 22 6r 48 13r 22 9 4r 48 3r
9 22 1 3 18r 1 22 10r 9 8r 22 6r 48 8r 9 4r 22 9 4r 48 3r 9 2r 1 1r
3 16r 1 22 10r 9 8r 22 6r 48 8r 9 4r 22 9 4r 48 3r 9 2r 22 1r 1 3 15r
1 22 10r 9 8r 22 12r 9 7r 22 48 8r 9 2r 22 1r 1 3 15r 1 22 10r 9 8r
22 5r 9 22 5r 9 7r 22 48 8r 9 22 3r 1 3 15r 1 22 26r 48 1r 22 2r
9 9r 48 7r 9 1r 22 3r 1 3 16r 1 22 24r 48 2r 22 1r 9 10r 48 4r 9 4r
22 3r 1 3 16r 1 22 24r 48 2r 22 1r 9 10r 48 4r 9 4r 22 2r 1 3 18r
1 1r 22 22r 48 9 14r 48 1r 9 6r 22 2r 1 3 21r 1 22 21r 9 17r 22 1r
9 22 1 5r 3 23r 1 22 2r 9 7r 22 9r 9 11r 22 6r 1 2r 3 30r 1 22 1r
9 7r 22 9r 9 8r 22 1r 1 7r 3 34r 1 2r 22 6r 1 10r 9 1r 1 7r 3 45r
1 1r 22 1r 1 2r 3 10r 1 1r 3 55r 1 1r 3 4576r 1 14r 3 56r 1 1r 22 3r
9 3r 22 1r 9 22 3r 1 7r 3 47r 1 22 5r 9 3r 22 1r 9 1r 22 2r 9 22 6r
1 21r 3 24r 1 22 6r 9 3r 22 1r 9 1r 22 2r 9 22 21r 9 5r 22 1 3r 3 20r
22 7r 9 3r 22 1r 9 3r 22 9 46 22 9 5r 22 13r 9 5r 22 4r 1 2r 3 17r
1 22 6r 9 3r 22 1r 9 46 9 1r 22 1r 46 9 7r 22 12r 9 5r 22 7r 1 3 16r
1 22 6r 9 3r 22 1r 9 46 9 1r 22 1r 46 9 7r 22 12r 9 5r 22 8r 1 3 16r
1 22 5r 9 3r 22 1r 9 46 9 1r 46 22 1r 9 11r 22 8r 9 5r 22 9r 1 3 16r
1 22 4r 9 3r 22 1r 9 22 9 22 46 22 2r 9 10r 22 9 5r 22 1r 9 5r 22 9r
1 3 17r 1 22 3r 9 3r 22 1r 9 22 2r 46 22 1r 46 2r 9 5r 22 2r 9 6r
22 1r 9 10r 22 4r 1 3 18r 1 22 2r 9 3r 22 1r 9 22 1r 46 1r 22 1r
46 2r 9 5r 22 2r 9 6r 22 1r 9 10r 22 4r 1 3 18r 1 22 2r 9 3r 22 8r
46 2r 22 1r 9 4r 22 5r 9 2r 22 6r 9 5r 22 4r 1 3 19r 1 22 1r 9 3r
22 17r 9 22 1r 9 22 4r 9 22 6r 9 5r 22 3r 1 3 21r 1 22 25r 9 6r 22 2r
9 2r 22 9 5r 22 2r 1 3 22r 1 22 12r 9 22 9 6r 22 5r 9 4r 22 2r 9 2r
22 7r 1 1r 3 24r 1 22 11r 9 22 9 6r 22 5r 9 4r 22 2r 9 2r 22 6r 1
3 27r 1 22 11r 9 46 3r 9 3r 22 12r 9 2r 22 5r 1 3 29r 1 22 11r 46 2r
9 3r 46 1r 22 18r 1 1r 3 31r 1 5r 22 7r 9 3r 46 11r 22 2r 1 6r 3 39r
1 26r 3 4109r 1 29r 3 40r 1 2r 22 3r 9 8r 22 16r 1 2r 3 36r 1 22 6r
9 8r 22 12r 9 6r 1 1r 3 33r 1 22 7r 9 8r 22 10r 48 4r 9 22 3r 9 1 2r
3 29r 1 22 8r 9 8r 22 6r 48 8r 22 8r 1 2r 3 25r 1 22 9r 9 8r 22 6r
Fig. 5.5. Sample input of MCNPX geometry card.
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CHAPTER VI
METHODS FOR BUILDING AN MCNPX INPUT CODE
Introduction
MCNPX requires several elements as part of its input file. The first element
usually contains a message block followed by a blank line delimiter. This element is
optional but recommended. The second element is a One-line Problem Title Card. This
is followed by the third element which contains the Cell Card. A blank line delimiter is
next followed by the fourth element which contains a Surface Card. Another Blank Line
Delimiter follows and than the fifth element contains the Data Card. Finally, a Blank
Line terminator is optional (RSICC 2002).
Cell card
Knowing that multiple input files would be used, the most generic form of code
was chosen. The title of the input file was simply One Plane Code followed by a blank
line delimiter. A comment line was used to notify the user that the following lines
would begin the MCNP input deck. The Cell card consists of 73 cells, the first is
defined by cell 998 that does not initially contain any material but is bounded by 6
surfaces defined as -2, 1, -4, 3, -6 and 5. The second cell is defined by cell 999 that
initially contains a void and is bounded by 6 surfaces defined as -7, 1, -8, 3, -9, 5 and
contains universe 999. A lattice command is inserted with a fill instruction of 0 to 73
elements in the x-direction, 0 to 157 elements in the y-direction and 0 to 486 elements in
the z-direction. The following lines from 6 through 26318 hold the MAX phantom that
has been redefined by the MATLAB program mentioned in Chapter V. The third is
defined as Cell 1, filled with material one, has a density of 1.09 g/cm3, bounded by
surfaces -7, 1, -8, 3, -9, 5, and contains universe one. A comment notes that this material
is defined as skin. Cells 2 through 189 are bounded by surfaces like one but contain a
different material, have a defined density and a unique universe. A comment has been
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added to the end of each cell that defines the specific material represented in the
phantom. Cells 180 through 189 are defined as air within a detector located outside of
the MAX phantom but within the phantom matrix. Cell 74 is a void that contains no
materials or cells and is bounded by opposite surfaces 2, -1, 4, -3, 6 and -5 as those
bounding Cell 998. Figure 6.1 provides an example of part of the Cell card.
Surface card
As per the MCNPX manual, a blank line delineator has been added to separate
the cell card from the surface card. Since the phantom consists of a cubed matrix, planer
surfaces were the natural choice for the surface card. Figure 6.2 provides an example of
the surface card. Each surface that is used in the cell card must contain a surface
number. Following the surface number is the surface type. The letters px, py and pz
indicate planes normal to the x-, y- and z-axis. The following entry on the command
line is the numerical position in centimeters where the surface starts. Therefore, Cell
998 is bound by two planes normal to the x axis from 0 cm to 26.64 cm, two planes
normal to the y-axis from 0 cm to 56.88 cm and two planes normal to the z-axis from 0
cm to 175.32 cm. A blank line delineator separates the cell card from the surface card.
Data card
Figure 6.3 represents the important commands within the data card. The data
card is broken down into five distinct subsections. The first section is the mode. Since
neutrons or protons are not a concern for this experiment, the mode that was chosen for
the program was “p e” which directs the MCNPX program to perform photon and
electron transport only. For proton or neutron sources, the program can easily be
modified to accommodate those types of radiations. A line of code was added after the
mode section. The line of code specifies the number of particles or number of histories
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that will be followed by the program. The larger the number of histories, the better the
statistics but it will also mean the longer the time it will require to complete the
simulation. One million histories provided good statistics without the prolonged
expenditure of time.
Fig. 6.1. Sample of MCNPX input deck Cell card.
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Fig. 6.2. Sample of an MCNPX input deck surface card.
Fig. 6.3. Sample of an MCNPX input deck data card.
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Material definition card
An example of the material definition card can be seen in Figure 6.4. The
material definition card refers to the cell and surface parameters defined by their
appropriate cards. The importance of each cell must be entered in the order that they
appear. An importance must be given to each mode and for each cell. For photons and
electrons, an importance of one was selected for cells 1 through 73. For cell 74 an
importance of zero was chosen. The program would than be directed to consider all
electron and photon interactions within cells 1 through 73 but would ignore any
interactions within cell 74. The importance command was placed at the end of the data
card. This provided easier access to the line command when small errors were
encountered while writing the code. To save time and memory, a repeat command was
used since all of the cells were given equal importance with the exception of the last cell.
The third section refers to the source specification card. In Figure 6.3, line 26405
is the SDEF command line. This will define the starting history. The first part of the
command is the position of the starting history. In the code listed above, “pos=d1”
refers to a subset command listed in line 26406. The abbreviation “si1” refers to the first
source information card. The “L” refers to a lattice that will follow with a matrix of x-,
y- and z-positions. A volume source was desired and for that another MATLAB
computer program was created that would search for all of the voxels associated with a
given material. To improve efficiency, a fraction of the total voxels was used that would
represent the entire organ without losing statistical significance. This program would
than select the positions of the identified voxels, reformat and print them in accordance
with the strict MCNPX code and create a probability of having a starting history occur in
each of the selected voxels.
The program to create the source file was added as a subsection to the original
read file that creates the MAX phantom “voxmap”. The source program creates a
minimum z-variable and sets it to one and a maximum z-variable and sets it to the
maximum z-value of 487. Selecting a source is an option available to the user.
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The user may choose any material to become a volume source or the user may
read in just the phantom into the “voxmap”. By placing the value one in the variable
“makingasource”, the command will initiate the source code. If the user does not wish
to create a source, a zero is assigned to the variable. The next line asks the user to select
the organ or material into which a source is to be placed. By entering the unique
material identifier within the brackets separated by a space, the user can enter as many
sources as there are materials. The fraction of activity from zero to one can than be
entered for each source organ specified in the organ variable. This allows the user to
create a spectrum of activities throughout the body by normalizing all activity to unity.
As the activity changes over time, the user can create a source output file that will match
the change by adjusting the fraction of activity in accordance with each source organ.
The source density is defined by the user. The optimum source density was based on
several statistical simulations for the lung. A density fraction of 15,000 source voxels
per 87,506 total lung voxels was sufficient to provide a volume source for each material
Fig. 6.4. Sample of an MCNPX input deck material definition card.
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within the body. The user would specify the name of a new source file. The voxmap is
created and the values from the MAX phantom are read into the voxmap. The source
file is opened and five blank spaces, “si1”, a space and the letter “L” are printed in the
first line. An if-statement is used to determine if a source will be created. A variable is
set to zero and used to count the number of sources that have been entered by the user.
A loop is used starting from one up to the number of values entered in the organ string.
Based on the number of source organs, the program counts the number of voxels
associated with each organ in the voxmap and assigns that to a new variable. Another
variable will be assigned the value based on the size of the entire voxmap. The
“sourcesfound” variable will be set to zero. The source density is calculated based on
the lung fraction multiplied by the number of voxels for the organ in the phantom. The
result is rounded to the nearest whole number. This value is assigned to another
variable. A loop is set up to measure the number of sources found with the number of
sources calculated. Three random number generators are used to select a random
position along each of the three axes and retrieve the unique number value located at that
location. The material located at a random position is compared to the source organ
value. If the two values are equal, the "sourcesfound" and "totalsourcesfound" variables
are incremented by one. The x, y and z position indicators are than converted to
centimeters. Another limitation of the MCNP code is that a source cannot be located on
any surface. Therefore, each x-, y- and z-position is altered by 0.18 cm ensuring that the
source is placed in the middle of the voxel. The new source position is printed with a
blank space between the x-, y- and z-values. Another if-statement was inserted to print
the three source position values on one code line before creating another code line with
10 blank spaces at the beginning of the line. This keeps all of the source values in three
even columns. This loop will continue until the number of source positions is equal to
the calculated value for each source organ. The program will print a new line, four
blank spaces, "sp1" and two more blank spaces. It will assign a new variable based on
normalizing the activity. The variable is equal to the activity in each source organ
provided by the user divided by the total activity of all source organs. A loop is set up
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to print the source probability for each source organ followed by a space. The source
probability is the normalized activity for each source organ divided by the number of
source organ voxels. This result is followed by a space until all source organs have a
corresponding probability associated with each source organ voxel. All of the data are
printed to the source organ file. This information is cut and pasted into the data card.
The fourth section is the material specification card. Each cell card must have a
material number and each material number must be identified on the material card.
Each material within the human body is made up of a number of elements. Each
element has a different interaction cross-section for different radiations at different
energies. The elemental compositions and densities of all the selected body tissues were
provided by ICRU Report 46 (ICRP 1990). Material numbers one through 160 were
chosen for this code. Each material number is followed by an identification number
corresponding to the constituent element or nuclide followed by the atomic fraction of
that element or nuclide. This process continues until all of the elements needed to define
the material have been listed. The atomic number is followed by the mass number. The
".04p" refers to the photon interaction library that is used to determine the interaction
cross section. A negative sign followed by a three digit number behind a decimal refers
to the weight fraction of element in the material. A comment has been included to
identify the organ associated with the material.
The final section of the data card is the tally card. The tally cards are used to
specify what values the program should return. The return information is requested with
specific codes. The "f6:p" code was used to track the estimate of energy deposition and
the "f4:p" code was used to track the estimate of fluence rate through a cell.
Output file
MCNP automatically prints out a listing of the input file, a problem summary of
particle creation and loss, KCODE cycle summaries, tallies, tally fluctuation charts
along with basic and default tables. There are many different print variations that the
user can activate but are not included in the input file (RSICC 2002).
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The output file is the return that MCNP provides the user based on the input file
and tallies that the user has requested. The first section of the output card is a simple
copy and paste of the input card. The program that was created had 31,990 lines of
code. This is followed by a list of warnings that notify the user of potential problems
within the code. The input code created 10 warnings. The first six warnings notify the
user that surfaces 1, 3, 5, 7, 8, 9 appear more than once in a chain. This is not a concern
because the input code does not ask for any tallies based on individual surfaces within
the code. The seventh warning is that one material contains an unnormalized fraction.
The materials that were used in the input code were derived from ICRU Report 46 and
some contain fractions of less than 0.03 percent (ICRU 1990). This does not produce
any significant problems with the cross-section data libraries. The final two warnings
represent the volume or area for repeated structure tally 4 and 6 may be wrong. This is
based on the duplication of more than one surface. The volume and area used within the
tally have been verified to be correct.
MCNPX creates a table that lists the basic properties of the cell. The table
consists of the cell and material numbers, calculated atomic and mass density values,
volume and mass of a cell along with photon and electron importance. The next section
contains the random number control along with the starting random number. Following
the random number is a print table that provides material cross sections. The cross
section information comes from a MCNP library. ENDF/B-VI Release 8 Photoatomic
Data provides the cross sections for all of the elements contained in the phantom and
listed in the material section. The table is accessed by the designator ".04p" which
follows the element and atomic number of the material. The next section provides a
table with the maximum photon and electron energies as well as the minimum or cutoff
energy for the history. The energies can be adjusted to better optimize the time
requirements of the program but some information may be lost at lower energies.
Following the energy table is the table that provides the dynamic memory allocation.
The program tracks the number of histories and the time that the first history begins as
well as the time the last history ends.
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The next section is the problem summary section. Two tables tracking
information on photons and electrons are provided. For photons, one table provides
information on the creation of photons while the other table provides information on the
loss of photons. The same two tables apply for electrons. The photon creation table
provides the number and energy of source particles, the number and energy of
bremsstrahlung, positron annihilation, electron and first fluorescence x rays created. A
total for each category is provided at the end. The photon loss table provides the same
track, weight per source particle and energy for photons that escape, are captured,
interact via Compton scatter or are involved in pair production. The electron creation
table measures pair production, Compton recoil, photoelectric, photon-auger, electron-
auger and knock-on collisions that are produced. The electron loss table provides the
number of electrons that are lost and the number that achieve energy cutoff. It also
provides the energy lost from scattering and bremsstrahlung.
Following the creation and loss table is the bin tally analysis. The tally is listed
in two tables for photons and electrons. The table provides a summation of activity in
each cell. It provides the number of particles entering the cell, population and number of
collisions within the cell. It also provides the average track weight and distance.
The last section is the estimate of particle fluence for photons across user defined
cells. The user has created 10 defined cells representing the location of detectors outside
of the predefined phantom but inside the air boundary. The detectors are air but can
contain any predefined user material. The detectors are placed in user defined positions
around the anterior and posterior of the lung. The top of the table provides the volumes
within each cell followed by the fluence in units of 1/cm2. The middle portion contains
the tabulated fluence along with their associated error. The bottom portion provides an
analysis of the tallies which includes 10 statistical checks. The test file passed all 10
statistical analyses for the fluence tally.
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CHAPTER VII
METHODS FOR BUILDING VOLUME DETECTORS INTO THE MODEL
Introduction
Part of the MCNPX output tallies allow the user to request a fluence rate
(particles per unit area per second) or a dose (energy per gram). It would be convenient
to derive a volume detector that allows the user to predefine the volume and material
outside of the human phantom but within the universe. With this information, the user
can match up various commercial detectors for calibration and use in the field.
Method description
Figure 7.1 is a three-dimensional representation of the basic voxmap created by
the Scion program. The voxmap is simulation through a MATLAB voxplot program to
create the image (MathWorks 2007). A 55 percent opacity was used to allow the viewer
to see internal organs. The color bar to the right provides each organ with a specific
color. Each organ has a unique number identifier that is given a color code from 160
(Dark Red) to 0 (Dark Blue). The universe outside of the phantom is made up of air.
The user defines air based on the chemical make-up and density in the material section
of the MCNPX input program. Since the entire model is made up of small voxels, a
program has been created to allow the user to define a point in space where the center of
a detector would be.
The user would define a material number that does not coincide with any of the
predefined materials within the phantom. Ten arbitrary detectors were chosen and
placed in a pattern around the front and back of the phantom. Since the lung was chosen
as the primary organ of interest, the detectors where positioned at the top, bottom, left,
right and center. The positions where chosen based on the accessibility and ease of
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Fig. 7.1. MATLAB three-dimensional representation of the voxmap using the
voxplot program.
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identifying locations by emergency responders. The flexibility of the program allows
the user to define the size, volume, density and location of a single detector or multiple
detectors.
For ease of this test, a detector made of air with a circular radius of 5 cm and a
thickness of one voxel was selected. This configuration represents a standard Geiger-
Mueller pancake probe that represents a common detector issued to emergency
responders. The detector number selected was 180 and the geometry selected was a
circle with a radius of 5 cm. As an example, the center of detector 180 was located at
[20 90 401]. The position of the detector is located in the x-, y-, and z-direction by
taking each number and multiplying it by 0.36 cm. The program starts two loops that
run from minus the radius to plus the radius based on the center of the detector. Three
separate if-statements are built into the program to determine which plane the user wants
to define as running parallel to the detector. This allows the user to determine the
detector orientation. Once the user selects the orientation, the program finds the material
located at the center of the detector position. Based on the radius of the detector, the
program determines if any of the voxels are inside the human phantom and if so, it will
end and notify the user that the detector is hitting the body. If all of the detector voxels
are outside of the body, the program replaces the old air number with the new detector
number. Figure 7.2 provides an example of a detector being placed at the upper, left,
front of the lung. Figure 7.3 provides a side view to show that the detector is not located
within the body. Figure 7.4 provides the anterior view of the test phantom that was used
in this problem. Figure 7.5 provides the lateral view of the test phantom. The color
scale to the right of each figure represents the tissue or organ number. Each number is
assigned a unique color. The colors range from dark blue to dark red. It is based on the
10 detector design of a simple one voxel thick 5 cm diameter cylinder with 5 detectors
placed around the front and five around the back of the lung.
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Fig. 7.2. Anterior View of MAX phantom with 5 cm diameter detector located at the
upper left chest wall.
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Fig. 7.3. Lateral view of MAX phantom with 5 cm diameter detector located at upper
chest wall without entering the phantom.
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Fig. 7.4. Anterior view of MAX phantom with five 5 cm diameter detectors placed
around the chest wall.
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Fig. 7.5. Lateral view of MAX phantom with ten 5 cm diameter detectors located
around the anterior and posterior portions of the lung.
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CHAPTER VIII
METHODS FOR EVALUATING ACTIVITY AND DOSE OVER TIME BASED ON
LIKELY SOURCES FROM AN RDD EVENT
Introduction
MCNPX is an extremely good program for calculating dose to a defined material
located within a defined universe. The program requires a known source at a specified
location. Inhalation of radioactive materials within the human body delivers a dose to
known organs that change over time. The activity changes with time, either increasing
or decreasing following a set of simple 2nd order differential equations. Internal
dosimetry tries to model the change in activity and hence the change in dose to selected
organs.
In 1978, the International Committee on Radiation Protection (ICRP) issued
ICRP Publication 30 which describes Limits for Intakes of Radionuclides by Workers
(ICRP 1978). The report focuses on how an internal limit is reached over a 50 year time
period. It is recognized that radioactive material is transported throughout the body at
different rates. Depending upon how the radionuclide emissions, energy can be
transported and deposited to various organs throughout the body. The commission
decided that the selected organ limit should not be exceeded over an integrated exposure
time frame of 50 years (ICRP 1978). The committee decided that in any year of
practice, the values of the committed dose equivalent (H50) in all the organs of the body
must be limited so that the resulting total risk of cancer and hereditary disease is less
than or equal to the risk from irradiating the whole body uniformly to the appropriate
annual dose equivalent limit of 50 mSv (5rem) as recommended by ICRP Publication
26.
In order to derive an activity that will result in any one organ receiving a
committed dose equivalent, the radionuclide, chemical form, particle size and the
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method of intake, either inhalation or ingestion must be considered. For the most
common radionuclides, the Annual Limits on Intake (ALI) have been derived for
ingestion or by inhalation using a Reference Man listed in ICRP Publication 23 (ICRP
1975). A second quantity, called the Derived Air Concentration (DAC) can be
calculated, which would provide the minimum activity present in air that would result in
a selected organ reaching the ALI. Based upon the methodology provided in ICRP
Publication 30, a program was created to measure the number of transformations that
would occur in the body over the 50-year time period. This program could be used to
calculate the time integrated activity and dose to various organs.
Method description
The MATLAB program is set up using a program called Simulink (MathWorks
2007). The program was designed in shells that interact with one inside the other. All
functional data are calculated and displayed in the outer shell. Figure 8.1 shows a wire
diagram of the outer shell of the Radionuclide Dose Calculator. This program will
automatically assume a time period of 50 years or the user can select a different time
period.
The user inputs three pieces of information into the outer shell. The first is an
inhalation function in the form of activity in units of becquerel (Bq). A box that displays
a final tally for activity in the whole body over time from inhalation is attached. The
second is an ingestion function also in the form of activity in units of becquerel (Bq).
The third input is the activity median aerodynamic diameter (AMAD) of the inhaled
particles. This input allows the program to adjust for different particle sizes. Particle
size ranges from 0.2 to 10 μm. A program code safety feature will convert any other
particle size to the nearest allowable size. Particle size affects the amount and location
of radioactive deposition in the respiratory system. The three inputs flow into the
second shell that is tailored for a specific radionuclide.
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Three separate final tally boxes provide the user with activity over time. The
first tracks activity for the four main organs of the gastrointestinal tract: stomach, small
intestine, upper and lower large intestines. The second tracks activity originating from
inhalation: the lung, body transfer compartment, and activity excreted from the transfer
compartment. A final tally box displays the activity in the entire body as a function of
time. There are seven separate adders that show the total number of transformations that
occur in each of the pertinent compartments over the pre-selected time. There are 10
adders that sum the committed dose equivalent (CDE) for each of the selected organs
listed in ICRP-30 (ICRP 1978). A final adder is attached to show the committed
effective dose equivalent (CEDE). Finally, three tally boxes are added to show the CDE
as a function of time for each of the selected organs. Figure 8.2 provides a picture of the
Simulink wire diagram for the second shell.
The second shell requires four separate user inputs that are specific to the
radionuclide that will be used: 1. The "F1" transfer value from the GI tract to the
transfer compartment. This information can be found in the ICRP-30 metabolic data
(ICRP 1978). 2. The half life of the radionuclide in days. This information can be found
in the chart of the nuclides (KAPL 2002). 3. The half-life of the transfer compartment
in days. This information can be found in the ICRP-30 metabolic data (ICRP 1978). 4.
An inhalation class, the user will enter either 1, 2 or 3 which corresponds to days (D),
weeks (W) and years (Y). This information is also found in the ICRP-30 metabolic data
(ICRP 1978). These inputs, combined with the outer shell inputs for inhalation and the
AMAD size, are fed into a third-shell comprised of the lung model. The lung model
provides ten activity outputs that are sent to an adder and on to a vector integrator.
There is an output flow to the GI tract as well as an output flow to the transfer
compartment. The "F1" input is sent directly into a third-shell GI tract compartment.
The half life is converted into a decay constant which is used in all third-shell
compartments. The ingestion intake activity from the outer shell is converted into
decays per second and than input into an adder before going into the third-shell GI tract
compartment. The same adder receives an input from the third-shell lung compartment.
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INPUT PARAMETERS
Cobalt 60 Dose Calculator. Will automatically run for 50 years (18262 days). Ingestion and Inhalation intakes should be
entered seperately.
Number of AMADs (um )
Valid Range [0.2 < X < 10 ]
Any other value will result in
computation using the nearest value
within the range above .
1
Inhalation Function (Bq)
Ingestion Function (Bq)
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Inhalation Intake
Ingestion Intake
In2
Activity ST
Activity SI
Activity ULI
Activity LLI
Activity Ecreeted
Activity TC
Activity Lung
Activity Liver
Activity Body
Number Transformations ST
Number Transformations SI
Number Transformations ULI
Number Transformations LLI
Number Transformations LUNG
Number Transformations LIVER
Number Transformations BODY
CDE Gonads
CDE Breast
CDE RBM
CDE Lung
CDE SI
CDE ULI
CDE LLI
CDE Liver
CDE Thyroid
CDE BS
CEDE
CEDE
CDE in ULI
CDE in Thyroid
CDE in SI
CDE in RBM
CDE in Lung
CDE in Liver
CDE in LLI
CDE in Gonads
CDE in Breast
CDE in BS
CDE Vs. Time 2
CDE Vs. Time 1
CDE Vs. Time
Add
Activity Vs . Time 1
Activity Vs . Time
Activity In The
Entire Body vs . Time 1
Activity In The
Entire Body vs . Time
#Trans ULI
#Trans ST
#Trans SI
#Trans LUNG
#Trans LLI
#Trans LIVER
#Trans BODY
Activity In Stomach (Bq)
Activity In Small Intesting (Bq)
Activity in Upper Large Intestine (Bq)
Activity in Lower Large Intestine (Bq)
Activity Excreeted (Bq)
Activity in Transfer Compartment (Bq)
Activity in Lung (Bq)
Activity in Liver (Bq)
Activity in Body (Bq)
CDE in Gonads
CDE in Breast
CDE in RBM
CDE in Lung
CDE in Small Intestine
CDE in Upper Large Intestine
CDE in Lower Large Intestine
CDE in Liver
CDE in Thyroid
CDE in Bone Surface
Committed Effective Dose Equivilent
Number of Transformations in Stomach
Number of Transformations in Small Intestine
Number of Transformations in Upper Large Intestine
Number of Transformations in Lower Large Intestine
Number of Transformations in Lung
Number of Transformations in Liver
Number of Transformations in Whole Body
Fig. 8.1. Outer shell wire diagram of MATLAB Simulink internal dose program.
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The output from the GI tract model provides four activity outputs for the various
digestive organs that are sent to the first shell readers as well as to a vector integrator.
The activity integrator takes the activity input, multiplies it by a gain of 86,400
which corresponds to the number of seconds in one day. It adds the activity on a second
by second basis. It outputs the integrated sum as the number of transformations (U) for
each of the appropriate organs into a dose calculator as well as to the first stage readers.
The dose calculator is a function that includes an embedded MATLAB editor. The
editor sets up a matrix for each of the selected organs listed in the ICRP-30 supplement
and provides the specific effective energy that a target organ would absorb from a
radionuclide located in a source organ (ICRP 1978). It calculates a dose to each organ
by multiplying the specific effective energy by the number of transformations along with
a conversion factor to change energy into dose. It also calculates a committed effective
dose equivalent (CEDE) by multiplying the dose from each organ by its weighting factor
and summing the products. The final step is to calculate an Annual Limit on Intake
(ALI) by dividing 0.05 by the CEDE as long as the ALI is controlled by the stochastic
limit. The dose calculator outputs the CDE for each organ to the first shell readers.
There are two other third-shell compartments that play a part in this program.
The third-shell transfer compartment receives three inputs and provides two outputs.
There is an inflow of activity summed from the lung compartment and the GI tract
compartment. The decay constant comes from the radiological half-life converted into a
decay constant. The removal coefficient comes from the biological half life converted
into a removal coefficient. The transfer compartment provides two outputs. The first
output is the current activity from the transfer compartment sent to the first shell and the
second output is total activity from the transfer compartment sent to the third-shell
subsystem compartment. The third-shell subsystem compartment requires input from
the transfer compartment as well as the decay constant used in the other third-shell
compartments. This third-shell subsystem calculates excreted activity and outputs the
activity to an adder and to the first shell. The excreted activity receives additional inputs
40
Fig. 8.2. Simulink second shell wire diagram of internal dose program.
27
CEDE
26
CDE BS
25
CDE Thyroid
24
CDE Liver
23
CDE LLI
22
CDE ULI
21
CDE SI
20
CDE Lung
19
CDE RBM
18
CDE Breast
17
CDE Gonads
16
Number Transformations
BODY
15
Number Transformations
LIVER
14
Number Transformations
LUNG
13
Number Transformations
LLI
12
Number Transformations
ULI
11
Number Transformations
SI
10
Number Transformations
ST
9
Activity Body
8
Activity Liver
7
Activity Lung
6
Activity TC
5
Activi ty Ecreeted
4
Activity LLI
3
Activi ty ULI
2
Activi ty SI
1
Activi ty ST
A_ST
A_SI
A_ULI
A_LLI
A_LUNG
A_LIVER
A_BOD
U_ST
U_SI
U_ULI
U_LLI
U_LUNG
U_IVER
U_BOD
Vector
Integrator
InFlow
Decay Const.
Remov al Coef .
Current Activ ity
OutFlow
TRANSFER COMPARTMENT
Inf low
Decay Const.
Activ ity Liv er
Activ ity Body
Activ ity Excreeted
Subsystem
SUM1
SUM
Decay Constant
Total Intake
Class
AMAD
Flow To Transf er Compartment
Flow To GI Tract
Activ ity A
Activ ity B
Activ ity C
Activ ity D
Activ ity E
Activ ity F
Activ ity G
Activ ity H
Activ ity I
Activ ity J
LUNG MODEL
3
Inhi lation Class
Enter 1 for D
Enter 2 for W
Enter 3 for Y
Entering Any Other Value
wi ll Defaul t to 'D'
.5
Half Life of Transfer Compartment
(DAYS)
1.92523e3
Hal f Li fe of Radionuclide
(DAYS)
-K-
Gain4
.5
Gain2
86400
Gain
F1
Inf low to GI
Decay Const.
Flow To Transf er Compartment
Activ ity ST
Activ ity SI
Activ ity ULI
Activ ity LLI
Activ ity Excreted
GI TRACT MODEL
log(2) / u
Fcn1
log(2) / u
Fcn
.05
F1 Value for Transfer
from GI Tract to Transfer Compartment
uST
uSI
uULI
uLLI
uLUNG
uLIVER
uBODY
Gonad
Breast
BMarrow
Lung
SIwall
ULIwall
LLIwall
Liv er
Thy roid
BSurf
CEDE
ALI_Stochastic
fcn
Dose Calculator
Add2
Add1
Add
3
In2
2
Ingestion Intake
1
Inhalation Intake
ST Activ ity
SI Activ ity
ULI Activ ity
LLI Activ ity
transf er comp.
Activ ity Excreted
Activ ity C
Activ ity D
Activ ity E
Activ ity F
Activ ity G
Activ ity H
Activ ity I
Activ ity J
Activ ity A
Activ ity B
41
from the GI tract compartment along with a negative input calculated by the radiological
decay constant before it enters the transfer compartment. The activity from the body and
liver are sent to a vector integrator and to the first shell. Figure 8.3 provides an overview
of the third stage lung model. The lung model follows the model discussed in ICRP-30
(ICRP 1978). The inhalation class input goes into an embedded MATLAB function that
is used to calculate the biological decay constants and absorption fractions for each
compartment and sub-compartment within the three lung regions. The absorption
fraction and biological removal constant is sent to the appropriate compartment.
The decay constant from the initial first stage input is sent to the ten
compartments that comprise the lung model. The compartments are broken down into
three regions consisting of the Nasal Pharyngeal (NP), Trachea Bronchial (TB) and
Pulmonary regions (P). The NP region consists of two compartments, A and B where A
represents the activity cleared to the transfer compartment and B represents the activity
cleared to the GI tract model. The TB region consists of two compartments C and D
where C is cleared to the transfer compartment and D is cleared to the GI tract model.
The P region consists of four compartments and two sub-compartments labeled E
through I. Compartment E is cleared to the transfer compartment and F and G are
cleared to the GI tract model. Compartment H clears to the pulmonary lymph nodes
with some portion of this activity moving through compartment I to the transfer
compartment. Compartment J represents the possibility that some activity may be
retained in the lymph nodes. Each region consists of a split function contained in an
embedded MATLAB editor. There are four inputs and two outputs. The total intake
comes from the total activity converted into disintegrations per second. The second
input comes from the fraction that is deposited in the NP region. The third and fourth
inputs come from the fraction that is absorbed in compartments A and B based on the
inhalation class of the compound. The two outputs are the intakes for compartments A
and B. Figure 8.4 show an example of the input, calculations and output from
compartment A. The intake from each compartment is fed into an adder and than
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compiled over time. The compiler removes a portion of the activity based on the decay
and removal constants. There are two outputs from the compartment. The first output is
the current activity and the second is the activity that goes to the transfer compartment.
Compartments B, C, E and G are similar in nature. Compartment D has an additional
input from Compartments F and G. Compartments I and J are similar to the other
compartments but J does not have any output flow.
The GI tract model contains four sections that represent the four major sections
of the digestive system. Two inputs flow into the stomach. The first is the radiological
decay constant and the second is the inflow to the GI tract compartment either from
ingestion or inhalation transport. Figure 8.5 represents the stomach compartment. The
intake activity is integrated over time. The radiological decay and the biological
removal constants reduce the activity over time. The reduced activity based on the
biological removal constant is sent to the small intestine compartment. An output from
this compartment allows the user to see the real time activity. A second output sends the
reduced activity based on the radiological decay constant into the upper large intestine
compartment. Figure 8.6 shows the small intestine compartment. The only difference
between this compartment and the stomach compartment is that there is one additional
input and output. That additional input is based on the reduction of activity in the
compartment from the fractional uptake of activity into the blood. The output is the
amount of activity removed from the small intestine compartment and to the blood. The
upper and lower intestinal compartments are similar to the stomach compartment.
The transfer compartment is represented by a similar model. Figure 8.7 shows
the diagram of the transfer compartment. Two activity inputs flow into the transfer
compartment. The first is based on the activity removed from the lung system model by
the biological removal constant and the second is based on the small intestine
compartment in the GI tract model based on the biological removal constant. Two
outputs show the current activity in the transfer compartment and the outflow of activity
from the transfer compartment into the subsystem compartment. Figure 8.8 shows a
diagram of the subsystem compartment.
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The subsystem compartment is unique for each radionuclide. The current
example is based on the metabolic data for Co-60. The input activity from the GI tract
model undergoes a 3-way split that is governed by three different removal coefficients.
Each body region identified in the Co-60 metabolic data from ICRP-30 provides a
separate current activity and outflow for excretion, the liver and the whole body (ICRP
1978).
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CHAPTER IX
METHODS FOR IMPROVING EFFICIENCY BY TESTING THE NUMBER OF
HISTORIES AND NUMBER OF SOURCES IN A VOLUME
Introduction
Using the rules and terminology required by the MCNPX code, a basic input
deck was developed. The number of histories and the number of source voxels that
would be required to develop a volume source required statistical testing to improve
efficiency. Ideally, every voxel within the source organ would contain a source and the
user could simulate an infinite number of histories to acquire the best statistics. In an
emergency response situation, time is of the essence for emergency responders. At the
same time, prompt and accurate data are required. To optimize the two requirements,
the program was tested utilizing a 10 percent error mark for important organs (RSICC
2002).
Method description
Based on the most likely RDD scenario, an explosive device would be used to
disperse radioactive sources into the environment. This event would create radioactive
dust that would most likely be inhaled and potentially ingested by both civilians as well
as emergency responders. During this type of an event, the lungs, skin and eyes become
selected organs of concern. Once the radionuclide or radionuclides are identified, ICRP-
30 provides metabolic and elemental data that can be used to determine internal dose as
well the selected organs affected by the radionuclide (ICRP 1978). Cobalt-60 was
chosen as the standard radionuclide to which all other radionuclides will be compared.
Based on the five main radionuclides of concern, 11 organs were chosen for the male
MAX phantom to reflect the organs of most concern. The skin, lungs and eyes were
chosen based on the susceptibility to both external and internal exposure. The trachea,
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stomach, small intestine, colon (upper and lower large intestine), and rectum were
chosen based on their role in biologically removing internal contamination as well as the
large potential for ingestion. The ribs, which include the scapulae, sternum and clavicles
were chosen as representative examples of the skeletal system that include 16.6 percent
of the blood forming regions. The gonads were chosen based on the small risk of
passing on genetic defects and the thyroid was chosen based on its regulatory role as
well as its affinity for iodine.
Since inhalation is the primary means by which radioactive material would enter
the body in the scenario described above, the lung was chosen as the organ to provide
the statistical analysis necessary for determining the number of particles and number of
voxels necessary to create a volume source. The lung contains 87,506 voxels and is in a
shape that is not easily described with a mathematical model. Utilizing a volume source
that more closely follows the actual shape of the human lung would provide a more
accurate description of dose from sources within the lung. One million histories were
chosen to ensure good statistics. A range of 10, 100, 500, 1000, 5000, 10000, and 20000
source voxels where chosen out of a potential of 87,506 lung voxels. Four different
simulations, each with a different location of source voxels within the source organ were
used. One million histories were selected to test any variability in the program.
Volume source results
The approach was to optimize the simulation by providing good statistics based
on a volume source that approaches the shape of the source organ and minimize the
number of line codes necessary for the source input card. The dose to each organ was
simulated by four independent simulations that used a separate source card. Each source
card contained ten random voxels within the source organ. From the four independent
simulations, the dose to each organ was averaged and a standard deviation was
calculated. This test was repeated by increasing the number of source voxels randomly
selected from the source organ. Table 9.1 provides a high- and low-dose comparison,
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error range, average of all four simulations and the standard deviation for each organ as
a result of a volume source in the lung containing ten source voxels. The dose is based
on the average energy deposited in a single voxel from a 1.17 MeV photon emitted from
one of the ten source voxels located within the lung per history.
Table 9.1. Energy deposited in selected organs from a 1.17 MeV photon that is
randomly emitted from one of the ten source voxels.
Comparison of Radiation Dose for 10 Lung Source Voxels
Organ
Lowest Dose
(MeV/g)
Highest Dose
(MeV/g)
Avg Dose
(MeV/g) STD
Skin 2.97E-04 3.20E-04 3.09E-04 9.63E-06
Ribs/Sternum/
Clavical/Scapula 6.66E-01 7.17E-01 7.00E-01 2.39E-02
Gonads 1.01E-05 1.12E-04 9.48E-05 1.55E-05
Rectum 5.30E-04 6.55E-04 5.68E-04 5.87E-05
Leg Sup 1.09E-03 1.35E-03 1.23E-03 1.13E-04
Thyroid 8.15E-03 2.43E-02 1.50E-02 7.04E-03
Lung 4.35E+00 4.90E+00 4.59E+00 2.29E-01
Eyes 3.15E-04 3.98E-04 3.58E-04 3.41E-05
Trachea 2.51E-02 8.35E-02 4.88E-02 2.47E-02
Colon 3.34E-02 4.41E-02 4.03E-02 4.72E-03
Stomach 6.03E-02 1.47E-01 1.13E-01 3.84E-02
As expected, the most sensitive organ is the lung based on dose, followed by the
rib bone group and the stomach, which was expected based upon the organs in a
proximate position with the lungs. The gonads are the least exposed organs based on
size and proximal distance from the lungs. If the lung is used as the source organ and
the gonads are the smallest organ of the organs selected and located at the greatest
distance from the lungs, a condition would exist if the dose to the gonads from four
independent simulations with a source located within the lungs are within one standard
deviation, than the dose to all of the remaining selected organs should be within one
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standard deviation. In order to test this hypothesis, the dose to the gonads was compared
to the average of the four independent simulations using the calculated standard
deviation in order to determine if the dose to the gonads from each of the four
simulations is within one standard deviation as the number of source voxels within the
lung was increased. The approximate cut-off for the number of source voxels within the
lung was approximately 5,000. Once the minimum number of lung source voxels was
determined, the number of source voxels was increased to see if there was any
significant difference between the four independent simulations. The 5,000, 10,000 and
20,000 source voxels were compared to see if any significant differences occurred. An
example of the different number of source voxels is provided using the gonads. Figure
9.1 provides a dose profile for the gonads from different numbers of sources within the
lung. Good source volume statistics appear to stabilize with 5,000 or more sources. The
optimal number of sources for the lung is between 10,000 and 20,000. 15,000 sources
were selected to ensure good statistics without sacrificing simulation time.
Figure 9.2 shows the average gonad dose per history from four independent
simulations versus the number of histories from 15,000 source voxels located within the
lung. While there was still a significant difference between 100,000 histories and
1,000,000 histories, there was very little difference between the 1,000,000 histories and
10 million histories. Figure 9.3 provides a better visual of how the error in dose is
reduced as the number of histories is increased. The objective was to discover how
many histories were required to achieve less than a 10 percent error for each of the
selected organs. Using 1,000,000 histories reduced the gonad error to less than 10
percent. As expected, the other organs show a similar error reduction and dose profile
versus the number of histories used. Table 9.2 shows the simulation time difference
between the different number of histories. No significant time delays occurred between
10 and 100,000 particles. There is a large increase in time when 1,000,000 histories are
used and another ten fold increase when 10,000,000 histories are used. The error
reduction savings does not appear to be worth the added time cost.
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Table 9.2. Number of histories versus simulation time.
Number of Particles (nps) Time (m)
10 1.64
100 1.69
1000 1.69
10000 2.05
100000 5.07
1000000 36.39
10000000 334.39
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Fig. 9.3. Percent error in gonad dose vs number of histories with lung sources.
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CHAPTER X
STATISTICAL ANALYSIS BY MCNP
Introduction
MCNPX provides an in-depth statistical analysis of the program output based
upon default and user defined settings. The MCNP manual contains a detailed
description, including mathematical models to support the statistical analysis. A brief
synopsis will be provided in this section. Monte Carlo results represent an average of
the contributions from many histories sampled during the course of the problem. The
statistical error associated with the result is as important as the result itself. The error
defines the quality of the result. The major tools used to define the error include the
estimated mean, relative error, variance of the variance and history score probability
density function. The tally should be well behaved and properly converge in accordance
with the tally fluctuation charts (RSICC 2002).
Method description for Monte Carlo means, variances and standard deviations
Monte Carlo results are obtained by sampling possible random
walks and assigning a score xi to each random walk. Based on the tally
selected, a range of scores will be produced. The true mean is expressed
in equation 10.1 as the expected value of x, E(x), where
E(x) = ∫xf(x)dx = true mean.     
The function f(x) is seldom explicitly known and is implicitly sampled by
the Monte Carlo random walk process. The true mean can be estimated by
the sample mean X as in equation 10.2
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where xi is the value of x selected from f(x) for the ith history and N is the
number of histories in the problem. The Monte Carlo mean X is the
average value of the scores xi for all the histories calculated in the
problem. The variance of the population of x values is a measure of the
spread in these values and is given by equation 10.3:
The square root of the variance is σ, which is called the standard deviation
of the population of scores. As with E(x), σ is seldom known but can be
estimated by Monte Carlo as S, given by equations 10.4 and 10.5:
and
The quantity S is the estimated standard deviation of the population of x
based on the values of xi that were actually sampled. The estimated
variance of x is given by equation 10.6:
These formulas do not depend on any restriction on the distribution of x or
X .
Precision and accuracy
There is an extremely important difference between precision and
accuracy of a Monte Carlo calculation. Precision is defined as the
uncertainty in X caused by the statistical fluctuations of the xi's for the
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portion of physical phase space sampled by the Monte Carlo process. For
various user-defined reasons, portions of the physical phase space might
not be sampled. Accuracy is a measure of how close the expected value of
X is to the true physical quantity being estimated. The results of Monte
Carlo calculations refer only to the precision of the result.
There are three main factors that can affect the accuracy of a
Monte Carlo result, the code, problem modeling and the user. There are
four main user-controlled factors that affect the precision, forward vs.
adjoint calculation, tally type, variance reduction techniques and number
of histories simulated.
Central limit theorem and Monte Carlo confidence intervals
To define confidence intervals for the precision of a Monte Carlo
result, the Central Limit Theorem of probability theory is used. Equation
10.7 states that
where α and β can be any arbitrary values. Therefore, for any distribution
of tallies, the distribution of resulting X 's will be approximately normally
distributed. If S is approximately equal to σ, which is valid for a
statistically significant sampling of a tally, than equations 10.8 and 10.9
are valid:
from a standard table for the normal distribution function.
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Estimated relative errors in MCNP
All standard MCNP tallies are normalized to per starting particle
history and are printed in the output with a second numerical value, which
is the estimated relative error defined as equation 10.10:
.
The relative error is a convenient number because it represents the
statistical precision as a fractional result with respect to the estimated
mean. By combining the above equations, R can be written as shown in
equation 10.11:
If all the xi's are nonzero and equal, R is zero. Low-variance solutions
should strive to reduce the spread in the xi's. If the xi's are all zero, R is
defined to be zero. If only one nonzero score is made, R approaches unity
as N becomes large. For positive and negative xi's, R can exceed unity.
The range of R values for xi's of the same sign is therefore between zero
and unity.
Based on the qualitative analysis and the experience of Monte
Carlo practitioners, Table 10.1 presents the recommended interpretation of
the estimated 1 σ confidence interval X (1 ± R) for various values of R
associated with an MCNP tally. These guidelines were determined
empirically, based on years of experience using MCNP on a wide variety
of problems. Just before the tally fluctuation charts, a “Status of Statistical
Checks” table prints how many tally bins of each tally have values of R
exceeding these recommended guidelines.
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Table 1.1 Guidelines for interpreting the relative error Ra.
MCNP figure of merit
The estimated relative error squared, R2, should be proportional to
1/N. The computer time T used in an MCNP problem should be directly
proportional to N. The product of R2T should be approximately a constant
within any single Monte Carlo simulation. It is convenient to define a
figure of merit (FOM). Equation 10.12 defines a figure of merit as:
MCNP prints the FOM for one bin of each numbered tally as a function of
N, where the unit of computer time T is in minutes.
The FOM is a very important statistic about a tally bin and should
be studied by the user. It is a tally reliability indicator in the sense that if
the tally is well behaved, the FOM should be approximately a constant
with the possible exception of statistical fluctuations very early in the
problem. An order-of-magnitude estimate of the expected fractional
statistical fluctuations in the FOM is 2R. This result assumes that both the
relative statistical uncertainty in the relative error is of the order of the
relative error itself and the relative error is small compared to unity. The
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user should always examine the tally fluctuation charts at the end of the
problem to check that the FOMs are approximately constant as a function
of the number of histories for each tally.
Variance of the variance
Previous sections have discussed the relative error R and figure of
merit FOM as measures of the quality of the mean. A quantity called the
relative variance of the variance (VOV) is another useful tool that can
assist the user in establishing more reliable confidence intervals. The
VOV is the estimated relative variance of the estimated R. The VOV
involves the estimated third and fourth moments of the empirical history
score probability density function (PDF), f(x), and is much more sensitive
to large history score fluctuations than is R. The magnitude and behavior
of the VOV are indicators of tally fluctuation chart (TFC) bin convergence
(RSICC 2002).
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CHAPTER XI
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCE IN THE LUNG
Organ data verification
Based on the statistical simulations provided in Chapter X, a source volume of
15,000 lung voxels was selected and the number of source histories selected was one
million. The number of source voxels for additional organs will be based on the ratio of
lung source voxels divided by the total number of lung voxels. This fraction will than be
multiplied by the total number of organ voxels to determine the number of source voxels
in the organ. Of the five sources, Co-60 was chosen as the first test source for our
phantom model. To keep things simple, two simulations were set up. The first
simulation analyzed the lower energy photon of 1.17 MeV and the second tracked the
higher energy 1.33 MeV photon. Volumes and masses were checked against ICRU-46
established values for both simulations (ICRU 1990). Using the values from Table A-2
of Appendix A, the hand calculated lung volume was 4082.68 cm3, the volume of a
single voxel was 4.67 x 10-2 cm3 (Kramer 2003). According to figure A-1 of appendix
A, the MCNPX code calculated a volume of 4.67 x 10-2 cm3 for a single voxel. The
hand calculated mass of the lung was 1060 g and the mass per voxel was 1.21 x 10-2 g.
Based on Figure A-1 of appendix A, the code calculated a mass of 1.21 x 10-2 g in a
single voxel. Therefore, the phantom lung provided a good simulation that was
representative of standard man.
Dose to organ conversion
The MCNP output file provides a dose to all tissues defined within the phantom.
The dose is listed in g/cm3 and applies to a single voxel. The dose is based on the
average energy deposited per unit mass for a single history. In this case, a single 1.17
MeV photon would deliver an average dose of 4.75 ± 7.0 x 10-4 MeV/g of tissue
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contained in a single voxel. To derive any meaningful information from this value,
simple dose conversion calculations were applied to create an absorbed dose in gray
(Gy) for each organ. The above value provides an average lung dose of 9.48 x 10-19 Gy
from a single 1.17 MeV photon, if the photon originates within a lung volume source.
Because of the extremely small dose from a single photon, the organ dose is compared in
units of MeV/g for each organ. Co-60 also emits a beta radiation with a yield of 0.23
percent and an average energy of 606 KeV. The dose from the beta decay is only
applicable to the lung and the dose from the beta particle to the lung is over 1000 times
smaller than the dose to the lung from the photons. Table 11.1 provides calculated dose
conversions for each of the selected organs that were considered in this problem.
Table 11.1. Organ doses from a Co-60 volume source in the lung.
Organs
MCNP Dose
(MeV/g-his)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g-his)
Organ Dose
(Gy/his)
Skin 6.98E-04 3.01E-11 5.09E-02 3.55E-05 2830 1.26E-08 2.01E-18
Rib Bone Group 1.53E+00 1.02E-07 6.58E-02 1.00E-01 2167 4.63E-05 7.42E-15
Small Int 1.51E-01 1.87E-07 4.81E-02 7.26E-03 640 1.13E-05 1.82E-15
Gonads 2.38E-04 6.69E-08 4.85E-02 1.16E-05 37.1 3.11E-07 4.99E-17
Rectum 1.30E-03 9.69E-08 4.90E-02 6.36E-05 63 1.01E-06 1.62E-16
Thyroid 2.10E-02 1.20E-06 4.90E-02 1.03E-03 19.6 5.26E-05 8.42E-15
Lung 9.98E+00 1.70E-07 1.21E-02 1.21E-01 999 1.21E-04 1.94E-14
Eyes 8.33E-04 3.05E-07 4.90E-02 4.08E-05 15 2.72E-06 4.36E-16
Trachea 5.19E-02 4.04E-06 4.90E-02 2.54E-03 10 2.54E-04 4.07E-14
Colon 9.43E-02 2.05E-07 4.90E-02 4.62E-03 369 1.25E-05 2.01E-15
Stomach 3.13E-01 8.78E-07 4.90E-02 1.53E-02 150 1.02E-04 1.64E-14
As expected, the largest dose concentrations are to the organs in the immediate
vicinity of the lung which includes the trachea, stomach and thyroid. The dose to the
skin is smaller than the dose to the lung by a factor of 1,000. This reflects the average
dose over the entire volume of skin. This is a large assumption. In reality, the dose to
the skin is a gradient based on the distance each skin voxel is from each source voxel.
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Statistical analysis of output file
The tally-four fluence analysis for each detector, setup as described in chapter
VII provided a random behavior for the mean. The desired relative error should be less
than 0.10 and the observed relative error was 0.02. The desired and observed relative
errors decreased in relation to the inverse of the square root of the number of histories.
The desired variance of the variance should be less than 0.10 and the observed VoV was
0.02. The figure of merit value was constant and the behavior was random. The
probability density function (pdf) desired should be greater than three, the observed pdf
value was 10. The tally-four fluence passed all 10 statistical checks. Out of 10 tally-
four bins, only one had a zero value and no bins contained relative errors greater than
0.10. This occurred because the tenth lung detector was not created and located at the
center back position. This error was not discovered until after a significant number of
simulation files were created. While this can easily be rectified for future phantoms, it is
not significant to the current MCNPX problem. The second 1.33 MeV photon
simulation provided similar statistical results with the exception of the VoV. The
observed VoV value was 0.00.
The tally-six dose analysis for each tissue showed a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.02 for the 1.17 MeV photon and 0.00 for the 1.33 MeV photon. The desired and
observed relative errors decreased in relation to the inverse of the square root of the
number of histories. The desired variance of the variance should be less than 0.10 and
the observed VoV was 0.00. The figure of merit value was constant and the behavior
was random. The desired probability density function (pdf) should be greater than 3.00
and the observed value was 10.00 for the 1.17 MeV photon and 5.87 for the 1.33 MeV
photon. The tally-six dose passed all 10 statistical checks. Out of 61 tally-six bins, no
bin had a zero value and only 7 bins contained relative errors greater than 0.10.
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Co-60 organ dose profile
A Co-60 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 2.54 x 10-4 MeV/g to the trachea and a low of 1.26 x
10-8 MeV/g to the skin. This organ dose contribution is the sum of two photons emitted
from Co-60 that occur with a yield of about 100 percent. Figure 11.1 provides a
simulated 3-dimensional view of the human body with a color profile that equates to the
MCNP dose for the high-energy photon of Co-60 absorbed by each organ. The color bar
units to the right of the phantom are in MeV/organ weight in grams. The current
MATLAB program that was created to provide a simulated 3-dimensional view of dose
to the human body can only read and convert one MCNPX output file at a time. Each
axis is represented in the figure along with a color bar that indicates the organ dose in
MeV/g provided by the MCNPX output file. In the MCNPX output file, the trachea
receives a slightly lesser dose than the lung based upon the number of voxels versus the
measured mass of the trachea. The phantom includes the airway as part of the trachea.
The dose difference is not significant.
Cs-137 organ dose profile
A Cs-137 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 7.54 x 10-5 MeV/g for the trachea and a low of 3.41 x
10-9 MeV/g for the skin. This organ dose contribution is from a 0.66 MeV photon
emitted from Cs-137 that occur with a yield of about 86 percent. Cs-137 also emits a
beta particle with a yield of approximately 5.3 percent and an average energy of 416
KeV. The dose from the beta decay is only applicable to the lung and the dose delivered
to the lung by the beta particle is over 1000 times smaller than the dose to the lung from
the photons. Table 11.2 provides the dose output to the selected organs from the 0.66
MeV photon.
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Fig. 11.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within the lung.
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Table 11.2. Organ doses for a Cs-137 volume source in the lung.
Organs
MCNP Dose
(MeV/g-his)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g-his)
Organ Dose
(Gy/his)
Skin 1.90E-04 4.10E-12 5.09E-02 9.66E-06 2830 3.41E-09 5.47E-19
Rib Bone Group 4.61E-01 1.40E-08 6.58E-02 3.03E-02 2167 1.40E-05 2.24E-15
Small Int 4.17E-02 2.54E-08 4.81E-02 2.00E-03 640 3.13E-06 5.01E-16
Gonads 3.77E-05 6.85E-09 4.85E-02 1.83E-06 37.1 4.94E-08 7.91E-18
Rectum 2.75E-04 1.15E-08 4.90E-02 1.35E-05 63 2.14E-07 3.43E-17
Thyroid 6.30E-03 1.75E-07 4.90E-02 3.09E-04 19.6 1.58E-05 2.52E-15
Lung 2.96E+00 2.52E-08 1.21E-02 3.59E-02 999 3.60E-05 5.76E-15
Eyes 1.87E-04 3.66E-08 4.90E-02 9.17E-06 15 6.11E-07 9.79E-17
Trachea 1.54E-02 5.81E-07 4.90E-02 7.54E-04 10 7.54E-05 1.21E-14
Colon 2.61E-02 2.81E-08 4.90E-02 1.28E-03 369 3.47E-06 5.56E-16
Stomach 9.21E-02 1.26E-07 4.90E-02 4.51E-03 150 3.01E-05 4.82E-15
As expected, the dose to the selected organs is similar to the dose produced by
the Co-60 photons. The largest dose concentration remains with organs in the
immediate vicinity of the lung. The lung dose is reduced by approximately a factor of
two. This reduction is expected based on the energy reduction between the 1.17 MeV
Co-60 photon and the 0.66 MeV photon of Cs-137.
Statistical checks were performed on the Cs-137 Dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence analysis passed and produced similar results. The 10 statistical checks for tally-
six dose passed and produced similar results as with Co-60. Of the 61 tally bins, 9 bins
had relative errors exceeding 0.10. Figure 11.2 provides a simulated 3-dimensional view
of the human body with a color profile that shows the MCNP dose for the single photon
of Cs-137 absorbed by each organ. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
The Co-60 lung dose was 5.77 x 10-5 MeV/g for the 1.17 MeV photon compared
with the Cs-137 lung dose of 3.60 x 10-5 MeV/g for the 0.66 MeV photon. As expected,
the dose profile is similar to that of the photons emitted by Co-60. The dose to each
individual organ is proportionally reduced based on the lower-energy of the source
photon and the energy dependent stopping power of the material within the phantom.
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Ir-192 organ dose profile
An Ir-192 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 9.45 x 10-05 MeV/g for the trachea and a low of 3.96 x
10-9 MeV/g for the skin. This organ dose is sum of two photons with energies of 0.47
MeV and 0.32 MeV along with two electrons that have maximum energies of 0.66 MeV
and 0.54 MeV. All four emissions are produced with a yield of about 26.2%, 22.4%,
10.1% and 6.7%, respectively. Table 11.3 provides the calculated dose conversions for
each of the selected organs.
Table 11.3. Organ doses for an Ir-192 volume source in the lung.
Organs
MCNP Dose
(MeV/g-his)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g-his)
Organ Dose
(Gy/his)
Skin 2.20E-04 1.65E-10 5.09E-02 1.12E-05 2830 3.96E-09 6.35E-19
Rib Bone Group 6.02E-01 4.91E-07 6.58E-02 3.96E-02 2167 1.83E-05 2.93E-15
Gonads 3.11E-05 1.27E-08 4.85E-02 1.51E-06 37.1 4.06E-08 6.51E-18
Small Int 3.91E-04 9.54E-09 4.81E-02 1.88E-05 640 2.94E-08 4.70E-18
Rectum 2.52E-04 2.20E-07 4.90E-02 1.24E-05 63 1.96E-07 3.14E-17
Thyroid 7.92E-03 4.74E-06 4.90E-02 3.88E-04 19.6 1.98E-05 3.17E-15
Lung 3.69E+00 6.68E-07 1.21E-02 4.48E-02 999 4.48E-05 7.18E-15
Eyes 1.84E-04 1.03E-06 4.90E-02 9.03E-06 15 6.02E-07 9.65E-17
Trachea 1.93E-02 1.50E-05 4.90E-02 9.45E-04 10 9.45E-05 1.51E-14
Colon 3.11E-02 1.00E-06 4.90E-02 1.52E-03 369 4.13E-06 6.62E-16
Stomach 1.15E-01 1.92E-06 4.90E-02 5.64E-03 150 3.76E-05 6.02E-15
As expected, the organ dose was driven by the two photons over the two
electrons by a factor of 100 or greater. This confirms the ICRP assumption for beta
sources where the absorbed fraction is equal to one when the source organ is equal to the
target organ. Compared to the Co-60 and Cs-137 organ dose, the most sensitive organs
for Ir-192 were the lung, trachea and thyroid. The total lung dose in Gy/his from Ir-192
located in the lung is slightly greater than the total lung dose from Cs-137 located in the
lung. The sum of the two Ir-192 photons is comparable to the energy of the single Cs-
137 photon.
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Fig. 11.2. Three-dimensional human dose profile from a Cs-137 source located within
the lung.
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Statistical checks on the Ir-192 Dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, 9 bins had
relative errors exceeding 0.10 for the 0.47 MeV photon.
The tallies for the electron sources in the lung had to be evaluated in a slightly
different manner based on their inability to penetrate uniformly throughout the phantom.
Secondary emissions, such as bremsstrahlung, characteristics x rays and electrons were
the primary radiation source for organs outside of the lung. Three of the 10 statistical
checks did not pass. The relative error for tally-four fluence was 0.26, the VoV was 0.35
and the pdf was 0. This reflects a large number of zero doses and slightly greater than
zero doses based on the volume electron source in the lung. For the electron source,
only the selected organs were reviewed for their relative error.
Figures 11.3 and 11.4 provide a simulated 3-dimensional view of the human
body with a color profile that equates to the MCNP dose for the 0.47 MeV photon of Ir-
192 and the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The
color bar units to the right of the phantom are in MeV/organ weight in grams.
Sr-90 organ dose profile
A Sr-90 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 2.94 x 10-7 MeV/g for the trachea and a low of 4.60 x -
12 MeV/g for the skin. This organ dose contribution is from a single beta particle with a
maximum energy of 0.55 MeV. The beta particle is produced with a yield of about
100%. Table 11.4 provides the calculated dose conversions for each of the selected
organs that will be considered in this problem.
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Table 11.4. Organ doses from a Sr-90 volume source in the lung.
Organs
MCNP Dose
(MeV/g-his)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g-his)
Organ Dose
(Gy/his)
Skin 2.56E-07 9.85E-14 5.09E-02 1.30E-08 2830 4.60E-12 7.37E-22
Rib Bone Group 2.66E-03 1.07E-09 6.58E-02 1.75E-04 2167 8.08E-08 1.29E-17
Gonads 1.87E-07 2.44E-10 4.85E-02 9.06E-09 37.1 2.44E-10 3.91E-20
Small Int 5.15E-05 4.18E-10 4.81E-02 2.47E-06 640 3.86E-09 6.19E-19
Rectum 6.74E-07 5.24E-10 4.90E-02 3.30E-08 63 5.24E-10 8.40E-20
Thyroid 1.60E-05 4.69E-09 4.90E-02 7.85E-07 19.6 4.01E-08 6.42E-18
Lung 2.30E-02 1.98E-09 1.21E-02 2.79E-04 999 2.79E-07 4.47E-17
Eyes 0.00E+00 0.00E+00 4.90E-02 0.00E+00 15 0.00E+00 0.00E+00
Trachea 6.00E-05 2.09E-08 4.90E-02 2.94E-06 10 2.94E-07 4.71E-17
Colon 3.46E-05 4.91E-10 4.90E-02 1.69E-06 369 4.59E-09 7.36E-19
Stomach 2.07E-04 3.09E-09 4.90E-02 1.01E-05 150 6.76E-08 1.08E-17
As expected, the lung and trachea receive the greatest dose from a moderately
energetic beta particle source located within the lung. The stomach and thyroid due to
their close proximity to the source organ receive less than half the dose of the lung.
Statistical checks on the Sr-90 Dose output file were performed. The same warnings
present with Co-60 were observed. The 10 statistical checks for tally-four fluence
missed four of the 10 checks. The relative error was 0.22, VoV did not decrease with a
rate of inverse the number of histories, the FOM was not constant and increased and the
pdf was 0. The 10 statistical checks for tally-six dose passed. Of the 61 tally bins, 9
bins had no dose and 31 bins had relative errors exceeding 0.10 for the 0.55 MeV beta
radiation. Figure 11.5 provides a simulated 3-dimensional view of the human body with
a color profile that equates to the MCNP dose for the beta radiation of Sr-90 absorbed by
each organ. The color bar units to the right of the phantom are in MeV/organ weight in
grams.
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Fig. 11.3. Three-dimensional human dose profile from the 0.47 MeV Ir-192 photon
source located within the lung.
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Fig. 11.4. Three-dimensional human dose profile from the 0.66 MeV Ir-192 electron
source located within the lung.
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Y-90 organ dose profile
A Y-90 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 3.42 x 10-6 MeV/g for the trachea and a low of 9.11 x
10-11 MeV/g for the skin. This organ dose contribution is from a single beta particle with
a maximum energy of 2.281 MeV. The beta radiation is produced with a yield of about
100%. The energy dose and relative errors are provided in Table 11.5.
Table 11.5. Organ doses from a Y-90 volume source in the lung.
Organs
MCNP Dose
(MeV/g-his)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g-his)
Organ Dose
(Gy/his)
Skin 5.07E-06 7.66E-13 5.09E-02 2.58E-07 2830 9.11E-11 1.46E-20
Rib Bone Group 2.77E-02 3.87E-09 6.58E-02 1.82E-03 2167 8.40E-07 1.35E-16
Gonads 3.14E-07 3.98E-10 4.85E-02 1.52E-08 37.1 4.11E-10 6.58E-20
Small Int 1.12E-03 3.61E-09 4.81E-02 5.36E-05 640 8.38E-08 1.34E-17
Rectum 7.12E-06 1.57E-09 4.90E-02 3.49E-07 63 5.53E-09 8.87E-19
Thyroid 2.48E-04 2.87E-08 4.90E-02 1.21E-05 19.6 6.19E-07 9.92E-17
Lung 1.44E-01 6.82E-09 1.21E-02 1.75E-03 999 1.75E-06 2.80E-16
Eyes 6.15E-06 6.41E-09 4.90E-02 3.01E-07 15 2.01E-08 3.22E-18
Trachea 6.99E-04 9.93E-08 4.90E-02 3.42E-05 10 3.42E-06 5.49E-16
Colon 7.12E-04 4.06E-09 4.90E-02 3.49E-05 369 9.45E-08 1.51E-17
Stomach 3.03E-03 1.90E-08 4.90E-02 1.48E-04 150 9.90E-07 1.59E-16
As with Sr-90, the lung and trachea received the highest dose from a highly-
energetic beta particle source located within the lung. The stomach and thyroid, due to
their close proximity to the source organ, received approximately 80% of the dose to the
lung. The Y-90 lung dose was approximately 10 times greater than the dose delivered
by the Sr-90 beta particle even though the energy of the Y-90 beta particle was
approximately 4 times greater than the Sr-90. The difference in dose is attributed to the
difference in energy dependent stopping power as well as the energy and type of
secondary radiations.
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Fig. 11.5. Three-dimensional human dose profile from a Sr-90 volume source located
within the lung.
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Statistical checks on the Y-90 Dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all checks except for the pdf which was 0. The 10 statistical checks for
tally-six dose passed. Of the 61 tally bins, 2 bins had a zero dose and 25 bins had
relative errors exceeding 0.10 for the 2.28 MeV beta particle. Figure 11.6 provides a
simulated 3-dimensional view of the human body with a color profile that equates the
MCNP organ dose for an Y-90 source in the lung. The color bar units to the right of the
phantom are in MeV/organ weight in grams.
Results from lung volume source
Figure 11.7 provides an graph of all of the potential sources distributed in the
lung. Based upon the results of the observed programs, Co-60 is the most limiting
radionuclide. The trachea and lungs appear to be the most sensitive organs based upon a
single decay from a source located within the lung. Even though the trachea shows the
highest sensitivity, the dose is a little deceiving. The observed dose for the trachea is
based on the number of voxels which include the air encircled by the trachea. The actual
dose based on the weight of the organ is less than that for the lung. The dose to all of the
selected organs from Sr-90 and Y-90 appears to be almost 100 times lower than the other
three radionuclides. Ir-192 and Cs-137 appear to deliver almost identical doses to the
selected organs.
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Fig. 11.6. Three-dimensional human dose profile from a Y-90 beta source located
within the lung.
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Fig. 11.7. Comprehensive graph of organ doses for the five potential lung sources.
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CHAPTER XII
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCE IN THE LUNG FOR
THE FEMALE PHANTOM ALONG WITH MALE LUNG COMPARISON
Organ data verification
The number of source voxels for additional organs will be based on the ratio of
MAX lung source voxels divided by the total number of MAX lung voxels. This
fraction will than be multiplied by the total number of organ voxels to determine the
number of source voxels in the organ. The female phantom contained 78,315 lung
voxels, therefore using the same ratio, 13,425 voxels were selected as the source volume
and one million histories were selected. Co-60 was chosen for a comparison test
between the two phantom models. The same two simulations were established. The
first simulation analyzed the 1.17 MeV photon and the second tracked the 1.33 MeV
photon. Volumes and masses were checked against ICRU-46 established values for
both simulations (ICRU 1990). Using the provided values from Table A-2 of Appendix
A, the hand calculated lung volume was 3,653.86 cm3, the volume of a single voxel was
4.67 x 10-2 cm3 (Kramer 2003). According to figure A-1 of Appendix A, the MCNPX
code calculated a volume of 4.67 x 10-2 cm3 for a single voxel. The hand calculated
mass of the lung was 1,000 g and the mass per voxel was 1.27 x 10-2 g. Based on Figure
A-1 of Appendix A, the code calculated a mass of 1.21 x 10-2 g in a single voxel.
Therefore, the phantom lung provided a good simulation that was representative of
standard woman based on standard man.
Dose to organ conversion
The MCNP output file provides a dose to all tissues defined within the phantom.
The dose is listed in MeV/g and applies to a single voxel. The dose is based on the
average energy deposited per unit mass for a single history. For the female phantom, a
78
single 1.17 MeV photon would deliver an average dose of 4.00 ± 7.0 x 10-4 MeV/g of
tissue contained in a single voxel. To derive any meaningful information from this
value, simple dose conversion calculations were applied to obtain a dose in gray (Gy) for
each organ. The above value provided an average lung dose of 7.79 x 10-15 Gy from a
single 1.17 MeV photon, if the photon originates within a lung volume source. Because
of the extremely small dose from a single photon, the organ dose is compared in units of
MeV/g for each organ. Co-60 also emits a beta radiation with a yield of 0.23 percent
and an average energy of 606 KeV. The dose from the beta decay is only applicable to
the lung and the dose from the beta radiation to the lung is over 1000 times smaller than
the dose to the lung from the photons. Table 12.1 provides the calculated dose
conversions for each of the selected organs that were considered in this problem.
Table 12.1. Organ doses from a Co-60 volume source in the female lung.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 7.52E-04 3.24E-11 5.09E-02 3.83E-05 2830 1.35E-08 2.17E-18
Rib Bone Group 5.90E-01 5.01E-08 6.58E-02 3.88E-02 2167 1.79E-05 2.87E-15
Small Int 9.08E-02 1.35E-07 4.81E-02 4.36E-03 640 6.82E-06 1.09E-15
Breasts 8.13E-03 3.40E-07 4.85E-02 3.94E-04 26 1.52E-05 2.43E-15
Thyroid 7.85E-03 6.37E-07 4.90E-02 3.84E-04 19.6 1.96E-05 3.14E-15
Ovaries 4.07E-04 1.51E-07 4.90E-02 1.99E-05 16 1.24E-06 1.99E-16
Lung 8.41E+00 1.43E-07 1.21E-02 1.02E-01 999 1.02E-04 1.64E-14
Eyes 7.80E-04 2.70E-07 4.90E-02 3.82E-05 15 2.55E-06 4.08E-16
Trachea 2.85E-02 2.58E-06 4.90E-02 1.39E-03 10 1.39E-04 2.23E-14
Colon 8.31E-02 1.68E-07 4.90E-02 4.07E-03 369 1.10E-05 1.77E-15
Stomach 1.78E-01 7.86E-07 4.90E-02 8.73E-03 150 5.82E-05 9.32E-15
As expected, like the male phantom, the largest dose concentrations are to the
organs in the immediate vicinity of the lung which includes the trachea, breasts, colon,
stomach and thyroid. The dose to the skin is smaller by a factor of 10,000. The
assumption applied to the skin dose is that the dose is uniform across the entire volume
of skin. The actual skin dose is delivered on a gradient depending upon the distance
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from the source as well as the amount and type of material between the source and the
skin.
Statistical analysis of output file
Similar to the male MAX lung phantom, the tally-four fluence analysis for each
simulated detector, setup in accordance with chapter VII provided a random behavior for
the mean. The desired relative error should be less than 0.10 and the observed relative
error was 0.02. The desired and observed relative errors decreased according to the
inverse of the square root of the number of histories. The desired variance of the
variance should be less than 0.10 and the observed VoV was 0.00. The figure of merit
value was constant and the behavior was random. The probability density function (pdf)
desired should be greater than three, the observed pdf was 6.63. The tally-four fluence
passed all 10 statistical checks. Out of 10 tally-four bins, no bins had a zero value and
no bins contained relative errors greater than 0.10. The second 1.33 MeV photon
simulation provided similar results with the exception of the pdf where the observed
value was 10.00.
The tally-six dose analysis for each tissue showed a random behavior for the
mean. The desired relative error was less than 0.10 and the observed relative error was
0.00 for both the 1.17 MeV and 1.33 MeV photons. The desired and observed relative
errors decreased according to the inverse of the square root of the number of histories.
The desired variance of the variance was less than 0.10 and the observed VoV was 0.00.
The figure of merit value was constant and the behavior was random. The desired
probability density function (pdf) should be greater than 3.00 and the observed value
was 8.67 for the lower-photon and 6.71 for the higher-photon. The tally-six dose passed
all 10 statistical checks. Out of 61 tally-six bins, no bin had a zero value and only 5 bins
contained relative errors greater than 0.10.
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Co-60 organ dose profile
A Co-60 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 1.39 x 10-4 MeV/g for the trachea and a low of 1.35 x
10-8 MeV/g for the skin. This organ dose contribution is the sum of two photons emitted
from Co-60 that occur with a yield of about 100 percent. Figure 12.1 provides a
simulated 3-dimensional view of the human body with a color profile that shows the
organ dose for the 1.33 MeV photon of Co-60. The color bar units to the right of the
phantom are in MeV/organ weight in grams. Each axis is represented in the figure along
with a color bar that indicates the organ dose in MeV/g provided by the MCNPX output
file. In the MCNPX output file, the trachea receives a slightly lesser dose than the lung
based upon the number of voxels versus the measured gram weight of the trachea. The
phantom includes the airway as part of the trachea. The dose difference is not
significant.
Cs-137 organ dose profile
A Cs-137 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 4.14 x 10-5 MeV/g for the trachea and a low of 3.73 x
10-9 MeV/g for the skin. This organ dose contribution is from a 0.66 MeV photon
emitted from Cs-137 that occurs with a yield of about 86 percent. Table 12.2 provides
the dose output to the selected organs from 0.66 MeV photon.
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Fig. 12.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within the female lung.
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Table 12.2. Organ doses for a Cs-137 volume source in the female lung.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 2.07E-04 4.47E-12 5.09E-02 1.05E-05 2830 3.73E-09 5.97E-19
Rib Bone Group 1.77E-01 7.51E-09 6.58E-02 1.16E-02 2167 5.36E-06 8.59E-16
Small Int 2.38E-02 1.78E-08 4.81E-02 1.14E-03 640 1.78E-06 2.86E-16
Breasts 2.18E-03 4.64E-08 4.85E-02 1.06E-04 26 4.07E-06 6.52E-16
Thyroid 2.37E-03 9.37E-08 4.90E-02 1.16E-04 19.6 5.93E-06 9.50E-16
Ovaries 9.45E-05 1.86E-08 4.90E-02 4.63E-06 16 2.89E-07 4.63E-17
Lung 2.49E+00 2.11E-08 1.21E-02 3.02E-02 999 3.02E-05 4.84E-15
Eyes 1.76E-04 3.29E-08 4.90E-02 8.63E-06 15 5.75E-07 9.22E-17
Trachea 8.46E-03 3.73E-07 4.90E-02 4.14E-04 10 4.14E-05 6.64E-15
Colon 2.24E-02 2.29E-08 4.90E-02 1.10E-03 369 2.97E-06 4.76E-16
Stomach 5.18E-02 1.12E-07 4.90E-02 2.54E-03 150 1.69E-05 2.71E-15
As expected, the dose to the selected organs is similar to the dose produced by
the Co-60 photons. The largest dose concentration remains in the immediate vicinity of
the lung. The lung dose is reduced by approximately 25%. All organs reflect a similar
reduction in dose. Compared with the male Cs-137 lung source, the female dose is
slightly lower in all organs with the exception of the skin. This difference is attributed to
the reduction in the number of skin voxels without reducing the organ mass of the skin.
Statistical checks on the Cs-137 Dose output file were performed. The same warnings
present with Co-60 were observed. The 10 statistical checks for tally-four passed and
produced similar results. The 10 statistical checks for tally-six passed and produced
similar results as with Co-60. Of the 61 tally bins, 5 bins had relative errors exceeding
0.10. Figure 12.2 provides a simulated 3-dimensional view of the human body with a
color profile that shows the MCNP dose for the single photon of Cs-137. The color bar
units to the right of the phantom are in MeV/organ weight in grams.
The Co-60 lung dose was 1.02 x 10-4 MeV/g for the 1.17 MeV photon compared
with the Cs-137 lung dose of 3.02 x 10-5 MeV/g for the 0.66 MeV photon. As expected,
the dose profile is similar to that of the photons emitted by Co-60. As expected, the dose
to each individual organ is proportionally reduced based on the lower-energy of the
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source photon and the energy dependent stopping power of the material within the
phantom.
Ir-192 organ dose profile
An Ir-192 source located within the lung would deliver a dose to the 11 selected
organs that ranges from a high of 5.10 x 10-5 MeV/g for the trachea and a low of 4.37 x
10-9 MeV/g for the skin. This organ dose is the sum of two photons with energies of
0.47 MeV and 0.32 MeV along with two electrons that have maximum energies of 0.66
MeV and 0.54 MeV. All four emissions are produced with a yield of 26.2%, 22.4%,
10.1% and 6.7%, respectively. Table 12.3 provides the calculated dose conversions for
each of the selected organs.
Table 12.3. Organ doses for an Ir-192 volume source in the female lung.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 2.43E-04 1.67E-10 5.09E-02 1.24E-05 2830 4.37E-09 7.00E-19
Rib Bone Group 2.26E-01 2.37E-07 6.58E-02 1.49E-02 2167 6.85E-06 1.10E-15
Small Int 2.75E-02 5.48E-07 4.81E-02 1.32E-03 640 2.07E-06 3.31E-16
Breasts 2.63E-03 1.54E-06 4.85E-02 1.28E-04 26 4.91E-06 7.86E-16
Thyroid 2.71E-03 2.91E-06 4.90E-02 1.33E-04 19.6 6.78E-06 1.09E-15
Ovaries 1.06E-04 6.95E-07 4.90E-02 5.21E-06 16 3.26E-07 5.22E-17
Lung 3.07E+00 5.56E-07 1.21E-02 3.73E-02 999 3.73E-05 5.97E-15
Eyes 1.82E-04 1.10E-06 4.90E-02 8.94E-06 15 5.96E-07 9.55E-17
Trachea 1.04E-02 1.07E-05 4.90E-02 5.09E-04 10 5.09E-05 8.16E-15
Colon 2.57E-02 6.42E-07 4.90E-02 1.26E-03 369 3.41E-06 5.47E-16
Stomach 6.35E-02 3.01E-06 4.90E-02 3.11E-03 150 2.07E-05 3.32E-15
As expected with the male phantom, the organ dose was driven by the two
photons over the two electrons by a factor of 100 or greater. Compared to the Co-60 and
Cs-137 organ dose, the most sensitive organs for Ir-192 were the lung, trachea and
stomach. The dose to the lung is slightly greater than the Cs-137 lung dose. The sum of
the two Ir-192 photons is comparable to the energy of the single Cs-137 photon.
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Fig. 12.2. Three-dimensional human dose profile from a Cs-137 photon source located
within the lung.
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Statistical checks on the Ir-192 Dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, 5 bins had
relative errors exceeding 0.10 for the 0.47 MeV photon. The 0.32 MeV photon
produced similar results.
The tallies for the electron sources in the lung had to be evaluated in a slightly
different manner based on their inability to penetrate uniformly throughout the phantom.
Secondary emissions, such as bremsstrahlung and characteristics x rays and electrons
were the primary radiation source for organs outside of the lung. Two of the 10
statistical checks did not pass. The relative error for electron simulation was 0.17 and
the pdf was 0. This reflects a large number of zero doses and slightly greater than zero
doses based on the volume electron source in the lung. For the electron source, only the
selected organs were reviewed for their relative error.
Figures 12.3 and 12.4 provide a simulated 3-dimensional view of the human
body with a color profile that equates to the MCNP dose for the 0.47 MeV photon of Ir-
192 and the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The
color bar units to the right of the phantom are in MeV/organ weight in grams.
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Fig. 12.3. Three-dimensional human dose profile from a 0.47 MeV Ir-192 photon
source located within the lung.
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Fig. 12.4. Three-dimensional human dose profile from a 0.66 MeV Ir-192 electron
source located within the lung.
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Sr-90 organ dose profile
A Sr-90 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 2.65 x 10-7 MeV/g for the lung and a low of 6.34 x 10-
12 MeV/g for the skin. This organ dose contribution is from a single beta particle with a
maximum energy of 0.55 MeV. The beta particle is produced with a yield of about
100%. Table 12.4 provides the calculated dose conversions for each of the selected
organs that will be considered in this problem.
Table 12.4. Organ doses from a Sr-90 volume source in the female lung.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 3.54E-07 1.21E-13 5.09E-02 1.80E-08 2830 6.36E-12 1.02E-21
Rib Bone Group 1.10E-03 5.70E-10 6.58E-02 7.23E-05 2167 3.34E-08 5.34E-18
Small Int 2.60E-05 2.58E-10 4.81E-02 1.25E-06 640 1.95E-09 3.12E-19
Breasts 4.78E-06 1.27E-09 4.85E-02 2.32E-07 26 8.91E-09 1.43E-18
Thyroid 3.75E-06 2.02E-09 4.90E-02 1.84E-07 19.6 9.37E-09 1.50E-18
Ovaries 0.00E+00 0.00E+00 4.90E-02 0.00E+00 16 0.00E+00 0.00E+00
Lung 2.18E-02 1.88E-09 1.21E-02 2.65E-04 999 2.65E-07 4.24E-17
Eyes 3.51E-08 1.09E-10 4.90E-02 1.72E-09 15 1.15E-10 1.84E-20
Trachea 2.51E-05 1.14E-08 4.90E-02 1.23E-06 10 1.23E-07 1.97E-17
Colon 3.00E-05 3.87E-10 4.90E-02 1.47E-06 369 3.98E-09 6.38E-19
Stomach 1.26E-04 2.69E-09 4.90E-02 6.15E-06 150 4.10E-08 6.57E-18
As expected, the lung and trachea receive the greatest dose from a moderately
energetic beta particle source located within the lung. The stomach and thyroid, due to
their close proximity to the source organ, receive less than half the dose of the lung.
Statistical checks on the Sr-90 Dose output file were performed. The same warnings
present with Co-60 were observed. The 10 statistical checks for tally-four fluence
missed three of the 10 checks. The relative error was 0.22, VoV was 0.13 and increased
and the pdf was 0. The 10 statistical checks for tally-six dose passed. Of the 61 tally
bins, 9 bins had no dose and 25 bins had relative errors exceeding 0.10 for the 0.55 MeV
beta particle. Figure 12.5 provides a simulated 3-dimensional view of the human body
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with a color profile that equates to the MCNP dose for the beta radiation of Sr-90
absorbed by each organ. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
Y-90 organ dose profile
A Y-90 source located within the lung would deliver a dose to the selected
organs that ranges from a high of 1.52 x 10-6 MeV/g for the lung and a low of 1.06 x 10-
10 MeV/g for the skin. This organ dose contribution is from a single beta particle with a
maximum energy of 2.28MeV. The beta radiation is produced with a yield of about
100%. The energy dose and relative errors are provided in Table 12.5.
Table 12.5. Organ doses from a Y-90 volume source in the female lung.
Organs
MCNP Dose
(MeV/g-his)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g-his)
Organ Dose
(Gy/his)
Skin 5.07E-06 7.66E-13 5.09E-02 2.58E-07 2830 9.11E-11 1.46E-20
Rib Bone Group 2.77E-02 3.87E-09 6.58E-02 1.82E-03 2167 8.40E-07 1.35E-16
Gonads 3.14E-07 3.98E-10 4.85E-02 1.52E-08 37.1 4.11E-10 6.58E-20
Small Int 1.12E-03 3.61E-09 4.81E-02 5.36E-05 640 8.38E-08 1.34E-17
Rectum 7.12E-06 1.57E-09 4.90E-02 3.49E-07 63 5.53E-09 8.87E-19
Thyroid 2.48E-04 2.87E-08 4.90E-02 1.21E-05 19.6 6.19E-07 9.92E-17
Lung 1.44E-01 6.82E-09 1.21E-02 1.75E-03 999 1.75E-06 2.80E-16
Eyes 6.15E-06 6.41E-09 4.90E-02 3.01E-07 15 2.01E-08 3.22E-18
Trachea 6.99E-04 9.93E-08 4.90E-02 3.42E-05 10 3.42E-06 5.49E-16
Colon 7.12E-04 4.06E-09 4.90E-02 3.49E-05 369 9.45E-08 1.51E-17
Stomach 3.03E-03 1.90E-08 4.90E-02 1.48E-04 150 9.90E-07 1.59E-16
As with Sr-90, the lung and trachea received the highest dose from a highly-
energetic, beta particle source located within the lung. The stomach and thyroid, due to
their close proximity to the source organ, received approximately 50% of the dose to the
lung. The Y-90 lung dose was approximately 10 times greater than the dose delivered
by the Sr-90 beta particle even though the energy of the Y-90 beta particle was
approximately 4 times greater than the Sr-90. The difference in dose is attributed to the
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Fig. 12.5. Three-dimensional human dose profile from a Sr-90 beta source located
within the lung.
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difference in energy dependent stopping power as well as the energy and type of
secondary radiations. The female lung dose was slightly less than the male lung dose.
Statistical checks on the Y-90 dose output file were performed. The same warnings
present with Co-60 were observed. The 10 statistical checks for tally-four fluence
passed all checks except two. The VoV did not decrease at a rate of inverse the number
of histories and the pdf was 0. The 10 statistical checks for tally-six passed all but one
check. The figure of merit did not exhibit a random behavior. Of the 61 tally bins, one
bin had a zero dose and 21 bins had relative errors exceeding 0.10 for the 2.28 MeV beta
particle. Figure 12.6 provides a simulated 3-dimensional view of the human body with a
color profile that equates the MCNP organ dose for the an Y-90 source in the lung. The
color bar units to the right of the phantom are in MeV/organ weight in grams.
Results from lung volume source
Figure 12.7 provides a graph of all of the potential sources distributed in the lung
and their organ doses. As with the male phantom, the results of the observed simulations
indicate that Co-60 is the most limiting radionuclide. The trachea and lungs appear to be
the most sensitive organs based upon a single decay from a source located within the
lung. Even though the trachea shows the highest sensitivity, the dose is a little
deceiving. The observed dose for the trachea is based on the number of voxels which
include the air encircled by the trachea. The actual dose, based on the weight of the
organ, is less than that for the lung. Figure 12.8 shows a dose comparison between the
male and female phantoms for Co-60 and Sr-90.
Based on the data, the Co-60 dose from the male phantom appears to be slightly
more sensitive than the female phantom. The Thyroid shows the largest difference
between the two. The male dose is 5.26 x 10-5 MeV/g and for the female it is
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Fig. 12.6. Three-dimensional human dose profile from a Y-90 beta source located
within the female lung.
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Fig. 12.7. Summary graph of organ doses for the five potential lung sources.
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1.96 x 10-5 MeV/g. The stomach and trachea show a slightly smaller difference between
the two genders. This is probably due to the difference in volume since the mass
remains the same. The volume for the male thyroid is 18.89 cm3 and for the female it is
16.19 cm3.
Based on the Sr-90 data, the female leg bone is more sensitive than the male.
The male sensitivity holds for the thyroid, trachea and stomach with the largest
difference in the thyroid. The dose to leg bone for the female is 2.99 x 10-9 MeV/g and
that for the male is 2.15 x 10-10 MeV/g. A key thing to note is that both male and female
dose falls within the margin of error for the female dose. The same is true for the
trachea and stomach where both genders are within the margin of error.
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CHAPTER XIII
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCE IN THE STOMACH
Organ data verification
The number of source voxels for additional organs will be based on the ratio of
MAX lung source voxels divided by the total number of MAX lung voxels. This
fraction will than be multiplied by the total number of organ voxels to determine the
number of source voxels in the organ. The number of source voxels calculated for the
stomach were 1,295. This number would represent a volume source based on the
dimension of the stomach. Volumes and masses were checked against ICRU-46
established values for both simulations (ICRU 1990). Using the provided values from
Table A-2 of Appendix A, the hand calculated volume of stomach was 380.95 cm3, the
volume of a single voxel was 4.67 x 10-2 cm3 (Kramer 2003). According to figure A-1 of
Appendix A, the MCNPX code calculated a volume of 4.67E-2 cm3 for a single voxel.
The hand calculated mass of the stomach was 400 g and the mass per voxel was 4.89 x
10-2 g which includes the stomach and its contents. The stomach alone weighs 150 g and
the mass per voxel would be 1.83 x 10-2 g. Based on Figure A-1 of Appendix A, the
code calculated a mass of 4.90 x 10-2 g in a single voxel. Therefore, the phantom
stomach provided a good simulation that was representative of standard man.
Co-60 organ dose profile
A Co-60 source located within the stomach would deliver a dose to the selected
organs that ranges from a high of 1.33 x 10-03 MeV/g for the stomach and a low of 1.25 x
10-8 MeV/g for the skin. This organ dose contribution is the sum of two photons emitted
from Co-60 that occur with a yield of about100 percent. Table 13.1 provides the
calculated dose conversions for each of the selected organs that will be considered in this
problem.
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Table 13.1. Organ doses from a Co-60 volume source in the stomach.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 6.98E-04 3.01E-11 5.09E-02 3.55E-05 2830 1.25E-08 2.01E-18
Rib Bone Group 8.25E-01 2.75E-08 6.58E-02 5.43E-02 2167 2.50E-05 4.01E-15
Small Int 5.96E-01 3.67E-07 4.81E-02 2.86E-02 640 4.47E-05 7.17E-15
Gonads 4.75E-04 9.59E-08 4.85E-02 2.30E-05 37.1 6.21E-07 9.94E-17
Rectum 2.59E-03 1.32E-07 4.90E-02 1.27E-04 63 2.02E-06 3.23E-16
Thyroid 3.60E-03 4.30E-07 4.90E-02 1.76E-04 19.6 8.99E-06 1.44E-15
Lung 3.42E+00 1.50E-07 1.21E-02 4.15E-02 999 4.15E-05 6.66E-15
Eyes 3.65E-04 1.97E-07 4.90E-02 1.79E-05 15 1.19E-06 1.91E-16
Trachea 8.88E-03 1.76E-06 4.90E-02 4.35E-04 10 4.35E-05 6.97E-15
Colon 2.24E-01 3.03E-07 4.90E-02 1.10E-02 369 2.97E-05 4.76E-15
Stomach 4.08E+00 2.26E-06 4.90E-02 2.00E-01 150 1.33E-03 2.13E-13
As expected, the largest dose concentration was to the stomach. The small
intestine, colon, lung and trachea received the next highest doses, which is not surprising
due to their central location to the stomach. The dose to the skin is reduced by a factor
of 100,000. The assumption applied to the skin dose is that the dose is uniform across
the entire volume of skin. The actual skin dose is delivered on a gradient depending
upon the distance from the source as well as the amount and type of material between
the source and the skin.
Statistical analysis of output file
The tally-four fluence analysis for each simulated detector, setup in accordance
with chapter VII provided a random behavior for the mean. The desired relative error
should be less than 0.10 and the observed relative error was 0.05. The desired and
observed relative errors decreased according to the inverse of the square root of the
number of histories. The desired variance of the variance should be less than 0.10 and
the observed VoV was 0.01. The figure of merit value was constant and the behavior
was random. The probability density function (pdf) desired should be greater than three,
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the observed pdf was 10. The tally-four fluence passed all 10 statistical checks. Out of
10 tally-four bins, no bin had a zero dose value and no bins contained relative errors
greater than 0.10. The second 1.33 MeV photon simulation provided similar statistical
results.
The tally-six dose analysis for each material showed a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for both the 1.17 MeV and 1.33 MeV photons. The desired and observed
relative errors decreased in relation to the inverse of the square root of the number of
histories. The desired variance of the variance should be less than 0.10 and the observed
VoV was 0.00. The figure of merit value was constant and the behavior was random.
The desired probability density function (pdf) should be greater than 3.00 and the
observed value was 4.68 for the 1.17 MeV photon and 5.66 for the 1.33 MeV photon.
The tally-six dose passed all 10 statistical checks. Out of 61 tally-six bins, no bin had a
zero value and only 5 bins contained relative errors greater than 0.10.
Figure 13.1 provides a simulated 3-dimensional view of the human body with a
color profile that shows the organ dose for the 1.33 MeV photon of Co-60. The color
bar units to the right of the phantom are in MeV/organ weight in grams. Each axis is
represented in the figure along with a color bar that indicates the organ dose in MeV/g
provided by the MCNPX output file. In the MCNPX output file, the stomach receives
the highest dose followed by the small intestine. The dose to the stomach is over 13
times that of the small intestine. The lung and trachea are closely matched.
99
Fig. 13.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within the stomach.
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Cs-137 organ dose profile
A Cs-137 source located within the stomach would deliver a dose to the selected
organs that ranges from a high of 3.90 x 10-4 MeV/g for the stomach and a low of 3.37 x
10-9 MeV/g for the skin. This organ dose contribution is from a 0.66 MeV photon
emitted from Cs-137 that occur with a yield of about 86 percent. Table 13.2 provides
the dose output to the selected organs from the 0.66 MeV photon.
Table 13.2. Organ doses for a Cs-137 volume source in the stomach.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 1.87E-04 4.04E-12 5.09E-02 9.53E-06 2830 3.37E-09 5.40E-19
Rib Bone Group 2.47E-01 8.26E-09 6.58E-02 1.63E-02 2167 7.51E-06 1.20E-15
Small Int 1.73E-01 5.06E-08 4.81E-02 8.30E-03 640 1.30E-05 2.08E-15
Gonads 9.19E-05 1.06E-08 4.85E-02 4.46E-06 37.1 1.20E-07 1.93E-17
Rectum 5.72E-04 1.57E-08 4.90E-02 2.80E-05 63 4.44E-07 7.12E-17
Thyroid 1.04E-03 6.07E-08 4.90E-02 5.11E-05 19.6 2.60E-06 4.17E-16
Lung 1.01E+00 2.21E-08 1.21E-02 1.23E-02 999 1.23E-05 1.97E-15
Eyes 8.14E-05 2.46E-08 4.90E-02 3.99E-06 15 2.66E-07 4.26E-17
Trachea 2.61E-03 2.46E-07 4.90E-02 1.28E-04 10 1.28E-05 2.05E-15
Colon 6.36E-02 4.22E-08 4.90E-02 3.11E-03 369 8.44E-06 1.35E-15
Stomach 1.20E+00 3.12E-07 4.90E-02 5.86E-02 150 3.90E-04 6.25E-14
As expected, the dose to the selected organs is similar to the dose produced by
the Co-60 photons. The largest dose concentration remains among the organs in the
immediate vicinity of the stomach. The stomach dose is reduced by an approximate
factor of two. This reduction is expected based on the energy reduction between the
1.17 MeV Co-60 photon and the 0.66 MeV photon from Cs-137.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, no bin had a
zero dose and 9 bins had relative errors exceeding 0.10. Figure 13.2 provides a
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simulated 3-dimensional view of the human body with a color profile that shows the
MCNP dose for the single photon of Cs-137 absorbed by each organ. The color bar
units to the right of the phantom are in MeV/organ weight in grams.
The Co-60 stomach dose was 6.33 x 10-4 MeV/g for the 1.17 MeV photon
compared with the Cs-137 stomach dose of 3.90 x 10-4 MeV/g for the 0.66 MeV photon.
As expected, the dose profile is similar to that of the photons emitted by Co-60. The
dose to each individual organ is proportionally reduced based on the lower-energy of the
source photon and the energy dependent stopping power of the material within the
phantom.
Ir-192 organ dose profile
An Ir-192 source located within the stomach would deliver a dose to the selected
organs that ranges from a high of 4.79 x 10-04 MeV/g for the stomach and a low of 3.89 x
10-9 MeV/g for the skin. This organ dose is the sum of two photons with energies of
0.47 MeV and 0.32 MeV along with two electrons with maximum energies of 0.66 MeV
and 0.54 MeV. All four emissions are produced with a yield of 26.2%, 22.4%, 10.1%
and 6.7%, respectively. Table 13.3 provides the calculated dose conversions for each of
the selected organs.
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Fig. 13.2. Three-dimensional human dose profile from a Cs-137 photon source located
within the stomach.
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Table 13.3. Organ doses for an Ir-192 volume source in the stomach.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 2.16E-04 1.73E-10 5.09E-02 1.10E-05 2830 3.89E-09 6.23E-19
Rib Bone Group 3.27E-01 1.09E-08 6.58E-02 2.15E-02 2167 9.93E-06 1.59E-15
Small Int 2.15E-01 1.55E-06 4.81E-02 1.03E-02 640 1.62E-05 2.59E-15
Gonads 7.83E-05 1.01E-07 4.85E-02 3.80E-06 37.1 1.02E-07 1.64E-17
Rectum 5.97E-04 5.84E-07 4.90E-02 2.93E-05 63 4.64E-07 7.44E-17
Thyroid 1.34E-03 1.77E-06 4.90E-02 6.55E-05 19.6 3.34E-06 5.35E-16
Lung 1.27E+00 6.94E-07 1.21E-02 1.54E-02 999 1.54E-05 2.46E-15
Eyes 8.72E-05 5.44E-08 4.90E-02 4.27E-06 15 2.85E-07 4.56E-17
Trachea 3.33E-03 6.52E-06 4.90E-02 1.63E-04 10 1.63E-05 2.61E-15
Colon 7.82E-02 1.28E-06 4.90E-02 3.83E-03 369 1.04E-05 1.66E-15
Stomach 1.47E+00 7.52E-06 4.90E-02 7.18E-02 150 4.79E-04 7.67E-14
As expected, the organ dose was driven by the two photons over the two
electrons by a factor of 100 or greater. Compared to the Co-60 and Cs-137 organ dose,
the most sensitive organs for Ir-192 were the stomach, small intestine, lung, trachea and
colon. The dose to the stomach is slightly greater than the Cs-137 stomach dose. The
sum of the two Ir-192 photons dose is comparable to the dose from the energy of the Cs-
137 photon.
Statistical checks on the Ir-192 Dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, no bins
contained a zero dose and 10 bins had relative errors exceeding 0.10 for the 0.47 MeV
photon. The 0.32 MeV photon produced similar results with the exception that the testes
did not exceed the relative error of 0.10.
The tallies for the electron sources in the stomach had to be evaluated in a
slightly different manner based on their lack of ability to penetrate uniformly throughout
the phantom. Secondary emissions, such as bremsstrahlung and characteristics x rays
and delta rays were the primary radiation source for organs outside of the stomach.
Three of the 10 statistical checks did not pass. The relative error was 0.49, the VoV was
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0.30 and the pdf was 0. This reflects a large number of zero doses and slightly greater
than zero doses based on the volume electron source in the stomach. For the electron
source, only the selected organs were reviewed for their relative error.
Figures 13.3 and 13.4 provide a simulated 3 dimensional view of the human body
with a color profile that equates to the MCNP dose for the 0.47 MeV photon of Ir-192
and the 0.66 MeV of Ir-192 absorbed by each organ, respectively. The color bar units to
the right of the phantom are in MeV/organ weight in grams.
Sr-90 organ dose profile
A Sr-90 source located within the stomach would deliver a dose to the selected
organs that ranges from a high of 2.21 x 10-6 MeV/g for the stomach and a low of 4.06 x
10-12 MeV/g for the skin. This organ dose contribution is from a single beta radiation
with a maximum energy of 0.55 MeV. The beta radiation is produced with a yield of
about 100%. Table 13.4 provides the calculated dose conversions for each of the
selected organs that will be considered in this problem.
Table 13.4. Organ doses from a Sr-90 volume source in the stomach.
Organs
MCNP
Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 2.26E-07 8.98E-14 5.09E-02 1.15E-08 2830 4.06E-12 6.51E-22
Rib Bone Group 1.06E-03 3.53E-11 6.58E-02 6.96E-05 2167 3.21E-08 5.14E-18
Small Int 3.03E-04 1.00E-09 4.81E-02 1.46E-05 640 2.28E-08 3.65E-18
Gonads 0.00E+00 0.00E+00 4.85E-02 0.00E+00 37.1 0.00E+00 0.00E+00
Rectum 5.81E-07 2.02E-10 4.90E-02 2.85E-08 63 4.52E-10 7.24E-20
Thyroid 1.91E-06 1.46E-09 4.90E-02 9.38E-08 19.6 4.78E-09 7.66E-19
Lung 2.34E-03 6.22E-10 1.21E-02 2.84E-05 999 2.84E-08 4.55E-18
Eyes 0.00E+00 0.00E+00 4.90E-02 0.00E+00 15 0.00E+00 0.00E+00
Trachea 4.52E-06 4.89E-09 4.90E-02 2.21E-07 10 2.21E-08 3.55E-18
Colon 1.12E-04 9.40E-10 4.90E-02 5.47E-06 369 1.48E-08 2.38E-18
Stomach 6.78E-03 1.66E-08 4.90E-02 3.32E-04 150 2.21E-06 3.55E-16
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Fig. 13.3. Three-dimensional human dose profile from the 0.47 MeV Ir-192 photon
source located within the stomach.
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Fig. 13.4. Three-dimensional human dose profile from the 0.66 MeV Ir-192 electron
source located within the stomach.
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As expected, the stomach received the greatest dose from a moderately energetic
beta radiation source located within the stomach. The lung, small intestine and colon
received a dose that was 100 times smaller than the dose to the stomach.
Statistical checks on the Sr-90 dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence missed three of the 10 checks. The relative error was 0.38, VoV was 0.25 and
the pdf was 0. The 10 statistical checks for tally-six passed. Of the 61 tally bins, 11 bins
had a zero dose and 27 bins had relative errors exceeding 0.10 for the 0.55 MeV beta
radiation. Figure 13.5 provides a simulated 3-dimensional view of the human body with
a color profile that shows the MCNP dose for the beta radiation of Sr-90 absorbed by
each organ. The color bar units to the right of the phantom are in MeV/organ weight in
grams.
Y-90 organ dose profile
A Y-90 source located within the stomach would deliver a dose to the selected
organs that ranges from a high of 1.70 x 10-5 MeV/g for the stomach and a low of 9.00 x
10-11 MeV/g for the skin. This organ dose contribution is from a single beta radiation
with a maximum energy of 2.28 MeV. The beta radiation is produced with a yield of
about 100%. The energy dose and relative errors are provided in Table 13.5.
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Fig. 13.5. Three-dimensional human dose profile from a Sr-90 beta source located
within the stomach.
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Table 13.5. Organ doses from a Y-90 volume source in the stomach.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 5.01E-06 7.65E-13 5.09E-02 2.55E-07 2830 9.00E-11 1.44E-20
Rib Bone Group 1.18E-02 3.95E-10 6.58E-02 7.78E-04 2167 3.59E-07 5.75E-17
Small Int 5.36E-03 7.60E-09 4.81E-02 2.57E-04 640 4.02E-07 6.44E-17
Gonads 8.63E-07 5.29E-10 4.85E-02 4.19E-08 37.1 1.13E-09 1.81E-19
Rectum 1.74E-05 2.77E-09 4.90E-02 8.50E-07 63 1.35E-08 2.16E-18
Thyroid 3.29E-05 8.47E-09 4.90E-02 1.61E-06 19.6 8.24E-08 1.32E-17
Lung 3.45E-02 3.68E-09 1.21E-02 4.18E-04 999 4.19E-07 6.71E-17
Eyes 9.38E-07 1.28E-09 4.90E-02 4.59E-08 15 3.06E-09 4.91E-19
Trachea 7.90E-05 3.22E-08 4.90E-02 3.87E-06 10 3.87E-07 6.20E-17
Colon 1.82E-03 5.76E-09 4.90E-02 8.90E-05 369 2.41E-07 3.86E-17
Stomach 5.22E-02 7.33E-08 4.90E-02 2.56E-03 150 1.70E-05 2.73E-15
As with Sr-90, the stomach received the highest dose from a highly-energetic,
beta radiation source located within the stomach. The small intestine, trachea, lung and
colon, due to their close proximity to the source organ, received approximately one
percent of the dose absorbed by the stomach. The Y-90 stomach dose was
approximately 10 times greater than the dose delivered by the Sr-90 beta radiation even
though the energy of the Y-90 beta radiation was approximately 4 times greater than the
Sr-90. The difference in dose is attributed to the difference in energy dependent
stopping power as well as the energy and type of secondary radiations.
Statistical checks on the Y-90 Dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all but two checks. The relative error was 0.16 and the pdf was 0. The
10 statistical checks for tally-six dose passed. Of the 61 tally bins, no bins had a zero
dose and 33 bins had relative errors exceeding 0.10 for the 2.28 MeV beta radiation.
Figure 13.6 provides a simulated 3-dimensional view of the human body with a color
profile that shows the MCNP organ dose for an Y-90 source in the stomach. The color
bar units to the right of the phantom are in MeV/organ weight in grams.
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Fig. 13.6. Three-dimensional human dose profile from a Y-90 beta source located
within the stomach.
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Results from stomach volume source
Figure 13.7 provides a graph of all of the potential sources distributed in the
stomach and their organ doses. Based upon the results of the observed programs, Co-60
is the most limiting radionuclide. The stomach and lungs appear to be the most sensitive
organs based upon a single decay from a source located within the stomach. Even
though the trachea shows a higher sensitivity than the lung, the dose is a little deceiving.
The observed dose for the trachea is based on the number of voxels which include the air
encircled by the trachea. The actual dose, based on the weight of the organ, is less than
the dose for the lung. The dose to all of the selected organs from Sr-90 and Y-90
appears to be almost 100 times lower than the other three radionuclides. Ir-192 and Cs-
137 appear to deliver an almost identical dose to the selected organs.
112
1.00E-12
1.00E-11
1.00E-10
1.00E-09
1.00E-08
1.00E-07
1.00E-06
1.00E-05
1.00E-04
1.00E-03
1.00E-02
1.00E-01
1.00E+00
Skin Rib Bone
Group
Small Int Gonads Rectum Thyroid Lung Eyes Trachea Colon Stomach
ORGANS
D
os
e
(M
eV
/g
)
Cs-137 Sr-90 Y-90 Co-60 Ir-192
Fig. 13.7. Summary graph of organ doses for the five potential stomach sources.
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CHAPTER XIV
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCE IN THE COLON
Organ data verification
The number of source voxels for additional organs will be based on the ratio of
MAX lung source voxels divided by the total number of MAX lung voxels. This
fraction will than be multiplied by the total number of organ voxels to determine the
number of source voxels in the organ. Based on the lung fraction, the number of sources
calculated for the colon was 2,379. This number would represent a volume source based
on the dimension of the colon. Volumes and masses were checked against ICRU-46
established values for both simulations (ICRU 1990). Using the values from Table A-2
of Appendix A, the hand calculated colon volume was 578.11 cm3, the volume of a
single voxel was 4.67 x 10-2 cm3 (Kramer 2003). According to figure A-1 of Appendix
A, the MCNPX code calculated a volume of 4.67 x 10-2 cm3 for a single voxel. The
hand calculated mass of the colon was 590 g and the mass per voxel was 4.76 x 10-2 g
which includes the stomach and its contents. The stomach alone weighs 370g and the
mass per voxel would be 2.99 x 10-2g. Based on Figure A-1 of Appendix A, the code
calculated a mass of 4.90 x 10-2 g in a single voxel. Therefore, the phantom colon
provided a good simulation that was representative of standard man.
Co-60 organ dose profile
A Co-60 source located within the colon would deliver a dose to the selected
organs that ranges from a high of 4.81 x 10-4 MeV/g for the colon and a low of 1.22 x 10-
8 MeV/g for the skin. This organ dose contribution is the sum of two photons emitted
from Co-60 that occur with a yield of about 100 percent. Table 14.1 provides the
calculated dose conversions for each of the selected organs that will be considered in this
problem.
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Table 14.1. Organ doses from a Co-60 volume source in the colon.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ
Wt (g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 3.19E-04 6.89E-12 5.09E-02 1.62E-05 2830 5.74E-09 9.20E-19
Rib Bone Group 1.43E-01 1.17E-08 6.58E-02 9.39E-03 2167 4.33E-06 6.94E-16
Small Int 6.70E-01 1.21E-07 4.81E-02 3.22E-02 640 5.03E-05 8.06E-15
Gonads 1.02E-03 4.82E-08 4.85E-02 4.97E-05 37.1 1.34E-06 2.15E-16
Rectum 1.13E-02 1.00E-07 4.90E-02 5.53E-04 63 8.78E-06 1.41E-15
Thyroid 5.41E-04 5.60E-08 4.90E-02 2.65E-05 19.6 1.35E-06 2.17E-16
Lung 3.12E-01 1.67E-08 1.21E-02 3.78E-03 999 3.79E-06 6.07E-16
Eyes 8.05E-05 3.35E-08 4.90E-02 3.94E-06 15 2.63E-07 4.21E-17
Trachea 1.28E-03 2.36E-07 4.90E-02 6.27E-05 10 6.27E-06 1.00E-15
Colon 1.72E+00 2.06E-07 4.90E-02 8.45E-02 369 2.29E-04 3.67E-14
Stomach 6.84E-02 1.43E-07 4.90E-02 3.35E-03 150 2.23E-05 3.58E-15
As expected, the largest dose concentration is to the organs in the immediate
vicinity of the colon which includes the small intestine and stomach. The dose to the
skin is smaller than the dose to the colon by a factor of 10,000. The assumption applied
to the skin dose is that the dose is uniform across the entire volume of skin. The actual
skin dose is delivered on a gradient depending upon the distance from the source as well
as the amount and type of material between the source and the skin.
Statistical analysis of output file
The tally-four fluence analysis for each detector setup, as described in chapter
VII, provided a random behavior for the mean. The desired relative error should be less
than 0.10 and the observed relative error was 0.08. The desired and observed relative
errors decreased according to the inverse of the square root of the number of histories.
The desired variance of the variance should be less than 0.10 and the observed VoV was
0.02. The figure of merit value was constant and the behavior was random. The
probability density function (pdf) desired should be greater than three, the observed pdf
value was 0. There was insufficient tfc bin tally information to estimate the large tally
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slope reliably. The tally-four fluence passed all 10 statistical checks except the pdf. Out
of 10 tally-four bins, one had a zero value and no bins contained relative errors greater
than 0.10. The second 1.33 MeV photon simulation provided similar results.
The tally-six dose analysis for each material showed a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for both photons. The desired and observed relative error decreased at a rate
of inverse square root of the number of histories. The desired variance of the variance
should be less than 0.10 and the observed VoV was 0.00. The figure of merit value was
constant and the behavior was random. The desired probability density function (pdf)
should be greater than 3.00 and the observed value was 10.0 for both photons. The tally-
six dose passed all 10 statistical checks. Out of 61 tally-six bins, no bin had a zero value
and only 11 bins contained relative errors greater than 0.10.
Figure 14.1 provides a simulated 3-dimensional view of the human body with a
color profile that equates to the organ dose for the 1.33 MeV photon of Co-60. The
color bar units to the right of the phantom are in MeV/organ weight in grams. Each axis
is represented in the figure along with a color bar that indicates the organ dose in MeV/g
provided by the MCNPX output file. In the MCNPX output file, the colon receives the
highest dose followed by the small intestine. The dose to the colon is roughly 5 times
that of the small intestine. The stomach and trachea are closely matched.
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Fig. 14.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within the colon.
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Cs-137 organ dose profile
A Cs-137 source located within the colon would deliver a dose to the selected
organs that ranges from a high of 1.42 x 10-4 MeV/g for the colon and a low of 3.25 x 10-
9 MeV/g for the skin. This organ dose contribution is from 0.66 MeV photon emitted
from Cs-137 that occurs with a yield of about 86 percent. Table 14.2 provides the dose
output to the selected organs from the 0.66 MeV photon.
Table 14.2. Organ doses for a Cs-137 volume source in the colon.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ
Wt (g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 3.59E-04 7.75E-12 5.09E-02 1.83E-05 2830 6.46E-09 1.03E-18
Rib Bone Group 1.59E-01 1.30E-08 6.58E-02 1.05E-02 2167 4.83E-06 7.73E-16
Small Int 7.40E-01 1.33E-07 4.81E-02 3.55E-02 640 5.55E-05 8.90E-15
Gonads 1.19E-03 5.50E-08 4.85E-02 5.78E-05 37.1 1.56E-06 2.50E-16
Rectum 1.25E-02 1.11E-07 4.90E-02 6.12E-04 63 9.72E-06 1.56E-15
Thyroid 5.92E-04 6.23E-08 4.90E-02 2.90E-05 19.6 1.48E-06 2.37E-16
Lung 3.49E-01 1.86E-08 1.21E-02 4.23E-03 999 4.24E-06 6.79E-16
Eyes 1.02E-04 4.10E-08 4.90E-02 5.02E-06 15 3.35E-07 5.36E-17
Trachea 1.37E-03 2.59E-07 4.90E-02 6.70E-05 10 6.70E-06 1.07E-15
Colon 1.90E+00 2.27E-07 4.90E-02 9.31E-02 369 2.52E-04 4.04E-14
Stomach 7.63E-02 1.59E-07 4.90E-02 3.74E-03 150 2.49E-05 3.99E-15
As expected, the dose to the selected organs is similar to the dose produced by
the Co-60 photons. The largest dose concentration remains with organs in the
immediate vicinity of the colon. The colon dose from Cs-137 is reduced by
approximately a factor of two compared to the colon dose from the 1.17 MeV photon
from Co-60. This reduction is expected based on the energy reduction between the low-
energy Co-60 photon and that of Cs-137.
Statistical checks were performed on the Cs-137 Dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed with the exception of the pdf. There was insufficient tfc bin tally
information to estimate the large tally slope reliably. The 10 statistical checks for tally-
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six dose passed and produced similar results as with Co-60. Of the 61 tally bins, no bins
contained zero dose and 11 bins had relative errors exceeding 0.10. Figure 11.2 provides
a simulated 3-dimensional view of the human body with a color profile that shows the
MCNP dose for the single photon of Cs-137. The color bar units to the right of the
phantom are in MeV/organ weight in grams.
The Co-60 colon dose was 2.29 x 10-4 MeV/g for the 1.17 MeV photon compared
with the Cs-137 colon dose of 1.42 x 10-4 MeV/g for the 0.66 MeV photon. As
expected, the dose profile is similar to that of the photons emitted by Co-60. The dose to
each individual organ is proportionally reduced based on the lower-energy of the source
photon and the energy dependent stopping power of the material within the phantom.
Ir-192 organ dose profile
An Ir-192 source located within the colon would deliver a dose to the selected
organs that ranges from a high of 7.38 x 10-5 MeV/g for the colon and a low of 3.03 x 10-
9 MeV/g for the skin. This organ dose contribution is the sum of two photons with
energies of 0.47 MeV and 0.32 MeV along with two electrons with maximum energies
of 0.66 MeV and 0.54 MeV. All four emissions are produced with a yield of 26.2%,
22.4%, 10.1% and 6.7%, respectively. Table 14.3 provides the calculated dose
conversions for each of the selected organs.
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Fig. 14.2. Three-dimensional human dose profile from a Cs-137 photon source located
within the colon.
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Table 14.3. Organ doses for an Ir-192 volume source in the colon.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ
Wt (g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 8.69E-05 1.87E-12 5.09E-02 4.42E-06 2830 1.56E-09 2.50E-19
Rib Bone Group 2.51E-01 8.37E-09 6.58E-02 1.65E-02 2167 7.60E-06 1.22E-15
Small Int 3.04E-01 5.26E-08 4.81E-02 1.46E-02 640 2.29E-05 3.66E-15
Gonads 1.03E-05 2.15E-09 4.85E-02 5.01E-07 37.1 1.35E-08 2.16E-18
Rectum 8.84E-05 4.27E-09 4.90E-02 4.33E-06 63 6.87E-08 1.10E-17
Thyroid 3.22E-03 8.54E-08 4.90E-02 1.58E-04 19.6 8.06E-06 1.29E-15
Lung 1.48E+00 1.26E-08 1.21E-02 1.79E-02 999 1.80E-05 2.88E-15
Eyes 6.85E-05 1.49E-08 4.90E-02 3.36E-06 15 2.24E-07 3.58E-17
Trachea 7.87E-03 2.81E-07 4.90E-02 3.86E-04 10 3.86E-05 6.18E-15
Colon 1.24E-02 1.30E-08 4.90E-02 6.09E-04 369 1.65E-06 2.65E-16
Stomach 4.70E-02 6.29E-08 4.90E-02 2.30E-03 150 1.53E-05 2.46E-15
As expected, the organ dose was driven by the two photons over the two
electrons by a factor of 100 or greater. Compared to the Co-60 and Cs-137 organ dose,
the most sensitive organs for Ir-192 were the colon, small intestine and trachea. The
dose to the colon is slightly less than the dose to the colon from Cs-137. The sum of the
two Ir-192 photons is comparable to the energy of the single 0.66 MeV Cs-137 photon.
Statistical checks on the Ir-192 photon dose output file were performed. The
same warnings present with Co-60 were observed. The 10 statistical checks for tally-
four fluence passed with the exception of the pdf. There was insufficient tfc bin tally
information to estimate the large tally slope reliably. The 10 statistical checks for tally-
six dose passed and produced similar results as with Co-60. Of the 61 tally bins, no bins
contained a zero dose result and 11 bins had relative errors exceeding 0.10 for the 0.32
MeV photon. The 0.47 MeV photon produced similar results.
The tallies for the electron sources in the colon had to be evaluated in a slightly
different manner based on their inability to penetrate throughout the entire phantom.
Secondary emissions, such as bremsstrahlung and characteristics x rays were the primary
radiation source for organs outside of the colon. All of the 10 tally-four fluence
statistical checks passed. The relative error was 0.02, the VoV was 0.01 and the pdf was
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7.50. In the case of an electron source, only the selected organs were reviewed for their
relative error.
Figures 14.3 and 14.4 provide a simulated 3-dimensional view of the human
body with a color profile that shows the MCNP dose for the 0.47 MeV photon of Ir-192
and the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The color
bar units to the right of the phantom are in MeV/organ weight in grams.
Sr-90 organ dose profile
A Sr-90 source located within the colon would deliver a dose to the selected
organs that ranges from a high of 3.31 x 10-4 MeV/g for the colon and a low of 4.35 x 10-
12 MeV/g for the skin. This organ dose contribution is from a single beta radiation with a
maximum energy of 0.55 MeV. The beta radiation is produced with a yield of about
100%. Table 14.4 provides the calculated dose conversions for each of the selected
organs that will be considered in this problem.
Table 14.4. Organ doses from a Sr-90 volume source in the colon.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ
Wt (g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 3.72E-07 1.27E-13 5.09E-02 1.89E-08 2830 6.69E-12 1.07E-21
Rib Bone Group 3.85E-04 3.81E-10 6.58E-02 2.53E-05 2167 1.17E-08 1.87E-18
Small Int 1.42E-03 2.22E-09 4.81E-02 6.84E-05 640 1.07E-07 1.71E-17
Gonads 9.17E-07 5.23E-10 4.85E-02 4.45E-08 37.1 1.20E-09 1.92E-19
Rectum 1.77E-05 1.64E-09 4.90E-02 8.65E-07 63 1.37E-08 2.20E-18
Thyroid 2.02E-07 3.47E-10 4.90E-02 9.90E-09 19.6 5.05E-10 8.09E-20
Lung 3.45E-04 2.41E-10 1.21E-02 4.19E-06 999 4.19E-09 6.71E-19
Eyes 0.00E+00 0.00E+00 4.90E-02 0.00E+00 15 0.00E+00 0.00E+00
Trachea 2.39E-06 3.99E-09 4.90E-02 1.17E-07 10 1.17E-08 1.88E-18
Colon 8.81E-03 7.72E-09 4.90E-02 4.31E-04 369 1.17E-06 1.87E-16
Stomach 9.94E-05 2.19E-09 4.90E-02 4.87E-06 150 3.25E-08 5.20E-18
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Fig. 14.3. Three-dimensional human dose profile from the 0.47 MeV Ir-192 photon
source located within the colon.
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Fig. 14.4. Three-dimensional human dose profile from the 0.66 MeV Ir-192 beta
source located within the colon.
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As expected, the colon and small intestine received the greatest dose from a
moderately energetic beta radiation source located within the colon. The stomach, due
to its close proximity to the source organ received a smaller dose by a factor of 10 than
the dose received by the colon.
Statistical checks on the Sr-90 dose output file were performed. The same
warnings present with Co-60 were observed. No non-zero tallies were made in the tally
fluctuation bin therefore no statistical checks could be made for tally-four. For tally-six,
the relative error was 0.03, VoV was 0.00 and the pdf was 8.59. The 10 statistical
checks for tally-six passed. Of the 61 tally bins, 20 bins had zero dose and 20 bins had
relative errors exceeding 0.10 for the 0.55 MeV beta radiation. Figure 14.5 provides a
simulated 3 dimensional view of the human body with a color profile that shows the
MCNP dose for the beta radiation of Sr-90 absorbed by each organ. The color bar units
to the right of the phantom are in MeV/organ weight in grams.
Y-90 organ dose profile
A Y-90 source located within the colon would deliver a dose to the 11 selected
organs that ranges from a high of 6.41 x 10-6 MeV/g for the colon and a low of 8.59 x 10-
11 MeV/g for the skin. This organ dose contribution is from a single beta radiation with a
maximum energy of 2.28 MeV. The beta radiation is produced with a yield of about
100%. Table 14.5 provides the calculated dose conversions for each of the selected
organs.
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Fig. 14.5. Three-dimensional human dose profile from a Sr-90 beta source located
within the colon.
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Table 14.5. Organ doses from a Y-90 volume source in the colon.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ
Wt (g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 2.40E-07 9.50E-14 5.09E-02 1.22E-08 2830 4.32E-12 6.92E-22
Rib Bone Group 2.70E-04 3.12E-10 6.58E-02 1.78E-05 2167 8.19E-09 1.31E-18
Small Int 9.68E-04 1.78E-09 4.81E-02 4.65E-05 640 7.27E-08 1.16E-17
Gonads 2.27E-07 2.14E-10 4.85E-02 1.10E-08 37.1 2.97E-10 4.75E-20
Rectum 1.33E-05 1.38E-09 4.90E-02 6.49E-07 63 1.03E-08 1.65E-18
Thyroid 2.53E-07 3.67E-10 4.90E-02 1.24E-08 19.6 6.34E-10 1.01E-19
Lung 2.60E-04 2.15E-10 1.21E-02 3.16E-06 999 3.16E-09 5.06E-19
Eyes 0.00E+00 0.00E+00 4.90E-02 0.00E+00 15 0.00E+00 0.00E+00
Trachea 1.46E-06 3.81E-09 4.90E-02 7.17E-08 10 7.17E-09 1.15E-18
Colon 6.67E-03 6.64E-09 4.90E-02 3.27E-04 369 8.85E-07 1.42E-16
Stomach 5.98E-05 1.64E-09 4.90E-02 2.93E-06 150 1.95E-08 3.13E-18
As expected with Sr-90, the colon and small intestine received the highest dose
from a highly energetic, beta radiation source located within the colon. The stomach,
due to its close proximity to the source organ, received approximately 10% of the dose
absorbed by the colon. The Y-90 colon dose was approximately 5 times greater than the
dose absorbed by the Sr-90 beta radiation.
Statistical checks were performed on the Y-90 organ dose. The same warnings
present with Co-60 were observed. The 10 statistical checks for tally-four fluence
passed all but three checks. The relative error was 0.36, the VoV was 0.29 and the pdf
was 0. The 10 statistical checks for tally-six dose passed. Of the 61 tally bins, 3 bins
had a zero dose and 26 bins had relative errors exceeding 0.10 for the 2.28 MeV beta
radiation. Figure 14.6 provides a simulated 3-dimensional view of the human body with
a color profile that shows the MCNP organ dose for an Y-90 source in the colon. The
color bar units to the right of the phantom are in MeV/organ weight in grams.
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Fig. 14.6. Three-dimensional human dose profile from a 2.28 MeV Y-90 beta source
located within the colon.
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Results from colon volume source
Figure 14.7 provides an overview of all of the potential sources distributed in the
colon and their organ doses. Based upon the results of the observed programs, Co-60 is
the most limiting radionuclide with the exception of the thyroid, lung and trachea. It
appears that Ir-192 becomes the most limiting radionuclide for those three organs. As
expected, the colon followed by the small intestine and stomach appear to be the most
sensitive organs based upon a single decay from a source located within the colon. Even
though the trachea shows a higher sensitivity than the lung, the dose is a little deceiving.
The observed dose for the trachea is based on the number of voxels which include the air
encircled by the trachea. The actual dose, based on the weight of the organ, is less than
that for the lung. As expected, the organ dose for the two beta sources was
approximately 100 times smaller than the three gamma sources. An interesting note, Ir-
192 and Cs-137 do not track the same for the thyroid, lung, trachea, colon and stomach.
Cs-137 provides a higher dose than Ir-192 to the colon but a smaller dose to the stomach
from a source located in the colon.
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Fig. 14.7. Comprehensive graph of organ doses for the five potential colon sources.
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CHAPTER XV
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCE IN THE SMALL
INTESTINES
Organ data verification
The number of source voxels for additional organs will be based on the ratio of
MAX lung source voxels divided by the total number of MAX lung voxels. This
fraction will than be multiplied by the total number of organ voxels to determine the
number of source voxels in the organ. Based on the fraction, the number of source
voxels calculated for the small intestine was 3,499. This number would represent a
volume source based on the dimension of the small intestine. Volumes and masses were
checked against ICRU-46 established values for both simulations (ICRU 1990). Using
the provided values from Table A-2 of Appendix A, the hand calculated volume of small
intestine was 952.39 cm3, the volume of a single voxel was 4.67 x 10-2 cm3 (Kramer
2003). According to figure A-1 of Appendix A, the MCNPX code calculated a volume
of 4.67 x 10-2 cm3 for a single voxel. The hand calculated mass of the small intestine
was 590 g and the mass per voxel was 5.09 x 10-2 g which includes the small intestine
and its contents. The small intestine alone weighs 640 g and the mass per voxel without
contents would be 3.14 x 10-2 g. Based on Figure A-1 of Appendix A, the code
calculated a mass of 4.81 x 10-2 g in a single voxel. Therefore, the phantom small
intestine provided a good simulation that was representative of standard man.
Co-60 organ dose profile
A Co-60 source located within the small intestine would deliver a dose to the
selected organs that ranges from a high of 4.01 x 10-4 MeV/g for the small intestine and a
low of 1.19 x 10-8 MeV/g for the skin. This organ dose contribution is the sum of two
photons emitted from Co-60 that occur with a yield of about 100 percent. Table 15.1
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provides the calculated dose conversions for each of the selected organs that will be
considered in this problem.
Table 15.1. Organ doses from a Co-60 volume source in the small intestine.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 6.62E-04 2.86E-11 5.09E-02 3.37E-05 2830 1.19E-08 1.91E-18
Rib Bone Group 2.67E-01 4.54E-08 6.58E-02 1.76E-02 2167 8.11E-06 1.30E-15
Small Int 5.33E+00 6.41E-07 4.81E-02 2.56E-01 640 4.01E-04 6.42E-14
Gonads 2.28E-03 2.13E-07 4.85E-02 1.11E-04 37.1 2.98E-06 4.77E-16
Rectum 1.22E-02 2.89E-07 4.90E-02 5.99E-04 63 9.51E-06 1.52E-15
Thyroid 9.67E-04 2.13E-07 4.90E-02 4.74E-05 19.6 2.42E-06 3.87E-16
Lung 6.54E-01 7.06E-08 1.21E-02 7.93E-03 999 7.94E-06 1.27E-15
Eyes 1.09E-04 9.34E-08 4.90E-02 5.33E-06 15 3.56E-07 5.70E-17
Trachea 2.61E-03 9.93E-07 4.90E-02 1.28E-04 10 1.28E-05 2.05E-15
Colon 8.73E-01 5.33E-07 4.90E-02 4.28E-02 369 1.16E-04 1.86E-14
Stomach 2.43E-01 6.81E-07 4.90E-02 1.19E-02 150 7.92E-05 1.27E-14
As expected, the largest dose concentration is to the small intestine and the
organs in the immediate vicinity of the small intestine. The dose to the skin is smaller
by a factor of 10,000. The assumption applied to the skin dose is that the dose is
uniform across the entire volume of skin. The actual skin dose is delivered on a gradient
depending upon the distance from the source as well as the amount and type of material
between the source and the skin.
Statistical analysis of output file
The tally-four fluence analysis for each detector, setup as described in chapter
VII provided a random behavior for the mean. The desired relative error should be less
than 0.10 and the observed relative error was 0.08. The desired and observed relative
error decreased according to the inverse of the square root of the number of histories.
The desired variance of the variance should be less than 0.10 and the observed VoV was
0.02. The figure of merit value was constant and the behavior was random. The
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probability density function (pdf) desired should be greater than three, the observed pdf
was 0. There was insufficient tfc bin tally information to estimate the large tally slope
reliably. The tally-four fluence passed all 10 statistical checks except the pdf. Out of 10
tally-four bins, one had a zero value and no bins contained relative errors greater than
0.10. The second 1.33 MeV photon simulation provided similar results.
The tally-six dose analysis for each material showed a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for both photons. The desired and observed relative errors decreased
according to the inverse of the square root of the number of histories. The desired
variance of the variance should be less than 0.10 and the observed VoV was 0.00. The
figure of merit value was constant and the behavior was random. The desired
probability density function (pdf) should be greater than 3.00 and the observed value
was 10.0 for the 1.17 MeV photon and 6.35 for the 1.33 MeV photon. The tally-six dose
passed all 10 statistical checks. Out of 61 tally-six bins, no bin had a zero dose value
and only 11 bins contained relative errors greater than 0.10.
Figure 15.1 provides a simulated 3-dimensional view of the human body with a
color profile that shows the organ dose for the 1.33 MeV photon of Co-60. The color
bar units to the right of the phantom are in MeV/organ weight in grams. Each axis is
represented in the figure along with a color bar that indicates the organ dose in MeV/g
provided by the MCNPX output file. In the MCNPX output file, the small intestine
received the highest dose followed by the colon. The dose to the small intestine is
roughly 2 times that of the colon. The stomach dose is within a factor of 3 compared to
the dose from the small intestine.
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Fig. 15.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within the small intestine.
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Cs-137 organ dose profile
A Cs-137 source located within the small intestine would deliver a dose to the
selected organs that ranges from a high of 1.17 x 10-4 MeV/g for the small intestine and a
low of 3.16 x 10-9 MeV/g for the skin. This organ dose contribution is from a 0.66
MeVphoton emitted from Cs-137 that occurs with a yield of about 86 percent. Table
15.2 provides the dose output to the selected organs from the 0.66 MeV photon.
Table 15.2. Organ doses for a Cs-137 volume source in the small intestine.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 1.76E-04 4.11E-12 5.09E-02 8.94E-06 2830 3.16E-09 5.06E-19
Rib Bone Group 7.73E-02 6.57E-09 6.58E-02 5.08E-03 2167 2.34E-06 3.76E-16
Small Int 1.56E+00 9.38E-08 4.81E-02 7.50E-02 640 1.17E-04 1.88E-14
Gonads 5.33E-04 2.59E-08 4.85E-02 2.59E-05 37.1 6.97E-07 1.12E-16
Rectum 3.51E-03 4.01E-08 4.90E-02 1.72E-04 63 2.73E-06 4.37E-16
Thyroid 2.58E-04 2.86E-08 4.90E-02 1.26E-05 19.6 6.45E-07 1.03E-16
Lung 1.78E-01 9.73E-09 1.21E-02 2.16E-03 999 2.16E-06 3.47E-16
Eyes 2.54E-05 1.31E-08 4.90E-02 1.24E-06 15 8.29E-08 1.33E-17
Trachea 6.36E-04 1.21E-07 4.90E-02 3.12E-05 10 3.12E-06 4.99E-16
Colon 2.53E-01 7.73E-08 4.90E-02 1.24E-02 369 3.36E-05 5.38E-15
Stomach 6.97E-02 9.79E-08 4.90E-02 3.42E-03 150 2.28E-05 3.65E-15
As expected, the dose to the selected organs is similar to the dose produced by
the Co-60 photons. The largest dose concentration remains with organs in the
immediate vicinity of the small intestine. The small intestine dose is reduced by
approximately a factor of two from the 1.17 MeV Co-60 photon dose. This reduction is
expected based on the energy reduction between the 1.17 MeV Co-60 photon and that of
Cs-137.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed with the exception of the pdf. There was insufficient tfc bin tally
information to estimate the large tally slope reliably. The 10 statistical checks for tally-
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six dose passed and produced similar results as with Co-60. Of the 61 tally bins, no bins
contained a zero dose and 11 bins had relative errors exceeding 0.10. Figure 15.2
provides a simulated 3-dimensional view of the human body with a color profile that
shows the organ dose for the single photon of Cs-137. The color bar units to the right of
the phantom are in MeV/organ weight in grams.
The Co-60 small intestine dose was 1.90 x 10-4 MeV/g for the 1.17 MeV photon
compared with the Cs-137 small intestine dose of 1.17 x 10-4 MeV/g for the 0.66 MeV
photon. As expected, the dose profile is similar to that of the photons emitted by Co-60.
The dose to each individual organ is proportionally reduced based on the lower-energy
of the source photon and the energy dependent stopping power of the material within the
phantom.
Ir-192 organ dose profile
An Ir-192 source located within the small intestine would deliver a dose to the
selected organs that ranges from a high of 1.45 x 10-4 MeV/g for the small intestine and a
low of 3.63 x 10-9 MeV/g for the skin. This organ dose contribution is from the sum of
two photons with energies of 0.47 MeV and 0.32 MeV along with two electrons with
maximum energies of 0.66 MeV and 0.54 MeV. All four emissions are produced with a
yield of 26.2%, 22.4%, 10.1% and 6.7%, respectively. Table 15.3 provides the
calculated dose conversions for each of the selected organs.
136
Fig. 15.2. Three-dimensional human dose profile from a Cs-137 photon source located
within the small intestine.
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Table 15.3. Organ doses for an Ir-192 volume source in the small intestine.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 2.02E-04 1.56E-10 5.09E-02 1.03E-05 2830 3.63E-09 5.81E-19
Rib Bone Group 1.00E-01 2.43E-07 6.58E-02 6.60E-03 2167 3.05E-06 4.88E-16
Small Int 1.93E+00 2.32E-06 4.81E-02 9.26E-02 640 1.45E-04 2.32E-14
Gonads 5.55E-04 6.65E-07 4.85E-02 2.69E-05 37.1 7.26E-07 1.16E-16
Rectum 4.21E-03 1.53E-06 4.90E-02 2.06E-04 63 3.27E-06 5.24E-16
Thyroid 2.98E-04 1.25E-06 4.90E-02 1.46E-05 19.6 7.44E-07 1.19E-16
Lung 2.10E-01 3.52E-07 1.21E-02 2.54E-03 999 2.55E-06 4.08E-16
Eyes 2.02E-05 2.44E-08 4.90E-02 9.89E-07 15 6.59E-08 1.06E-17
Trachea 7.13E-04 5.13E-06 4.90E-02 3.49E-05 10 3.49E-06 5.59E-16
Colon 3.16E-01 2.12E-06 4.90E-02 1.55E-02 369 4.20E-05 6.73E-15
Stomach 8.66E-02 3.16E-06 4.90E-02 4.24E-03 150 2.83E-05 4.53E-15
As expected, the organ dose was driven by the two photons over the two
electrons by a factor of 100 or greater. Compared to the Co-60 and Cs-137 organ dose,
the most sensitive organs for Ir-192 were the small intestine and colon. The dose to the
small intestine is slightly larger than the Cs-137 small intestine dose. The sum of the
two Ir-192 photons is comparable to the energy of the single Cs-137 photon.
Statistical checks on the Ir-192 photon dose output file were performed. The
same warnings present with Co-60 were observed. The 10 statistical checks for tally-
four fluence passed with the exception of the pdf. There was insufficient tfc bin tally
information to estimate the large tally slope reliably. The 10 statistical checks for tally-
six dose passed and produced similar results as with Co-60. Of the 61 tally bins, no bins
contained a zero dose and 12 bins had relative errors exceeding 0.10 for the 0.32 MeV
photon. The 0.47 MeV photon produced similar results.
The tallies for the electron sources within the small intestine had to be evaluated
in a slightly different manner based on their inability to penetrate uniformly throughout
the phantom. Secondary emissions, such as bremsstrahlung and characteristics x rays
were the primary radiation source for organs outside of the small intestine. All but three
of the 10 tally-four fluence statistical checks passed. The relative error was 1.00, the
VoV was 1.00 and the pdf was 0. This reflects a large number of zero doses and slightly
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greater than zero dose based on the electron source. In the case of an electron source,
only the selected organs were reviewed for their relative error.
Figures 15.3 and 15.4 provide a simulated 3 dimensional view of the human body
with a color profile that shows the MCNP dose for the 0.14 MeV photon of Ir-192 and
the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The color bar
units to the right of the phantom are in MeV/organ weight in grams.
Sr-90 organ dose profile
A Sr-90 source located within the small intestine would deliver a dose to the
selected organs that ranges from a high of 6.14 x 10-7 MeV/g for the small intestine and a
low of 4.17 x 10-12 MeV/g for the skin. This organ dose contribution is from a single
beta emission with a maximum energy of 0.55 MeV. The beta emission is produced
with a yield of about 100%. Table 15.4 provides the calculated dose conversions for
each of the selected organs that will be considered in this problem.
Table 15.4. Organ doses from a Sr-90 volume source in the small intestine.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 2.32E-07 8.85E-14 5.09E-02 1.18E-08 2830 4.17E-12 6.69E-22
Rib Bone Group 2.20E-04 2.68E-10 6.58E-02 1.45E-05 2167 6.69E-09 1.07E-18
Small Int 8.17E-03 4.66E-09 4.81E-02 3.93E-04 640 6.14E-07 9.83E-17
Gonads 2.25E-07 1.97E-10 4.85E-02 1.09E-08 37.1 2.95E-10 4.72E-20
Rectum 4.98E-06 6.81E-10 4.90E-02 2.44E-07 63 3.87E-09 6.21E-19
Thyroid 1.31E-07 2.76E-10 4.90E-02 6.44E-09 19.6 3.29E-10 5.26E-20
Lung 2.19E-04 1.88E-10 1.21E-02 2.66E-06 999 2.66E-09 4.26E-19
Eyes 0.00E+00 0.00E+00 4.90E-02 0.00E+00 15 0.00E+00 0.00E+00
Trachea 4.33E-07 1.53E-09 4.90E-02 2.12E-08 10 2.12E-09 3.40E-19
Colon 5.98E-04 2.03E-09 4.90E-02 2.93E-05 369 7.93E-08 1.27E-17
Stomach 1.15E-04 2.32E-09 4.90E-02 5.62E-06 150 3.75E-08 6.01E-18
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Fig. 15.3. Three-dimensional human dose profile from the 0.47 MeV Ir-192 photon
source located within the small intestine.
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Fig. 15.4. Three-dimensional human dose profile from the 0.66 MeV Ir-192 electron
source located within the small intestine.
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As expected, the small intestine received the greatest dose from a moderately
energetic beta radiation source located within the small intestine. The colon and
stomach, due to their close proximity to the source organ received approximately 10
percent of the dose to the small intestine.
Statistical checks were performed on the Sr-90 dose output file. The same
warnings present with Co-60 were observed. The tally-four fluence passed all but three
of the 10 statistical checks. The relative error was 1.00, the VoV was 1.00 and the pdf
was 0. For tally-six dose, the relative error was 0.02, VoV was 0.00 and the pdf was
5.01. The 10 statistical checks for tally-six dose passed. Of the 61 tally bins, 14 bins
had zero dose and 25 bins had relative errors exceeding 0.10 for the 0.55 MeV beta
radiation. Figure 15.5 provides a simulated 3-dimensional view of the human body with
a color profile that shows the organ dose for the beta radiation of Sr-90 absorbed by each
organ. The color bar units to the right of the phantom are in MeV/organ weight in
grams.
Y-90 organ dose profile
A Y-90 source located within the small intestine would deliver a dose to the
selected organs that ranges from a high of 5.06 x 10-6 MeV/g for the small intestine and a
low of 8.46 x 10-11 MeV/g for the skin. This organ dose contribution is from a single
beta emission with a maximum energy of 2.28 MeV. The beta emission is produced
with a yield of about 100%. Table 15.5 provides the calculated dose conversions for
each of the selected organs.
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Fig. 15.5. Three-dimensional human dose profile from a Sr-90 beta source located
within the small intestine.
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Table 15.5. Organ doses from a Y-90 volume source in the small intestine.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ Dose
(Gy)
Skin 4.71E-06 7.53E-13 5.09E-02 2.40E-07 2830 8.46E-11 1.36E-20
Rib Bone Group 3.02E-03 1.22E-09 6.58E-02 1.99E-04 2167 9.17E-08 1.47E-17
Small Int 6.74E-02 2.18E-08 4.81E-02 3.24E-03 640 5.06E-06 8.11E-16
Gonads 1.09E-05 2.77E-09 4.85E-02 5.27E-07 37.1 1.42E-08 2.28E-18
Rectum 9.30E-05 5.32E-09 4.90E-02 4.56E-06 63 7.23E-08 1.16E-17
Thyroid 5.32E-06 3.13E-09 4.90E-02 2.61E-07 19.6 1.33E-08 2.13E-18
Lung 4.56E-03 1.38E-09 1.21E-02 5.53E-05 999 5.53E-08 8.86E-18
Eyes 1.34E-06 3.35E-09 4.90E-02 6.58E-08 15 4.39E-09 7.03E-19
Trachea 1.45E-05 1.23E-08 4.90E-02 7.10E-07 10 7.10E-08 1.14E-17
Colon 8.68E-03 1.19E-08 4.90E-02 4.25E-04 369 1.15E-06 1.85E-16
Stomach 2.12E-03 1.47E-08 4.90E-02 1.04E-04 150 6.91E-07 1.11E-16
As with Sr-90, the small intestine received the highest dose from a highly-
energetic beta particle source located within the small intestine. The colon and stomach,
due to their close proximity to the source organ, received approximately 10 percent of
the dose to the small intestine. The Y-90 small intestine dose was approximately 10
times greater than the dose delivered by the Sr-90 beta radiation even though the energy
of the Y-90 beta radiation was approximately 4 times greater than the energy of the Sr-
90 beta radiation.
Statistical checks on the Y-90 dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all but three checks. The relative error was 0.41, the VoV was 0.47 and
the pdf was 0. The 10 statistical checks for tally-six dose passed. Of the 61 tally bins, 3
bins had zero dose and 26 bins had relative errors exceeding 0.10 for the 2.28 MeV beta
radiation. Figure 15.6 provides a simulated 3-dimensional view of the human body with
a color profile that shows the organ dose for an Y-90 source in the small intestine. The
color bar units to the right of the phantom are in MeV/organ weight in grams.
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Fig. 15.6. Three-dimensional human dose profile from a Y-90 beta source located
within the small intestine.
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Results from small intestine volume source
Figure 15.7 provides a graph of all of the potential sources distributed in the
small intestine. Based upon the results of the observed programs, Co-60 is the most
limiting radionuclide. The small intestine, followed by the colon appear to be the most
sensitive organs based upon a single emission from a source located within the small
intestine. Even though the trachea shows a higher sensitivity than the lung, the dose is a
little deceiving. The observed dose for the trachea is based on the number of voxels
which include the air encircled by the trachea. The actual dose, based on the weight of
the organ, is less than that for the lung.
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Fig. 15.7. Summary graph of organ doses for the five potential small intestine sources.
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CHAPTER XVI
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCE IN THE SKIN
Organ data verification
The number of source voxels for additional organs will be based on the ratio of
MAX lung source voxels divided by the total number of MAX lung voxels. This
fraction will than be multiplied by the total number of organ voxels to determine the
number of source voxels in the organ. Based on the fraction, the number of sources
calculated for the skin was 21,082. This number would represent a volume source based
on the dimension of the skin. Volumes and masses were checked against ICRU-46
established values for both simulations (ICRU 1990). Using the values from Table A-2
of Appendix A, the hand calculated volume of skin was 5,737.94 cm3, the volume of a
single voxel was 4.67 x 10-2 cm3 (Kramer 2003). According to figure A-1 of Appendix
A, the MCNPX code calculated a volume of 4.67 x 10-2 cm3 for a single voxel. The
hand calculated mass of the skin was 2,600 g and the mass per voxel was 2.11 x 10-2 g.
Based on Figure A-1 of Appendix A, the code calculated a mass of 5.01 x 10-2 g in a
single voxel. The skin mass is off by a factor of two but can be compensated by a
slightly lower density. Therefore, the phantom skin provided a fair simulation that is
representative of standard man.
Co-60 organ dose profile
A Co-60 source located within the skin would deliver a dose to the selected
organs that ranges from a high of 9.29 x 10-5 MeV/g for the gonads and a low of 3.34 x
10-8 MeV/g for the skin. This organ dose contribution is the sum of two photons emitted
from Co-60 that occur with a yield of about 100 percent. Table 16.1 provides calculated
dose conversions for each of the selected organs that will be considered in this problem.
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Table 16.1. Organ doses from a Co-60 volume source in the skin.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 1.86E-03 8.02E-11 5.09E-02 9.46E-05 2830 3.34E-08 5.35E-18
Rib Bone Group 1.95E-01 5.81E-08 6.58E-02 1.29E-02 2167 5.93E-06 9.50E-16
Small Int 1.05E-01 1.51E-07 4.81E-02 5.06E-03 640 7.91E-06 1.27E-15
Gonads 9.18E-03 4.82E-07 4.85E-02 4.46E-04 37.1 1.20E-05 1.92E-15
Rectum 7.36E-03 2.55E-07 4.90E-02 3.61E-04 63 5.72E-06 9.17E-16
Thyroid 2.16E-03 3.93E-07 4.90E-02 1.06E-04 19.6 5.41E-06 8.66E-16
Lung 4.69E-01 6.95E-08 1.21E-02 5.69E-03 999 5.69E-06 9.12E-16
Eyes 1.96E-03 4.61E-07 4.90E-02 9.58E-05 15 6.39E-06 1.02E-15
Trachea 6.15E-03 1.28E-06 4.90E-02 3.01E-04 10 3.01E-05 4.83E-15
Colon 6.63E-02 1.71E-07 4.90E-02 3.25E-03 369 8.81E-06 1.41E-15
Stomach 4.38E-02 3.60E-07 4.90E-02 2.14E-03 150 1.43E-05 2.29E-15
The largest dose concentration is to the gonads and stomach. The trachea
received an equivalent dose when the air inside the trachea is added to the mass of the
trachea.
Statistical analysis of output file
The tally-four fluence analysis for each detector, setup as described in chapter
VII, provided a random behavior for the mean. The desired relative error should be less
than 0.10 and the observed relative error was 0.05. The desired and observed relative
errors decreased according to the inverse of the square root of the number of histories.
The desired variance of the variance should be less than 0.10 and the observed VoV was
0.01. The figure of merit value was constant and the behavior was random. The
probability density function (pdf) desired should be greater than three, the observed pdf
value was 10.0. The tally-four fluence passed all 10 statistical checks. Out of 10 tally-
four bins, one had a zero dose value and no bins contained relative errors greater than
0.10. The second 1.33 MeV photon simulation provided similar results.
The tally-six dose analysis for each material showed a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
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was 0.00 for both photons. The desired and observed relative errors decreased
according to the inverse of the square root of the number of histories. The desired
variance of the variance should be less than 0.10 and the observed VoV was 0.00. The
figure of merit value was constant and the behavior was random. The desired
probability density function (pdf) should be greater than 3.00 and the observed value
was 10.0 for both photons. The tally-six dose passed all 10 statistical checks. Out of 61
tally-six bins, no bins had a zero value and no bins contained relative errors greater than
0.10.
Figure 16.1 provides a simulated 3-dimensional view of the human body with a
color profile that shows the organ dose for the 1.33 MeV photon of Co-60. Each axis is
represented in the figure along with a color bar that indicates the organ dose in
MeV/organ in grams provided by the MCNPX output file. In the MCNPX output file,
the gonads received the highest dose followed by the stomach and trachea. The dose to
the gonads is roughly 1000 times the dose of the skin.
Cs-137 organ dose profile
A Cs-137 source located within the skin would deliver a dose to the selected
organs that ranges from a high of 8.24 x 10-6 MeV/g for the trachea and a low of 9.53 x
10-9 MeV/g for the skin. This organ dose contribution is from a 0.66 MeV photon
emitted from Cs-137 that occurs with a yield of about 86 percent. Table 16.2 provides
the dose output to selected organs from the 0.66 MeV photon.
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Fig. 16.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within the skin.
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Table 16.2. Organ doses for a Cs-137 volume source in the skin.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 5.31E-04 1.14E-11 5.09E-02 2.70E-05 2830 9.53E-09 1.53E-18
Rib Bone Group 5.45E-02 8.10E-09 6.58E-02 3.58E-03 2167 1.65E-06 2.65E-16
Small Int 2.82E-02 2.06E-08 4.81E-02 1.36E-03 640 2.12E-06 3.40E-16
Gonads 2.65E-03 6.92E-08 4.85E-02 1.28E-04 37.1 3.46E-06 5.54E-16
Rectum 1.97E-03 3.47E-08 4.90E-02 9.66E-05 63 1.53E-06 2.46E-16
Thyroid 6.11E-04 5.54E-08 4.90E-02 2.99E-05 19.6 1.53E-06 2.45E-16
Lung 1.29E-01 9.83E-09 1.21E-02 1.56E-03 999 1.56E-06 2.50E-16
Eyes 5.52E-04 6.47E-08 4.90E-02 2.70E-05 15 1.80E-06 2.89E-16
Trachea 1.68E-03 1.79E-07 4.90E-02 8.24E-05 10 8.24E-06 1.32E-15
Colon 1.77E-02 2.32E-08 4.90E-02 8.66E-04 369 2.35E-06 3.76E-16
Stomach 1.18E-02 4.93E-08 4.90E-02 5.78E-04 150 3.85E-06 6.18E-16
As expected, the dose to the selected organs is similar to the dose produced by
the Co-60 photons. The largest dose concentration remains in the trachea. The stomach
and gonads received a dose approximately two times less than the dose to the trachea.
The 1.17 MeV photon from Co-60 produced a trachea dose of 3.01 x 10-5 MeV/g
compared to the Cs-137 trachea dose of 8.24 x 10-6 MeV/g. The Cs-137 trachea dose
was approximately one-fourth the dose of the Co-60 trachea dose.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed. The 10 statistical checks for tally-six dose passed all but one statistical
check and produced similar results as with Co-60. The figure of merit has a trend during
the last half of the problem. Of the 61 tally bins, no bins contained zero dose and no
bins had relative errors exceeding 0.10. Figure 16.2 provides a simulated 3-dimensional
view of the human body with a color profile that shows the organ dose for the single
photon of Cs-137 absorbed by each organ.
The Co-60 skin dose was 1.58 x 10-8 MeV/g for the 1.17 MeV photon compared
with the Cs-137 skin dose of 9.53 x 10-9 MeV/g for the 0.66 MeV photon. As expected,
the dose profile is similar to that of the photons emitted by Co-60. The dose to each
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individual organ is proportionally reduced based on the lower-energy of the source
photon and the energy dependent stopping power of the material within the phantom.
Ir-192 organ dose profile
An Ir-192 source located within the skin would deliver a dose to the selected
organs that ranges from a high of 9.65 x 10-6 MeV/g for the trachea and a low of 1.14 x
10-8 MeV/g for the skin. This organ dose contribution is from the sum of two photons
with energies of 0.47 MeV and 0.32 MeV along with two electrons with maximum
energies of 0.66 MeV and 0.54 MeV. All four emissions are produced with a yield of
26.2%, 22.4%, 10.1% and 6.7%, respectively. Table 16.3 provides the total dose output
calculated conversions for each of the 11 selected organs.
Table 16.3. Organ doses for an Ir-192 volume source in the skin.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 6.34E-04 1.10E-09 5.09E-02 3.22E-05 2830 1.14E-08 1.83E-18
Rib Bone Group 6.65E-02 2.66E-07 6.58E-02 4.37E-03 2167 2.02E-06 3.23E-16
Small Int 3.26E-02 7.80E-07 4.81E-02 1.56E-03 640 2.45E-06 3.92E-16
Gonads 3.12E-03 1.43E-06 4.85E-02 1.51E-04 37.1 4.08E-06 6.53E-16
Rectum 2.23E-03 9.81E-07 4.90E-02 1.09E-04 63 1.73E-06 2.77E-16
Thyroid 6.89E-04 1.85E-06 4.90E-02 3.38E-05 19.6 1.72E-06 2.76E-16
Lung 1.49E-01 3.80E-07 1.21E-02 1.81E-03 999 1.81E-06 2.90E-16
Eyes 6.29E-04 2.52E-06 4.90E-02 3.08E-05 15 2.05E-06 3.29E-16
Trachea 1.97E-03 6.21E-06 4.90E-02 9.65E-05 10 9.65E-06 1.55E-15
Colon 2.04E-02 8.21E-07 4.90E-02 9.98E-04 369 2.71E-06 4.33E-16
Stomach 1.37E-02 1.88E-06 4.90E-02 6.73E-04 150 4.49E-06 7.19E-16
153
Fig. 16.2. Three-dimensional human dose profile from a Cs-137 photon source located
within the skin.
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As expected, the organ dose was driven by the two photons over the two
electrons by a factor of 100 or greater. Compared to the Co-60 and Cs-137 organ dose,
the most sensitive organs for Ir-192 were the trachea, gonads and stomach. The dose to
the trachea from Ir-192 was slightly greater than the dose to the trachea from Cs-137.
The sum of the two Ir-192 photons is comparable to the energy of the single Cs-137
photon.
Statistical checks were performed on the Ir-192 photon dose output file. The
same warnings present with Co-60 were observed. The 10 statistical checks for tally-
four fluence passed. The 10 statistical checks for tally-six passed all but one check. The
figure of merit had a trend during the last half of the problem. The tally-six checks
produced similar results as with Co-60. Of the 61 tally bins, no bin contained a zero
dose and no bins had relative errors exceeding 0.10 for the 0.32 MeV photon. The 0.47
MeV photon produced similar results.
The tallies for the electron sources within the skin had to be evaluated in a
slightly different manner based on their lack inability to penetrate uniformly throughout
the phantom. Secondary radiations, such as bremsstrahlung and characteristics x rays
were the primary radiation source for organs inside of the skin. Four of the 10 statistical
checks failed. The relative error was 0.41, the VoV was 0.24, the VoV did not decrease
according to the inverse of the number of histories and the pdf was 0. This reflects a
large number of zero and slightly greater than zero dose based on the electron source. In
the case of an electron source, only the selected organs were reviewed for their relative
error.
Figures 16.3 and 16.4 provide a simulated 3-dimensional view of the human
body with a color profile that shows the MCNP dose for the 0.47 MeV photon of Ir-192
and the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The color
bar units to the right of the phantom are in MeV/organ weight in grams.
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Fig. 16.3. Three-dimensional human dose profile from a 0.47 MeV Ir-192 photon
source located within the skin.
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Fig. 16.4. Three-dimensional human dose profile from a 0.66 MeV Ir-192 electron
source located within the skin.
157
Sr-90 organ dose profile
A Sr-90 source located within the skin would deliver a dose to the selected
organs that ranges from a high of 1.42 x 10-8 MeV/g for the trachea and a low of 7.29 x
10-11 MeV/g for the skin. This organ dose contribution is from a single beta radiation
with a maximum energy of 0.55 MeV. The beta radiation is produced with a yield of
about 100%. Table 16.4 provides the calculated dose conversions for each of the
selected organs that will be considered in this problem.
Table 16.4. Organ doses from a Sr-90 volume source in the skin.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 4.06E-06 3.07E-12 5.09E-02 2.06E-07 2830 7.29E-11 1.17E-20
Rib Bone Group 1.04E-04 2.26E-10 6.58E-02 6.87E-06 2167 3.17E-09 5.08E-19
Small Int 2.28E-05 2.57E-10 4.81E-02 1.10E-06 640 1.71E-09 2.75E-19
Gonads 9.43E-06 1.78E-09 4.85E-02 4.58E-07 37.1 1.23E-08 1.98E-18
Rectum 2.16E-06 6.14E-10 4.90E-02 1.06E-07 63 1.68E-09 2.69E-19
Thyroid 3.73E-07 4.27E-10 4.90E-02 1.83E-08 19.6 9.32E-10 1.49E-19
Lung 1.20E-04 1.55E-10 1.21E-02 1.46E-06 999 1.46E-09 2.34E-19
Eyes 1.15E-06 1.47E-09 4.90E-02 5.63E-08 15 3.75E-09 6.01E-19
Trachea 2.90E-06 3.52E-09 4.90E-02 1.42E-07 10 1.42E-08 2.28E-18
Colon 1.30E-05 2.89E-10 4.90E-02 6.38E-07 369 1.73E-09 2.77E-19
Stomach 9.55E-06 7.47E-10 4.90E-02 4.68E-07 150 3.12E-09 4.99E-19
As expected, the trachea received the greatest dose from a moderately energetic
beta particle source located within the skin. The gonads received approximately 80
percent of the dose compared to the dose received by the trachea.
Statistical checks were performed on the Sr-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
missed five of the 10 checks. The relative error was 0.51, VoV did not decrease
according to the inverse of the number of histories and the value was 0.3, the FOM was
not constant and increased, and the pdf was 0. The 10 statistical checks for tally-six
passed. Of the 61 tally bins, one bin had a zero value and 48 bins had relative errors
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exceeding 0.10 for the 0.55 MeV beta particle. Figure 16.5 provides a simulated 3-
dimensional view of the human body with a color profile that shows the organ dose for
the beta radiation of Sr-90. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
Y-90 organ dose profile
A Y-90 source located within the skin would deliver a dose to the selected organs
that ranges from a high of 1.42 x 10-8 MeV/g for the trachea and a low of 1.90 x 10-10
MeV/g for the skin. This organ dose contribution is from a single beta radiation with a
maximum energy of 2.28 MeV. The beta radiation is produced with a yield of about
100%. Table 16.5 provides the calculated dose conversions for each of the selected
organs that will be considered in this problem.
Table 16.5. Organ doses from a Y-90 volume source in the skin.
Organs
MCNP Dose
(MeV/g)
Std
Deviation
MCNP
Wght (g)
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 1.06E-05 3.45E-12 5.09E-02 5.39E-07 2830 1.90E-10 3.05E-20
Rib Bone Group 1.73E-03 1.24E-09 6.58E-02 1.14E-04 2167 5.26E-08 8.43E-18
Small Int 6.08E-04 2.67E-09 4.81E-02 2.92E-05 640 4.57E-08 7.32E-18
Gonads 1.15E-04 1.21E-08 4.85E-02 5.57E-06 37.1 1.50E-07 2.41E-17
Rectum 3.91E-05 3.80E-09 4.90E-02 1.92E-06 63 3.04E-08 4.88E-18
Thyroid 1.33E-05 6.23E-09 4.90E-02 6.52E-07 19.6 3.32E-08 5.33E-18
Lung 2.83E-03 1.40E-09 1.21E-02 3.44E-05 999 3.44E-08 5.51E-18
Eyes 1.62E-05 1.10E-08 4.90E-02 7.93E-07 15 5.28E-08 8.47E-18
Trachea 3.64E-05 1.91E-08 4.90E-02 1.78E-06 10 1.78E-07 2.86E-17
Colon 4.22E-04 3.50E-09 4.90E-02 2.07E-05 369 5.60E-08 8.97E-18
Stomach 2.31E-04 6.53E-09 4.90E-02 1.13E-05 150 7.54E-08 1.21E-17
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Fig. 16.5. Three-dimensional human dose profile from a Sr-90 beta source located
within the skin.
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As expected with Sr-90, the trachea received the highest dose from a highly-
energetic beta radiation source located within the skin. The stomach received
approximately twenty percent less dose than the dose to the trachea. The Y-90 skin dose
was approximately three times the dose to the skin from Sr-90.
Statistical checks were performed on the Y-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all but four checks. The relative error was 0.27, The VoV was 0.25, the
VoV did not decrease according to the inverse of the number of histories and the pdf was
0. The 10 statistical checks for tally-six dose passed. Of the 61 tally bins, no bin had a
zero dose and 24 bins had relative errors exceeding 0.10 for the 2.28 MeV beta radiation.
Figure 16.6 provides a simulated 3-dimensional view of the human body with a color
profile that shows the organ dose for the 0.55 MeV beta radiation of Sr-90. The color
bar units to the right of the phantom are in MeV/organ weight in grams.
Results from skin volume source
Figure 16.7 provides an overview of all of the potential sources distributed in the
skin. Based upon the results of the observed programs, Co-60 is the most limiting
radionuclide. The trachea followed by the gonads and stomach appears to be the most
sensitive organs based upon a single emission from a source located within the skin.
The dose delivered to the organs from Ir-192 and Cs-137 appears to be equivalent within
their respective error of margin. The overall organ dose from the three photon sources
appear to deliver a dose that is approximately 100 times the dose delivered from the
highest beta source of Y-90. Even though the trachea shows a higher sensitivity than the
lung, the dose is a little deceiving. The observed dose for the trachea is based on the
number of voxels which include the air encircled by the trachea.
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Fig. 16.6. Three-dimensional human dose profile from a Y-90 electron source located
within the skin.
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Fig. 16.7. Comprehensive graph of organ doses for the five potential skin sources.
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CHAPTER XVII
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCES IN THE LUNG,
STOMACH, SMALL INTESTINE AND COLON ONE HOUR AFTER A LUNG
INHALATION
Dose to multiple organ verification
The MATLAB subprogram Simulink was used to build a time dependant activity
profile program that would calculate organ activities over time (MathWorks 2007).
Based on the most probable exposure route for an RDD event, the program was
simulated to calculate activity over time using the current ICRP-30 internal dose model
(ICRP 1978). By utilizing typical response times for emergency responders, time frames
of one, six, 12 and 24 hour post detonation where chosen to provide dose and organ
activities at specific times to assist emergency responders in assessing injured personnel
as well as establishing response time limits for emergency responders. Total activity for
each organ was established based on the pre-selected time intervals. The MATLAB
program file named Shannon, normalizes the activity in each source organ to one
disintegration per second. Based on the number of source voxels in each source organ, a
probability is calculated from the normalized activity for each organ. The number of
source voxels in each source organ is based on the fraction of source voxels in the lung,
a source volume of 15,000 lung voxels per 87,506 total lung voxels was selected and the
number of source particles chosen was one million. Being the most limiting of the five
sources, Co-60 was chosen as the first test source for our phantom model. To keep
things simple, two simulations were set up. The first simulation analyzed the lower
energy photon of 1.17 MeV and the second simulation tracked a 1.33 MeV photon.
Volumes and masses were checked against ICRU-46 established values for both
simulations (ICRU 1990).
The MCNP output file provides a dose to all tissues defined within the phantom.
The dose is listed in g/cm3 and applies to a single voxel. The dose is based on the
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average energy deposited per unit mass for a single history. In this case, a single
1.17MeV photon would deliver an average dose of 4.56 ± 0.0008 MeV/g of tissue
contained in a single voxel. In order to derive any meaningful information from this
value, simple calculated dose conversions were applied to create a dose in gray (Gy) for
each organ. The above value provides an average lung dose of 8.87 x 10-15 Gy from a
single 1.17 MeV photon when the photons originate within a lung, stomach, small
intestine, liver and colon volume source. Because of the extremely small dose from a
single photon, the dose graphs are in units of MeV/g. Table 17.1 provides calculated
dose conversions for each of the selected organs at time (T) plus one hour from
detonation.
Table 17.1. Organ doses from Co-60 volume source in multiple organs at T plus one
hour.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 6.97E-04 3.00E-11 1.25E-08 2.01E-18
Rib Bone Group 0 0.00E+00 1.48E+00 9.85E-08 4.48E-05 7.17E-15
Small Int 3499 1.10E-02 2.57E-01 2.35E-07 1.93E-05 3.09E-15
Gonads 0 0.00E+00 3.23E-04 7.79E-08 4.22E-07 6.76E-17
Rectum 0 0.00E+00 1.63E-03 1.04E-07 1.27E-06 2.03E-16
Thyroid 0 0.00E+00 2.04E-02 1.19E-06 5.09E-05 8.15E-15
Lung 15000 5.95E-01 9.58E+00 1.86E-07 1.16E-04 1.86E-14
Eyes 0 0.00E+00 7.08E-04 2.78E-07 2.31E-06 3.7E-16
Trachea 0 0.00E+00 4.98E-02 4.00E-06 2.44E-04 3.91E-14
Colon 2124 1.02E-03 1.19E-01 2.29E-07 1.58E-05 2.53E-15
Stomach 1400 2.00E-02 4.35E-01 1.05E-06 1.42E-04 2.27E-14
As expected, the majority of the activity remains in the lung at time T plus one
hour. The stomach contains the second highest activity. For Co-60, the most sensitive
organ is the trachea followed by the stomach, lung and small intestine. Compared to the
Co-60 dose with a source located in just the lung, the lung dose was 1.21 x 10-4 MeV/g
and from multiple source organs the lung dose was 1.16 x 10-4 MeV/g. The stomach
dose from Co-60 with a source located only in the stomach was 1.33 x 10-3 MeV/g and
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from multiple source organs the stomach dose was 1.42 x 10-4 MeV/g or approximately
10 percent of the stomach dose with the source located only in the stomach.
Statistical analysis of output file
The tally-four fluence analysis for each detector, setup as described in chapter
VII, provided a random behavior for the mean. The desired relative error should be less
than 0.10 and the observed relative error was 0.02. The desired and observed relative
errors decreased according to the inverse of the square root of the number of histories.
The desired variance of the variance should be less than 0.10 and the observed VoV was
0.00. The figure of merit value was constant and the behavior was random. The
probability density function (pdf) desired should be greater than three, the observed pdf
value was 10. The tally-four fluence passed all 10 statistical checks. Out of 10 tally-
four bins, only one had a zero dose value and no bins contained relative errors greater
than 0.10. The second 1.33 MeV photon simulation provided similar results.
The tally-six dose analysis for each material provided a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for the 1.17 MeV photon and 0.00 for the 1.33 MeV photon. The desired and
observed relative errors decreased according to the inverse of the square root of the
number of histories. The desired variance of the variance should be less than 0.10 and
the observed VoV was 0.00. The figure of merit value was constant and the behavior
was random. The desired probability density function (pdf) should be greater than 3.00
and the observed value was 5.51 for the 1.17 MeV photon and 5.57 for the 1.33 MeV
photon. The tally-six dose passed all 10 statistical checks. Out of 61 tally-six bins, no
bin had a zero dose and only 6 bins contained relative errors greater than 0.10.
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Co-60 organ dose Profile
A Co-60 source located within the multiple organs specified above would deliver
a dose to the selected organs that ranges from a high or 1.42 x 10-4 MeV/g for the
stomach and a low of 1.25 x 10-8 MeV/g for the skin after one hour from initial exposure.
This organ dose contribution is the sum of two photons emitted from Co-60 that occur
with a yield of about 100 percent. Figure 17.1 provides a simulated 3-dimensional view
of the human body with a color profile that equates the organ dose for the 1.33 MeV
photon of Co-60. Each axis is represented in the figure along with a color bar that
indicates the organ dose in MeV/organ in grams provided by the MCNPX output file. In
the MCNPX output file, the trachea receives a slightly lesser dose than the lung based
upon the number of voxels versus the measured gram weight of the trachea. The
phantom includes the airway as part of the trachea. The stomach becomes the most
sensitive organ.
Cs-137 organ dose profile
A Cs-137 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus one hour that ranges from a
high of 1.08 x 10-4 MeV/g for the stomach and a low of 3.41 x 10-9 MeV/g for the skin.
This organ dose contribution is from a 0.66 MeV photon emitted from Cs-137 that
occurs with a yield of about 86 percent. Table 17.2 provides the dose output to the
selected organs at time (T) plus one hour after exposure.
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Fig. 17.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within multiple organs after time T plus one hour.
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Table 17.2. Organ doses for a Cs-137 volume source in multiple organs at T plus one
hour.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 1.90E-04 4.10E-12 3.41E-09 5.47E-19
Rib Bone Group 0 0.00E+00 4.14E-01 1.38E-08 1.26E-05 2.01E-15
Small Int 3499 0.00E+00 6.91E-02 3.22E-08 5.19E-06 8.32E-16
Gonads 0 0.00E+00 5.18E-05 8.69E-09 6.78E-08 1.09E-17
Rectum 0 0.00E+00 3.40E-04 1.26E-08 2.65E-07 4.24E-17
Thyroid 0 0.00E+00 5.22E-03 1.58E-07 1.30E-05 2.09E-15
Lung 15000 2.63E-01 2.54E+00 2.78E-08 3.09E-05 4.95E-15
Eyes 0 0.00E+00 1.53E-04 3.29E-08 4.98E-07 7.98E-17
Trachea 0 0.00E+00 1.28E-02 5.31E-07 6.25E-05 1E-14
Colon 2124 0.00E+00 3.42E-02 3.18E-08 4.55E-06 7.28E-16
Stomach 1400 7.12E-02 3.30E-01 2.37E-07 1.08E-04 1.73E-14
As expected, unlike Co-60, the majority of the activity has been absorbed by the
body at time T plus one hour. Of the activity that remains, the lung contains the largest
percent followed by the stomach. For Cs-137, the most sensitive organ is the stomach
followed by the trachea and lung. Compared to the Cs-137 dose with a source located in
just the lung, the lung dose was 3.60 x 10-5 MeV/g and from multiple source organs the
lung dose was 3.09 x 10-5 MeV/g. The stomach dose from Cs-137 with a source located
only in the stomach was 3.90 x 10-4 MeV/g and from multiple source organs the dose
was 1.08 x 10-4 MeV/g. This produced a reduction in the stomach dose by
approximately 25 percent. The Co-60 multiple source organ dose to the lung dose was
1.16 x 10-4 MeV/g and from Cs-137, the multiple source organ dose to the lung was 3.09
x 10-5 MeV/g. The lung dose was reduced by approximately 25 percent. The stomach
dose from multiple source organs containing Co-60 was 1.42 x 10-4 MeV/g and for Cs-
137 it was 1.08 x 10-4 MeV/g or reduced by approximately 33 percent, respectively.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, no bins had a
zero dose and 8 bins had relative errors exceeding 0.10. Figure 17.2 provides a
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simulated 3-dimensional view of the human body with a color profile that shows the
MCNP dose for the single photon of Cs-137. The color bar units to the right of the
phantom are in MeV/organ weight in grams.
At T plus one hour, the most sensitive organ for a Co-60 exposure was the
trachea that received a dose of 1.16 x 10-4 MeV/g. For a Cs-137 exposure, the most
sensitive organ was the stomach which received a dose of 1.08 x 10-4 MeV/g. The
change in organ sensitivity can be attributed to the difference in activity present in the
lung and stomach at T plus one hour. For Co-60, 59 percent of the activity remains in
the lung while only 26 percent of the activity remains in the lung for Cs-137. Co-60
transfers 2.0 percent of the activity to the stomach while Cs-137 transfers 7.1 percent of
the activity to the stomach.
Ir-192 organ dose profile
An Ir-192 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus one hour that ranges from a
high of 1.15 x 10-4 MeV/g for the stomach and a low of 3.89 x 10-9 MeV/g for the skin.
This organ dose contribution is from the sum of two photons with energies of 0.47 MeV
and 0.32 MeV along with two electrons with maximum energies of 0.66 MeV and 0.54
MeV. All four particles are produced with a yield of 26.2%, 22.4%, 10.1% and 6.7%,
respectively. Table 17.3 provides the calculated dose conversions for each of the
selected organs at time (T) plus one hour from detonation.
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Fig. 17.2. Three-dimensional human dose profile from a Cs-137 photon source
located within multiple organs after time T plus one hour.
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Table 17.3. Organ doses for an Ir-192 volume source in multiple organs at T plus one
hour.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 2.16E-04 1.70E-10 3.89E-09 6.23E-19
Rib Bone Group 0 0.00E+00 4.64E-01 4.40E-07 1.41E-05 2.26E-15
Small Int 3499 6.30E-02 3.82E-01 1.17E-06 2.87E-05 4.59E-15
Gonads 0 0.00E+00 1.30E-04 1.97E-07 1.71E-07 2.73E-17
Rectum 0 0.00E+00 1.11E-03 6.56E-07 8.60E-07 1.38E-16
Thyroid 0 0.00E+00 5.32E-03 3.72E-06 1.33E-05 2.13E-15
Lung 15000 2.63E-01 2.65E+00 5.97E-07 3.21E-05 5.15E-15
Eyes 0 0.00E+00 1.48E-04 5.17E-07 4.82E-07 7.72E-17
Trachea 0 0.00E+00 1.31E-02 1.22E-05 6.41E-05 1.03E-14
Colon 2124 7.36E-03 1.08E-01 1.18E-06 1.44E-05 2.3E-15
Stomach 1400 7.12E-02 3.52E-01 4.29E-06 1.15E-04 1.84E-14
As expected and unlike Cs-137, the majority of the activity remains in the lung
but has begun to pass through the stomach, small intestine and colon. Of the 63 percent
of activity that started in the lung, the lung retains 26 percent, seven percent is in the
stomach and approximately 6.3 percent is in the small intestine. The most sensitive
organ for Ir-192 was the stomach followed by the lung, small intestine and colon.
Compared to the Ir-192 dose with a source located in just the lung, the lung dose was
4.48 x 10-5 MeV/g and from multiple source organs the lung dose was 3.21 x 10-5
MeV/g. The stomach dose from Ir-192 with a source located only in the stomach was
3.76 x 10-5 MeV/g and from multiple source organs the dose was 1.15 x 10-4 MeV/g.
This produced an increase in the stomach dose by approximately three times.
Statistical checks were performed on the Ir-192 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
photons passed and produced similar results as with Co-60 were observed. The 10
statistical checks for tally-six photons passed and produced similar results as with Co-60.
Of the 61 tally bins, no bins had a zero dose and 6 bins had relative errors exceeding
0.10 for the 0.47 MeV photon. The 0.32 MeV photon produced similar results.
The tallies for the electron sources within the organs had to be evaluated in a slightly
different manner based on their inability to penetrate uniformly throughout the phantom.
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Secondary emissions, such as bremsstrahlung and characteristics x rays were the primary
radiation source for organs outside of the source organs. Three of the 10 statistical
checks did not pass. The relative error was 0.26, the VoV was 0.14 and the pdf was 0.
This reflects a large number of zero doses and slightly greater than zero doses based on
the volume electron sources.
Figure 17.3 and 17.4 provide a simulated 3-dimensional view of the human body
with a color profile that shows the MCNP dose for the 0.47 MeV photon of Ir-192 and
the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The color bar
units to the right of the phantom are in MeV/organ weight in grams.
Sr-90 organ dose profile
A Sr-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus one hour after exposure that ranges
from a high of 4.41 x 10-7 MeV/g for the stomach and a low of 4.57 x 10-12 MeV/g for
the skin. This organ dose contribution is from a single beta emission with a maximum
energy of 0.57 MeV. The beta emission is produced with a yield of about 100%. Table
17.4 provides the calculated dose conversions for each of the selected organs that will be
considered in this problem.
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Fig. 17.3. Three-dimensional human dose profile from a 0.47 MeV Ir-192 photon
source located within multiple organs after T plus one hour.
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Fig. 17.4. Three-dimensional human dose profile from a 0.66 MeV Ir-192 electron
source located within multiple organs after T plus one hour.
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Table 17.4. Organ doses from a Sr-90 volume source in multiple organs at time T plus
one hour.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 2.54E-07 1.01E-13 4.57E-12 7.32E-22
Rib Bone Group 0 0.00E+00 1.96E-03 9.09E-10 5.94E-08 9.51E-18
Small Int 3499 6.10E-02 1.34E-03 1.91E-09 1.00E-07 1.61E-17
Gonads 0 0.00E+00 1.36E-07 1.78E-10 1.78E-10 2.85E-20
Rectum 0 0.00E+00 1.32E-06 3.15E-10 1.02E-09 1.64E-19
Thyroid 0 0.00E+00 1.07E-05 3.81E-09 2.68E-08 4.3E-18
Lung 15000 2.64E-01 1.54E-02 1.63E-09 1.87E-07 3E-17
Eyes 0 0.00E+00 1.15E-07 3.75E-10 3.75E-10 6E-20
Trachea 0 0.00E+00 3.72E-05 1.57E-08 1.82E-07 2.92E-17
Colon 2124 7.16E-03 2.51E-04 1.27E-09 3.34E-08 5.34E-18
Stomach 1400 7.18E-02 1.35E-03 7.46E-09 4.41E-07 7.07E-17
As expected, the most sensitive organ is the stomach followed by the lung,
trachea and small intestine. Of the 63 percent of activity that started in the lung, the lung
retained 26 percent. There was 7.1 percent of the activity in the stomach and
approximately 6.1 percent in the small intestine. Compared to the Sr-90 dose with a
source located in just the lung, the lung dose was 2.79 x 10-7 MeV/g and the lung dose
from multiple source organs was 1.87 x 10-7 MeV/g. The stomach dose from Sr-90 with
a source located only in the stomach was 6.76 x 10-8 MeV/g and the stomach dose from
multiple source organs was 4.41 x 10-7 MeV/g. This produced an increase in the
stomach dose by roughly seven times.
Statistical checks were performed on the Sr-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence missed three of the 10 checks. The relative error was 0.28, VoV was 0.16 and
the pdf was 0. The 10 statistical checks for tally-six dose passed with the exception of
the VoV that does not appear to decrease according to the inverse of the number of
histories for the last half of the problem. Of the 61 tally bins, 4 bins had a zero dose and
34 bins had relative errors exceeding 0.10 for the 0.55 MeV beta emission. Figure 17.5
provides a simulated 3-dimensional view of the human body with a color profile that
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shows the organ dose for the beta radiation of Sr-90. The color bar units to the right of
the phantom are in MeV/organ weight in grams.
Y-90 organ dose profile
A Y-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus one hour after exposure that ranges
from a high of 3.73 x 10-6 MeV/g for the stomach and a low of 9.08 x 10-11 MeV/g for
the skin. This organ dose contribution is from a single beta emission with a maximum
energy of 2.28 MeV. The beta emission is produced with a yield of about 100%. Table
17.5 provides the calculated dose conversions for each of the selected organs that will be
considered in this problem.
Table 17.5. Organ doses from a Y-90 volume source in multiple organs at time T plus
one hour.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 5.05E-06 7.72E-13 9.08E-11 1.46E-20
Rib Bone Group 0 0.00E+00 2.10E-02 3.37E-09 6.37E-07 1.02E-16
Small Int 3499 6.10E-02 1.21E-02 9.75E-09 9.11E-07 1.46E-16
Gonads 0 0.00E+00 4.29E-06 2.14E-09 5.61E-09 8.98E-19
Rectum 0 0.00E+00 2.59E-05 2.52E-09 2.01E-08 3.22E-18
Thyroid 0 0.00E+00 1.54E-04 2.08E-08 3.86E-07 6.18E-17
Lung 15000 5.95E-01 1.01E-01 5.75E-09 1.22E-06 1.96E-16
Eyes 0 0.00E+00 5.70E-06 9.32E-09 1.86E-08 2.98E-18
Trachea 0 0.00E+00 4.23E-04 7.65E-08 2.07E-06 3.32E-16
Colon 2124 7.16E-03 3.03E-03 7.44E-09 4.02E-07 6.45E-17
Stomach 1400 7.18E-02 1.14E-02 3.51E-08 3.73E-06 5.98E-16
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Fig. 17.5. Three-dimensional human dose profile from a Sr-90 beta source located
within multiple organs after T plus one hour.
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As expected and like Sr-90, the stomach, trachea and lung received the highest
dose from a highly-energetic beta particle source located in multiple organs at time T
plus one hour after exposure. Of the 63 percent of activity that started in the lung, the
lung retained 26 percent. Based on the IRCP-30 methodology, the organ activity follows
that of Sr-90. Compared to the Y-90 dose with a source located in just the lung, the lung
dose was 1.75 x 10-6 MeV/g and the lung dose from multiple source organs was 1.22 x
10-6 MeV/g. The stomach dose from Y-90 with a source located only in the stomach was
1.70 x 10-5 MeV/g and the stomach dose from multiple source organs was 3.73 x 10-6
MeV/g. This produced a decrease in the stomach dose by roughly 25 percent.
Statistical checks were performed on the Y-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all checks except the pdf which was 0. The 10 statistical checks for tally-
six dose passed all but two of the checks. The VoV does not monotonically decrease
over the last half of the problem nor does it decrease according to the inverse of the
number of histories. Of the 61 tally bins, 1 bin had a zero dose and 27 bins had relative
errors exceeding 0.10 for the 2.28 MeV beta emission. Figure 17.6 provides a simulated
3-dimensional view of the human body with a color profile that shows the MCNP dose
for the beta radiation of Y-90. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
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Fig. 17.6. Three-dimensional human dose profile from a Y-90 beta source located
within multiple organs after T plus one hour.
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Results from multi-organ lung, stomach, liver, small intestine and colon volume sources
after one hour
Figure 17.7 provides a graph of all of the potential sources distributed in multiple
organs at time T plus one hour. Based upon the results of the observed programs, after a
one hour inhalation, Co-60 is the most limiting radionuclide of concern with the
exception of the small intestine and stomach. Ir-192 appears to provide a higher dose to
the small intestine. Ir-192, Co-60 and Cs-137 all appear to be within a margin of error
for the stomach. The trachea appears to be the most sensitive organ based upon a single
emission from a source distribution described above. Even though the trachea shows the
highest sensitivity, the dose is a little deceiving. The observed dose for the trachea is
based on the number of voxels which include the air encircled by the trachea. The actual
dose based on the weight of the organ is less than that for the stomach and small
intestine. Only Sr-90 appears to have a much lower dose for the trachea based upon the
low energy beta. The stomach is the most sensitive organ for this material.
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Fig. 17.7. Summary graph of organ doses for the five potential multi-organ sources
located in multiple organs after time T plus one hour.
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CHAPTER XVIII
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCES IN THE LUNG,
STOMACH, SMALL INTESTINE AND COLON SIX HOURS AFTER A LUNG
INHALATION
Co-60 organ dose profile
A Co-60 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs that ranges from a high of 2.10 x 10-4 MeV/g
for the trachea and a low of 1.25 x 10-8 MeV/g for the skin six hours after initial
exposure. This organ dose contribution is from the sum of two photon emissions that
occur with a yield of about 100 percent. Table 18.1 provides the calculated dose
conversions for each of the selected organs at time (T) plus six hours from detonation.
Table 18.1. Organ doses from a Co-60 volume source in multiple organs at time T plus
six hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 6.93E-04 2.99E-11 1.25E-08 2.00E-18
Rib Bone Group 0 0.00E+00 1.33E+00 9.66E-08 4.03E-05 6.45E-15
Small Int 3499 7.00E-02 8.18E-01 3.93E-07 6.14E-05 9.84E-15
Gonads 0 0.00E+00 4.86E-04 9.35E-08 6.36E-07 1.02E-16
Rectum 0 0.00E+00 3.03E-03 1.47E-07 2.36E-06 3.77E-16
Thyroid 0 0.00E+00 1.72E-02 1.09E-06 4.30E-05 6.89E-15
Lung 15000 4.73E-01 8.49E+00 1.86E-07 1.03E-04 1.65E-14
Eyes 0 0.00E+00 6.74E-04 2.71E-07 2.20E-06 3.53E-16
Trachea 0 0.00E+00 4.30E-02 3.70E-06 2.10E-04 3.37E-14
Colon 2124 6.08E-02 2.35E-01 3.12E-07 3.12E-05 4.99E-15
Stomach 1400 2.19E-02 4.48E-01 1.05E-06 1.46E-04 2.34E-14
As expected, the activity in the lung was reduced from 59 percent to 47 percent
from time T plus one hour to time T plus six hours. The majority of activity remained in
the lung at time T plus six hours. Unlike T plus one hour, the small intestine contains
the second highest activity. The activity in the small intestine increased from 1.2 percent
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to 41 percent. The activity in the stomach was reduced from 7.1 percent to 2.2 percent.
The colon had an increase in activity from 0.7 percent to 6.1 percent. For Co-60, the
most sensitive organs were the trachea and stomach followed by the lung and small
intestine. Compared to the Co-60 dose at time T plus one hour, the lung dose was 1.16 x
10-4 MeV/g and the lung dose from multiple source organs was 1.03 x 10-4 MeV/g at T
plus six hours. The stomach dose from Co-60 at T plus one hour was 1.42 x 10-4 MeV/g
and the stomach dose at time T plus six hours was 1.46 x 10-4 MeV/g or roughly a 3
percent increase in dose to the stomach dose.
Statistical analysis of output file
The tally-four fluence analysis for each detector provided a random behavior for
the mean. The desired relative error should be less than 0.10 and the observed relative
error was 0.02. The desired and observed relative error decreased according to the
inverse of the square root of the number of histories. The desired variance of the
variance should be less than 0.10 and the observed VoV was 0.00. The figure of merit
value was constant and the behavior was random. The probability density function (pdf)
desired should be greater than three, the observed value was 10. The tally-four fluence
passed all 10 statistical checks. Out of 10 tally-four bins, only one had a zero dose and
no bins contained relative errors greater than 0.10. The 1.33 MeV photon simulation
provided similar results. The same single bin had a zero value.
The tally-six dose analysis for each material provided a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for the 1.17 MeV photon and 0.00 for the 1.33 MeV photon. The desired and
observed relative error decreased according to the inverse of the square root of the
number of histories. The desired variance of the variance should be less than 0.10 and
the observed VoV was 0.00. The figure of merit value was constant and the behavior
was random. The desired probability density function (pdf) should be greater than 3.00
and the observed value was 7.64 for the 1.17 MeV photon and 6.74 for the 1.33 MeV
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photon. The tally-six dose passed all 10 statistical checks. Out of 61 tally-six bins, no
bin had a zero dose and only 5 bins contained relative errors greater than 0.10.
Figure 18.1 provides a simulated 3-dimensional view of the human body with a
color profile that shows the organ dose for the 1.33 MeV photon of Co-60. Each axis is
represented in the figure along with a color bar that indicates the organ dose in
MeV/organ in grams provided by the MCNPX output file.
Cs-137 organ dose profile
A Cs-137 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus six hours from exposure that
ranges from a high of 7.46 x 10-5 MeV/g for the trachea and a low of 3.41 x 10-9 MeV/g
for the skin. This organ dose contribution is from a 0.66 MeV photon emitted from Cs-
137 that occurs with a yield of about 86 percent. Table 18.2 provides the dose output to
the selected organs at time (T) plus six hours from detonation.
Table 18.2. Organ doses for a Cs-137 volume source in multiple organs at time T plus
six hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 1.90E-04 4.09E-12 3.41E-09 5.47E-19
Rib Bone Group 0 0.00E+00 4.59E-01 1.53E-08 1.39E-05 2.23E-15
Small Int 3499 0.00E+00 4.25E-02 2.55E-08 3.19E-06 5.11E-16
Gonads 0 0.00E+00 4.09E-05 6.72E-09 5.35E-08 8.57E-18
Rectum 0 0.00E+00 2.69E-04 1.12E-08 2.09E-07 3.35E-17
Thyroid 0 0.00E+00 6.13E-03 1.73E-07 1.53E-05 2.45E-15
Lung 15000 1.92E-01 2.96E+00 2.51E-08 3.59E-05 5.75E-15
Eyes 0 0.00E+00 1.80E-04 3.62E-08 5.87E-07 9.41E-17
Trachea 0 0.00E+00 1.52E-02 5.82E-07 7.46E-05 1.19E-14
Colon 2124 0.00E+00 2.66E-02 2.86E-08 3.53E-06 5.65E-16
Stomach 1400 8.56E-04 9.84E-02 1.32E-07 3.21E-05 5.15E-15
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Fig. 18.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within multiple organs after T plus six hours.
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As expected, the activity in the lung was reduced from 26 percent to 19 percent
from time T plus one hour to time T plus six hours. Based on the ICRP-30
methodology, the majority of the activity was absorbed by the body. The activity in the
stomach is reduced from 7 percent to less than 0.1 percent. For Cs-137, the most
sensitive organs were the trachea followed by the lung, colon and stomach. Compared
to the Co-60 dose at time T plus one hour, the lung dose was 3.09 x 10-5 MeV/g and the
lung dose from multiple source organs was 3.59 x 10-5 MeV/g at T plus six hours. The
dose increase was due to the normalization of activity in the phantom. Even though the
total lung activity decreased, the total percent of residual activity that remained was
concentrated in the lung. The stomach dose from Co-60 at T plus one hour was 1.08 x
10-4 MeV/g and the stomach dose at time T plus six hours was 3.21 x 10-5 MeV/g or
roughly a 3 fold decrease in dose to the stomach dose.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, no bin had a
zero dose and 8 bins had relative errors exceeding 0.10. Figure 19.2 provides a
simulated 3-dimensional view of the human body with a color profile that shows the
MCNP dose for the single photon of Cs-137. The color bar units to the right of the
phantom are in MeV/organ weight in grams.
At T plus six hour, the most sensitive organ for a Co-60 and Cs-137 exposure
was the trachea that received a dose of 2.10 x 10-4 MeV/g and 7.46 x 10-5 MeV/g,
respectively. The change in organ sensitivity for Cs-137 can be attributed to the relative
difference in activity present in the lung and stomach at T plus six hours. For Cs-137
18.2 percent of the activity remains in the lung at T plus six hours while 26 percent of
the activity remains in the lung at T plus 1 hour. The key difference is the amount of
activity present in the stomach. At T plus 6 hours, only 0.09 percent of the activity
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remains in the stomach while at T plus 1 hour, 2.2 percent remains. The relative
majority of activity remains in the lung.
Ir-192 organ dose profile
An Ir-192 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus six hours after exposure that
ranges from a high of 6.05 x 10-5 MeV/g for the colon and a low of 3.83 x 10-9 MeV/g
for the skin. This organ dose contribution is from the sum of two photons with energies
of 0.47 MeV and 0.32 MeV along with two electrons with maximum energies of 0.66
MeV and 0.54 MeV. All four emissions are produced with a yield of 26.2%, 22.4%,
10.1% and 6.7%, respectively. Table 18.3 provides the calculated dose conversions for
each of the selected organs at time (T) plus six hours from detonation.
Table 18.3. Organ doses for an Ir-192 volume source in multiple organs at time T plus
six hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 2.13E-04 1.64E-10 3.84E-09 6.15E-19
Rib Bone Group 0 0.00E+00 3.56E-01 3.94E-07 1.08E-05 1.73E-15
Small Int 3499 4.90E-02 3.56E-01 1.39E-06 2.67E-05 4.28E-15
Gonads 0 0.00E+00 2.85E-04 6.04E-07 3.73E-07 5.97E-17
Rectum 0 0.00E+00 3.83E-03 1.04E-06 2.98E-06 4.77E-16
Thyroid 0 0.00E+00 4.13E-03 3.24E-06 1.03E-05 1.65E-15
Lung 15000 1.91E-01 1.95E+00 5.18E-07 2.36E-05 3.79E-15
Eyes 0 0.00E+00 9.21E-05 5.51E-08 3.01E-07 4.82E-17
Trachea 0 0.00E+00 9.87E-03 1.10E-05 4.83E-05 7.74E-15
Colon 2124 1.01E-01 6.29E-01 2.01E-06 8.35E-05 1.34E-14
Stomach 1400 8.00E-04 8.55E-02 3.24E-06 2.79E-05 4.48E-15
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Fig. 18.2. Three-dimensional human dose profile from a Cs-137 photon source located
within multiple organs at time T plus six hours.
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As expected, like the Ir-192 multiple source organs at time T plus one hour, the
majority of the activity remains in the lung but continues to pass through the stomach,
small intestine and colon. Of the 26 percent of activity that remained in the lung at time
T plus one hour, the lung contains 19 percent of the activity at time T plus six hours.
The activity in the stomach is reduced from seven percent to less than 0.1 percent and
the activity in the small intestine is reduced from 6.3 percent to 4.9 percent. The most
sensitive organs for Ir-192 at time T plus six hours were the colon followed by the
trachea, stomach and small intestine. The dose to the lung at time T plus one hour from
Ir-192 was 3.21 x 10-5 MeV/g and the lung dose at time T plus six hours was 2.36 x 10-5
MeV/g. The colon dose at time T plus one hour from Ir-192 was 1.44 x 10-5 MeV/g and
the colon dose at time T plus six hours was 8.35 x 10-5 MeV/g. This produced an
increase in the stomach dose by approximately four times.
Statistical checks were performed on the Ir-192 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence photons passed and produced similar results. The 10 statistical checks for tally-
six dose photons passed and produced similar results as with Co-60. Of the 61 tally
bins, no bin had a zero dose and 6 bins had relative errors exceeding 0.10 for the 0.47
MeV photon. The second 0.32 MeV photon produced similar results.
The tallies for the electron sources within the lung had to be evaluated in a
slightly different manner based on their inability to penetrate uniformly throughout the
phantom. Secondary emissions, such as bremsstrahlung and characteristics x rays were
the primary radiation source for organs outside of the source organs. Two of the 10
statistical checks did not pass. The relative error was 0.29 and the pdf was 0. This
reflects a large number of zero doses and slightly greater than zero doses based on the
volume electron source.
Figures 18.3 and 18.4 provide a simulated 3-dimensional view of the human
body with a color profile that shows the MCNP dose for the 0.47 MeV photon of Ir-192
and the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The color
bar units to the right of the phantom are in MeV/organ weight in grams.
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Fig. 18.3. Three-dimensional human dose profile from a 0.47 MeV Ir-192 photon
source located within multiple organs after T plus six hours.
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Fig. 18.4. Three-dimensional human dose profile from a 0.66 MeV Ir-192 beta source
located within multiple organs after T plus six hours.
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Sr-90 organ dose profile
A Sr-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus six hours after exposure that ranges
from a high of 2.57 x 10-7 MeV/g for the colon and a low of 4.40 x 10-12 MeV/g for the
skin. This organ dose contribution is from a single beta emission with a maximum
energy of 0.55 MeV. The beta emission is produced with a yield of about 86 percent.
Table 18.4 provides the calculated dose conversions for each of the selected organs that
will be considered in this problem.
Table 18.4. Organ doses from a Sr-90 volume source in multiple organs at time T plus
six hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 2.45E-07 1.04E-13 4.40E-12 7.05E-22
Rib Bone Group 0 0.00E+00 1.71E-03 8.55E-10 5.18E-08 8.30E-18
Small Int 3499 3.20E-02 1.15E-03 1.85E-09 8.66E-08 1.39E-17
Gonads 0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0
Rectum 0 0.00E+00 4.38E-06 7.21E-10 3.41E-09 5.45E-19
Thyroid 0 0.00E+00 1.03E-05 3.73E-09 2.58E-08 4.13E-18
Lung 15000 1.92E-01 1.44E-02 1.59E-09 1.75E-07 2.8E-17
Eyes 0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0
Trachea 0 0.00E+00 3.65E-05 1.89E-08 1.79E-07 2.86E-17
Colon 2124 8.36E-02 1.93E-03 3.59E-09 2.57E-07 4.11E-17
Stomach 1400 8.00E-04 1.72E-04 2.76E-09 5.60E-08 8.97E-18
The most sensitive organ for a Sr-90 electron source at time T plus six hours after
exposure has changed from the stomach to the colon. The trachea and lung follow the
colon in sensitivity. The colon retained 0.7 percent of the activity at T plus one hour and
8.4 percent at T plus six hours. Of the 26 percent of activity that remained in the lung at
T plus one hour, the lung retained 19.2 percent at T plus six hours. Compared to the Sr-
90 dose to the lung at T plus one hour, which was 1.87 x 10-7 MeV/g, the lung dose at T
plus six hours was 1.75 x 10-7 MeV/g.
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Statistical checks were performed on the Sr-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence missed three of the 10 checks. The relative error was 0.30, VoV was 0.20 and
the pdf was 0. The 10 statistical checks for tally-six dose passed. Of the 61 tally bins, 8
bins had a zero dose and 30 bins had relative errors exceeding 0.10 for the 0.55 MeV
beta emission. Figure 18.5 provides a simulated 3-dimensional view of the human body
with a color profile that shows the MCNP dose for the beta radiation of Sr-90 absorbed
by each organ. The color bar units to the right of the phantom are in MeV/organ weight
in grams.
Y-90 organ dose profile
A Y-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus six hours after exposure that ranges
from a high of 1.95 x 10-6 MeV/g for the trachea and a low of 9.04 x 10-11 MeV/g for the
skin. This organ dose contribution is from a single beta emission with a maximum
energy of 2.28 MeV. The beta emission is produced with a yield of about 100%. Table
18.5 provides the calculated dose conversions for each of the selected organs that will be
considered in this problem.
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Fig. 18.5. Three-dimensional human dose profile from a Sr-90 beta source located
within multiple organs after T plus six hours.
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Table 18.5. Organ doses from a Y-90 volume source in multiple organs at time T plus
six hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose
(Gy)/his
Skin 0 0.00E+00 5.03E-06 7.78E-13 9.04E-11 1.45E-20
Rib Bone Group 0 0.00E+00 1.86E-02 3.22E-09 5.65E-07 9.05E-17
Small Int 3499 3.20E-02 1.15E-02 9.77E-09 8.65E-07 1.39E-16
Gonads 0 0.00E+00 5.07E-06 2.00E-09 6.63E-09 1.06E-18
Rectum 0 0.00E+00 5.94E-05 3.92E-09 4.62E-08 7.40E-18
Thyroid 0 0.00E+00 1.58E-04 2.44E-08 3.94E-07 6.32E-17
Lung 15000 1.92E-01 9.21E-02 5.48E-09 1.12E-06 1.79E-16
Eyes 0 0.00E+00 3.40E-06 4.80E-09 1.11E-08 1.78E-18
Trachea 0 0.00E+00 3.99E-04 7.23E-08 1.95E-06 3.13E-16
Colon 2124 8.36E-02 1.44E-02 1.51E-08 1.92E-06 3.07E-16
Stomach 1400 8.00E-04 2.58E-03 1.70E-08 8.42E-07 1.35E-16
As with Sr-90, the colon, trachea and lung received the highest dose from a
highly-energetic beta radiation source located in multiple organs at time T plus six hours
after exposure. Of the 26 percent of activity that remained in the lung at T plus one
hour, the lung retained 19.2 percent at T plus six hours. The organ activity follows that
of Sr-90. Compared to the Y-90 dose at T plus one hour which was 1.22 x 10-6 MeV/g,
the lung dose at T plus six hours was 1.12 x 10-6 MeV/g. The colon dose from Y-90 at T
plus one hour was 1.44 x 10-5 MeV/g and at the colon dose at T plus six hours was 1.92 x
10-6 MeV/g. This produced a decrease in the colon dose by roughly seven fold.
Statistical checks were performed on the Y-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all checks except the pdf which was 0. The 10 statistical checks for tally-
six dose passed. Of the 61 tally bins, no bin had a zero dose and 25 bins had relative
errors exceeding 0.10 for the 2.28 MeV beta emission. Figure 18.6 provides a simulated
3-dimensional view of the human body with a color profile that shows the organ dose for
the beta emission of Y-90. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
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Fig. 18.6. Three-dimensional human dose profile from a Y-90 beta source located
within multiple organs after T plus six hours.
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Results from multi-organ lung, stomach, liver, small intestine and colon volume sources
after six hours
Figure 18.7 provides a graph of all of the potential sources distributed in multiple
organs after T plus 6 hours. Based upon the results of the observed programs, six hours
after inhalation, Co-60 is the most limiting radionuclide with the exception of the colon.
Ir-192 appears to provide a higher dose to the colon. Ir-192 and Co-60 appear to be
within a margin of error for the small intestine and gonads. The trachea and stomach
appear to be the most sensitive organs based upon a single emission from a source
distribution described above. Even though the trachea shows the highest sensitivity, the
dose is a little deceiving. The observed dose for the trachea is based on the number of
voxels which include the air encircled by the trachea. The actual dose based on the
weight of the organ is less than that for the lung, stomach and small intestine. The
stomach, followed by the lung, appears to be the most sensitive organs at this time
period.
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Fig. 18.7. Summary graph of organ doses for the five potential multi-organ sources
located in multiple organs after time T plus six hours.
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CHAPTER XIX
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCES IN THE LUNG,
STOMACH, SMALL INTESTINE AND COLON TWELVE HOURS AFTER A LUNG
INHALATION
Co-60 organ dose profile
A Co-60 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs that ranges from a high of 1.59 x 10-4 MeV/g
for the trachea and a low of 1.24 x 10-8 MeV/g for the skin. This organ dose contribution
is from the sum of two photon emissions that occur with a yield of about 100 percent.
Table 19.1 provides the calculated dose conversions for each of the selected organs at
time (T) plus twelve hours from exposure.
Table 19.1. Organ doses from a Co-60 volume source in multiple organs at time T plus
12 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ Dose
(Gy)/his
Skin 0 0.00E+00 6.90E-04 2.98E-11 1.24E-08 1.98644E-18
Rib Bone Group 0 0.00E+00 1.06E+00 8.97E-08 3.20E-05 5.13E-15
Small Int 3499 6.50E-02 1.05E+00 4.43E-07 7.91E-05 1.26752E-14
Gonads 0 0.00E+00 9.79E-04 1.39E-07 1.28E-06 2.05191E-16
Rectum 0 0.00E+00 7.76E-03 2.38E-07 6.03E-06 9.67E-16
Thyroid 0 0.00E+00 1.36E-02 9.75E-07 3.41E-05 5.45892E-15
Lung 15000 3.74E-01 6.41E+00 1.87E-07 7.78E-05 1.24664E-14
Eyes 0 0.00E+00 5.23E-04 2.36E-07 1.71E-06 2.73499E-16
Trachea 0 0.00E+00 3.24E-02 3.23E-06 1.59E-04 2.54653E-14
Colon 2124 1.61E-01 1.11E+00 6.48E-07 1.47E-04 2.36076E-14
Stomach 1400 1.40E-02 3.50E-01 9.37E-07 1.14E-04 1.831E-14
As expected, the activity in the lung was reduced from 47 percent to 37 percent
from time T plus six hours to time T plus 12 hours. Once again, the majority of the
activity remains in the lung at time T plus 12 hours. As with time T plus six hours, the
small intestine contains the second highest activity at T plus 12 hours. The activity of
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the small intestine decreased from 41 percent to 6.5 percent. The activity in the stomach
was further reduced from 2.2 percent to 1.4 percent. The activity in the colon increased
from 6.1 percent to 16.1 percent. For Co-60, the most sensitive organs were the trachea
followed closely by the colon, stomach and small intestine. Compared to the Co-60 dose
at time T plus six hours, the lung dose was 1.03 x 10-4 MeV/g and the lung dose at time
T plus 12 hours was 7.78 x 10-5 MeV/g. The stomach dose from Co-60 at T plus six
hours was 1.46 x 10-4 MeV/g and the stomach dose at time T plus 12 hours was 1.14 x
10-4 MeV/g or approximately a 22 percent decrease in dose to the stomach.
Statistical analysis of output file
The tally-four fluence analysis for each detector provided a random behavior for
the mean. The desired relative error should be less than 0.10 and the observed relative
error was 0.03. The desired and observed relative errors decreased according to the
inverse square root of the number of histories. The desired variance of the variance
should be less than 0.10 and the observed VoV was 0.00. The figure of merit value was
constant and the behavior was random. The probability density function (pdf) desired
should be greater than three and the observed value was 10. The tally-four fluence
passed all 10 statistical checks. Out of 10 tally-four bins, only one had a zero dose and
no bins contained relative errors greater than 0.10. The second 1.33 MeV photon
simulation provided similar results.
The tally-six dose analysis for each material provided a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for the 1.17 MeV photon and 0.00 for the 1.33 MeV photon. The desired and
observed relative error decreased according to the inverse square root of the number of
histories. The desired variance of the variance should be less than 0.10 and the observed
VoV was 0.00. The figure of merit value was constant and the behavior was random.
The desired probability density function (pdf) should be greater than 3.00 and the
observed value was 10.0 for the 1.17 MeV photon and 6.77 for the 1.33 MeV photon.
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The tally-six dose passed all 10 statistical checks. Out of 61 tally-six bins, no bin had a
zero dose and only 5 bins contained relative errors greater than 0.10.
Figure 19.1 provides a simulated 3-dimensional view of the human body with a
color profile that shows the MCNP dose for the 1.33 MeV photon of Co-60 absorbed by
each organ. Each axis is represented in the figure along with a color bar that indicates
the organ dose in MeV/organ in grams provided by the MCNPX output file. In the
MCNPX output file, the trachea received a slightly lesser dose than the lung based upon
the number of voxels versus the measured gram weight of the trachea. The phantom
includes the airway as part of the trachea. The dose difference is not significant.
Cs-137 organ dose profile
A Cs-137 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus twelve hours that ranges from
a high of 7.54 x 10-5 MeV/g for the trachea and a low of 3.41 x 10-9 MeV/g for the skin.
This organ dose contribution is from a 0.66 MeV photon emitted from Cs-137 that
occurs with a yield of about 86 percent. Table 19.2 provides the calculated dose
conversions for the selected organs at time (T) plus twelve hours from detonation.
Table 19.2. Organ doses for a Cs-137 volume source in multiple organs at time T plus
12 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ Dose
(Gy)/his
Skin 0 0.00E+00 1.90E-04 4.09E-12 3.41E-09 5.45694E-19
Rib Bone Group 0 0.00E+00 4.56E-01 1.52E-08 1.39E-05 2.22E-15
Small Int 3499 0.00E+00 4.15E-02 2.50E-08 3.12E-06 4.99783E-16
Gonads 0 0.00E+00 4.56E-05 7.80E-09 5.96E-08 9.54472E-18
Rectum 0 0.00E+00 2.74E-04 1.12E-08 2.13E-07 3.41E-17
Thyroid 0 0.00E+00 6.42E-03 1.76E-07 1.60E-05 2.56865E-15
Lung 15000 1.44E-01 2.96E+00 2.51E-08 3.59E-05 5.75445E-15
Eyes 0 0.00E+00 1.76E-04 3.69E-08 5.75E-07 9.21696E-17
Trachea 0 0.00E+00 1.54E-02 5.81E-07 7.54E-05 1.20779E-14
Colon 2124 0.00E+00 2.64E-02 2.84E-08 3.50E-06 5.61162E-16
Stomach 1400 1.20E-04 9.53E-02 1.31E-07 3.11E-05 4.98756E-15
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Fig. 19.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within multiple organs after T plus 12 hours.
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The activity in the lung was reduced from 19 percent to 14.4 percent from time T
plus six hours to time T plus 12 hours. The majority of the activity was absorbed by the
body. The activity in the stomach was reduced from 0.1 percent to less than 0.01
percent. For Cs-137, the most sensitive organs were the trachea followed by the lung,
stomach and colon. Compared to the Co-60 dose at time T plus six hours, the lung dose
was 4.91 x 10-5 MeV/g and the lung dose at T plus 12 hours was 3.59 x 10-5 MeV/g. The
stomach dose from Co-60 at T plus six hours was 3.21 x 10-5 MeV/g and the stomach
dose at time T plus 12 hours was 3.11 x 10-5 MeV/g or roughly a five percent decrease in
dose to the stomach.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The same single bin detector contained a
zero result. The 10 statistical checks for tally-six dose passed and produced similar
results as with Co-60. Of the 61 tally bins, no bin had a zero dose and 8 bins had
relative errors exceeding 0.10. Figure 19.2 provides a simulated 3-dimensional view of
the human body with a color profile that shows the organ dose for the single photon of
Cs-137. The color bar units to the right of the phantom are in MeV/organ weight in
grams.
At T plus twelve hours, the most sensitive organ for a Co-60 and Cs-137
exposure was the trachea that received a dose of 1.59 x 10-4 MeV/g and 7.54 x 10-5
MeV/g, respectively. The change in activity is not enough to alter the most sensitive
organ for either radionuclide. For Cs-137, 14.4 percent of the activity remained in the
lung at T plus twelve hours while 19.2 percent of the activity remained in the lung at T
plus 6 hours. The activity in the stomach dropped from 0.08 percent to 0.01 percent at T
plus 12 hours. The relative majority of the residual activity remained in the lung.
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Fig. 19.2. Three-dimensional human dose profile from a Cs-137 source located within
multiple organs after T plus 12 hours.
205
Ir-192 organ dose profile
An Ir-192 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus twelve hours from exposure
that ranges from a high of 8.35 x 10-5 MeV/g for the colon and a low of 3.84 x 10-9
MeV/g for the skin. This organ dose contribution is from the sum of two photons with
energies of 0.47 MeV and 0.32 MeV along with two electrons with maximum energies
of 0.66 MeV and 0.54 MeV. All four emissions are produced with a yield of 26.2%,
22.4%, 10.1% and 6.7%, respectively. Table 19.3 provides the calculated dose
conversions for each of the selected organs at time (T) plus twelve hours from
detonation.
Table 19.3. Organ doses for an Ir-192 volume source in multiple organs at time T plus
12 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ Dose
(Gy)/his
Skin 0 0.00E+00 2.13E-04 1.62E-10 3.83E-09 6.14052E-19
Rib Bone Group 0 0.00E+00 3.85E-01 4.03E-07 1.17E-05 1.87E-15
Small Int 3499 1.40E-02 4.59E-01 1.37E-06 3.45E-05 5.52347E-15
Gonads 0 0.00E+00 2.76E-04 6.43E-07 3.61E-07 5.78102E-17
Rectum 0 0.00E+00 3.15E-03 1.07E-06 2.45E-06 3.93E-16
Thyroid 0 0.00E+00 4.52E-03 3.44E-06 1.13E-05 1.81011E-15
Lung 15000 1.42E-01 2.16E+00 5.41E-07 2.63E-05 4.20752E-15
Eyes 0 0.00E+00 1.02E-04 7.20E-07 3.32E-07 5.3107E-17
Trachea 0 0.00E+00 1.10E-02 1.06E-05 5.38E-05 8.61934E-15
Colon 2124 1.30E-01 4.56E-01 1.80E-06 6.05E-05 9.69749E-15
Stomach 1400 0.00E+00 9.60E-02 3.14E-06 3.14E-05 5.0224E-15
As expected, like the Ir-192 multiple source organs at time T plus six hours, the
majority of the activity remained in the lung but continues to pass through the stomach,
small intestine and colon. Of the 19 percent of activity that remained in the lung at time
T plus six hours, the lung retained 14.2 percent at time T plus 12 hours. The activity in
the stomach was reduced from 0.1 percent to essentially zero and the activity in the
small intestine was reduced from 4.9 percent to 4.6 percent. The most sensitive organ
206
for Ir-192 at time T plus 12 hours were the colon followed by the trachea, stomach and
small intestine. The dose to the lung at time T plus six hours from Ir-192 was 3.59 x 10-5
MeV/g and the dose to the lung at time T plus 12 hours was 2.63 x 10-5 MeV/g. The
colon dose at time T plus six hours from Ir-192 was 3.53 x 10-6 MeV/g and the colon
dose at time T plus 12 hours was 6.05 x 10-5 MeV/g. This produced an increase in the
colon dose by approximately two times.
Statistical checks were performed on the Ir-192 Dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence photons passed and produced similar results. The 10 statistical checks for tally-
six dose photons passed and produced similar results as with Co-60. Of the 61 tally
bins, no bin had zero dose and 6 bins had relative errors exceeding 0.10 for the 0.47
MeV photon. The second 0.32 MeV photon produced similar results.
The tallies for the electron sources within the multiple organs had to be evaluated
in a slightly different manner based on their inability to penetrate uniformly throughout
the phantom. Secondary emissions, such as bremsstrahlung and characteristics x rays
were the primary radiation source for organs outside of the source organs. Four of the
10 statistical checks did not pass. The relative error was 0.36, the VoV was 0.39 and the
rate did not decrease according to the inverse of the number of histories, and the pdf
value was 0. This reflects a large number of zero doses and slightly greater than zero
doses based on the electron source.
Figures 19.3 and 19.4 provide a simulated 3-dimensional view of the human
body with a color profile that shows the MCNP dose for the 0.47 MeV photon of Ir-192
and the 0.66 MeV electron of Ir-192 absorbed by each organ, respectively. The color
bar units to the right of the phantom are in MeV/organ weight in grams.
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Fig. 19.3. Three-dimensional human dose profile from the 0.47 MeV Ir-192 photon
source located within multiple organs after T plus 12 hours.
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Fig. 19.4. Three-dimensional human dose profile from the 0.66 MeV Ir-192 electron
source located within multiple organs after T plus 12 hours.
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Sr-90 organ dose profile
A Sr-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus twelve hours that ranges from a
high of 3.48 x 10-7 MeV/g for the colon and a low of 4.47 x 10-12 MeV/g for the skin.
This organ dose contribution is from a single beta emission with a maximum energy of
0.55 MeV. The beta emission is produced with a yield of about 100%. Table 19.4
provides the calculated dose conversions for each of the selected organs that will be
considered in this problem.
Table 19.4. Organ doses from a Sr-90 volume source in multiple organs at time T plus
12 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ Dose
(Gy)/his
Skin 0 0.00E+00 2.49E-07 9.31E-14 4.47E-12 7.16824E-22
Rib Bone Group 0 0.00E+00 1.66E-03 8.31E-10 5.03E-08 8.07E-18
Small Int 3499 4.20E-03 5.90E-04 1.38E-09 4.43E-08 7.09273E-18
Gonads 0 0.00E+00 1.13E-07 1.48E-10 1.48E-10 2.3647E-20
Rectum 0 0.00E+00 5.88E-06 9.08E-10 4.57E-09 7.33E-19
Thyroid 0 0.00E+00 9.11E-06 3.02E-09 2.28E-08 3.64857E-18
Lung 15000 1.42E-01 1.36E-02 1.54E-09 1.65E-07 2.64667E-17
Eyes 0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0
Trachea 0 0.00E+00 3.42E-05 1.62E-08 1.67E-07 2.68191E-17
Colon 2124 9.38E-02 2.62E-03 4.14E-09 3.48E-07 5.57551E-17
Stomach 1400 0.00E+00 1.52E-04 2.85E-09 4.95E-08 7.93062E-18
The most sensitive organ for a Sr-90 electron source at time T plus 12 hours
remained the colon. The trachea and lung follow the colon in sensitivity. The colon
retained 8.4 percent of the activity at T plus six hours and 9.4 percent at T plus 12 hours.
Of the 19.2 percent of activity that remained in the lung at T plus six hours, the lung
retained 14.2 percent at T plus 12 hours. Compared to the Sr-90 lung dose at T plus six
hours which was 1.75 x 10-7 MeV/g, the lung dose at T plus 12 hours was 1.65 x 10-7
MeV/g.
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Statistical checks were performed on the Sr-90 Dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence missed three of the 10 checks. The relative error was 0.38, VoV was 0.33 and
the pdf was 0. The 10 statistical checks for tally-six dose passed. Of the 61 tally bins, 8
bins had a zero dose and 29 bins had relative errors exceeding 0.10 for the 0.55 MeV
beta emission. Figure 19.5 provides a simulated 3-dimensional view of the human body
with a color profile that shows the organ dose for the beta emission of Sr-90. The color
bar units to the right of the phantom are in MeV/organ weight in grams.
Y-90 organ dose profile
A Y-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus twelve hours that ranges from a
high of 2.55 x 10-6 MeV/g for the colon and a low of 8.94 x 10-11 MeV/g for the skin.
This organ dose contribution is from a single beta emission with a maximum energy of
2.28 MeV. The beta emission is produced with a yield of about 100%. Table 19.5
provides the calculated dose conversions for each of the selected organs that will be
considered in this problem.
Table 19.5. Organ doses from a Y-90 volume source in multiple organs at time T plus
12 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ Dose
(Gy)/his
Skin 0 0.00E+00 4.97E-06 7.77E-13 8.94E-11 1.43148E-20
Rib Bone Group 0 0.00E+00 1.80E-02 3.18E-09 5.48E-07 8.78E-17
Small Int 3499 4.20E-03 7.62E-03 8.69E-09 5.72E-07 9.1634E-17
Gonads 0 0.00E+00 6.34E-06 3.17E-09 8.29E-09 1.32831E-18
Rectum 0 0.00E+00 8.05E-05 5.12E-09 6.26E-08 1.00E-17
Thyroid 0 0.00E+00 1.32E-04 1.89E-08 3.29E-07 5.27426E-17
Lung 15000 1.42E-01 8.72E-02 5.30E-09 1.06E-06 1.69655E-16
Eyes 0 0.00E+00 4.71E-06 7.64E-09 1.54E-08 2.46646E-18
Trachea 0 0.00E+00 3.73E-04 6.51E-08 1.83E-06 2.92813E-16
Colon 2124 9.38E-02 1.92E-02 1.78E-08 2.55E-06 4.08413E-16
Stomach 1400 0.00E+00 2.29E-03 1.68E-08 7.49E-07 1.19915E-16
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Fig. 19.5. Three-dimensional human dose profile from a Sr-90 beta source located
within multiple organs after T plus 12 hours.
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As with Sr-90, the colon, trachea and lung received the highest dose from a
highly-energetic, beta radiation source located in multiple organs at time T plus 12
hours. Of the 19.2 percent of activity that remained in the lung at T plus six hours, the
lung retains 14.2 percent at T plus 12 hours. The organ activity follows that of Sr-90.
Compared to the Y-90 dose at T plus six hours which was 1.12 x 10-6 MeV/g, the lung
dose at T plus 12 hours was 1.06 x 10-6 MeV/g. The colon dose from Y-90 at T plus six
hours was 1.92 x 10-6 MeV/g and the colon dose at T plus 12 hours was 2.55 x 10-6
MeV/g. This produced an increase in the colon dose by roughly 30 percent.
Statistical checks were performed on the Y-90 Dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all but three checks. The VoV did not decrease according to the inverse
of the number of histories and the pdf was 0. The 10 statistical checks for tally-six dose
passed. Of the 61 tally bins, one bin had a zero dose and 24 bins had relative errors
exceeding 0.10 for the 2.28 MeV beta emission. Figure 19.6 provides a simulated 3-
dimensional view of the human body with a color profile that shows the organ dose for
an Y-90 source in multiple organs. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
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Fig. 19.6. Three-dimensional human dose from a Y-90 beta source located within
multiple organs after T plus 12 hours.
214
Results from multi-organ lung, stomach, liver, small intestine and colon volume sources
after twelve hours
Figure 19.7 provides a graph of all of the potential sources distributed in multiple
organs after T plus 12 hours and their organ doses. Based upon the results of the
observed programs, twelve hours after inhalation, Co-60 is the most limiting
radionuclide. The trachea, colon and stomach appear to be the most sensitive organs
based upon a single emission from a source distribution described above. Even though
the trachea shows the highest sensitivity, the dose is a little deceiving. The observed
dose for the trachea is based on the number of voxels which include the air encircled by
the trachea. The actual dose, based on the weight of the organ, is less than that for the
stomach and small intestine.
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Fig. 19.7. Summary graph of organ doses for the five potential multi-organ sources
after T plus 12 hours.
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CHAPTER XX
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCES IN THE LUNG,
STOMACH, SMALL INTESTINE AND COLON 18 HOURS AFTER A LUNG
INHALATION
Co-60 organ dose profile
A Co-60 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs that ranges from a high of 2.00 x 10-4 MeV/g
for the colon and a low of 1.23 x 10-8 MeV/g for the skin. This organ dose contribution
is from the sum of two photon emissions that occur with a yield of about 100 percent.
Table 20.1 provides the calculated dose conversions for each of the selected organs at
time (T) plus 18 hours from detonation.
Table 20.1. Organ doses from a Co-60 volume source in multiple organs at time T plus
18 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose (Gy)
Skin 0 0.00E+00 6.85E-04 2.96E-11 1.23E-08 1.97E-18
Rib Bone Group 0 0.00E+00 9.45E-01 8.61E-08 2.87E-05 4.60E-15
Small Int 3499 4.60E-02 1.04E+00 4.37E-07 7.80E-05 1.25E-14
Gonads 0 0.00E+00 1.15E-03 1.48E-07 1.51E-06 2.42E-16
Rectum 0 0.00E+00 1.18E-02 2.99E-07 9.18E-06 1.47E-15
Thyroid 0 0.00E+00 1.13E-02 8.68E-07 2.83E-05 4.53E-15
Lung 15000 3.10E-01 5.60E+00 1.77E-07 6.79E-05 1.09E-14
Eyes 0 0.00E+00 4.69E-04 2.27E-07 1.53E-06 2.45E-16
Trachea 0 0.00E+00 2.84E-02 3.04E-06 1.39E-04 2.23E-14
Colon 2124 2.27E-01 1.51E+00 7.22E-07 2.00E-04 3.21E-14
Stomach 1400 9.21E-03 3.04E-01 8.72E-07 9.91E-05 1.59E-14
The activity in the lung was reduced from 37 percent to 31 percent from time T
plus six hours to time T plus 18 hours. As expected, the majority of the activity remains
in the lung at time T plus 18 hours. As with time T plus six hours, the small intestine
contains the second highest activity at T plus 18 hours. The activity of the small
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intestine decreased from 6.5 percent to 4.6 percent. The activity in the stomach was
further reduced from 1.4 percent to 0.9 percent. The activity in the colon increased from
16.1 percent to 22.7 percent. For Co-60, the most sensitive organ changed from the
trachea to the colon followed closely by the stomach and small intestine. Compared to
the Co-60 dose at time T plus 12 hours, the lung dose was 7.78 x 10-5 MeV/g and the
lung dose at time T plus 18 hours was 6.79 x 10-5 MeV/g. The stomach dose from Co-60
at T plus 12 hours was 1.14 x 10-4 MeV/g and the stomach dose at time T plus 18 hours
was 9.91 x 10-5 MeV/g or roughly a 10 percent decrease in dose to the stomach.
Statistical analysis of output file
The tally-four fluence analysis for each detector, setup as described in chapter
VII, provided a random behavior for the mean. The desired relative error should be less
than 0.10 and the observed relative error was 0.03. The desired and observed relative
errors decreased according to the inverse of the square root of the number of histories.
The desired variance of the variance should be less than 0.10 and the observed VoV was
0.00. The figure of merit value was constant and the behavior was random. The
probability density function (pdf) desired should be greater than three, the observed pdf
value was 10. The tally-four fluence passed all 10 statistical checks. Out of 10 tally-
four bins, only one had a zero dose and no bins contained relative errors greater than
0.10. The second 1.33 MeV photon simulation provided similar results.
The tally-six dose analysis for each material provided a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for the 1.17 MeV photon and 0.00 for the 1.33 MeV photon. The desired and
observed relative errors decreased according to the inverse of the square root of the
number of histories. The desired variance of the variance should be less than 0.10 and
the observed VoV was 0.00. The figure of merit value was constant and the behavior
was random. The desired probability density function (pdf) should be greater than 3.00
and the observed value was 10.0 for the 1.17 MeV photon and 9.79 for the 1.33 MeV
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photon. The tally-six dose passed all 10 statistical checks. Out of 61 tally-six bins, no
bin had a zero dose and only 5 bins contained relative errors greater than 0.10.
Figure 20.1 provides a simulated 3-dimensional view of the human body with a
color profile that shows the organ dose for the 1.33 MeV photon of Co-60. Each axis is
represented in the figure along with a color bar that indicates the organ dose in
MeV/organ in grams provided by the MCNPX output file. In the MCNPX output file,
the trachea receives a slightly lesser dose than the lung based upon the number of voxels
versus the measured gram weight of the trachea. The phantom includes the airway as
part of the trachea.
Cs-137 organ dose profile
A Cs-137 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus 18 hours from exposure that
ranges from a high of 7.24 x 10-5 MeV/g for the trachea and a low of 3.41 x 10-9 MeV/g
for the skin. This organ dose contribution is from a 0.66 MeV photon emitted from Cs-
137 that occurs with a yield of about 86 percent. Table 20.2 provides the calculated dose
conversions to the selected organs at time (T) plus 18 hours from detonation.
Table 20.2. Organ doses for a Cs-137 volume source in multiple organs at time T plus
18 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose (Gy)
Skin 0 0.00E+00 1.90E-04 4.10E-12 3.41E-09 5.47E-19
Rib Bone Group 0 0.00E+00 4.59E-01 1.39E-08 1.39E-05 2.23E-15
Small Int 3499 0.00E+00 4.21E-02 2.53E-08 3.16E-06 5.06E-16
Gonads 0 0.00E+00 2.83E-05 5.67E-09 3.71E-08 5.94E-18
Rectum 0 0.00E+00 2.78E-04 1.13E-08 2.16E-07 3.47E-17
Thyroid 0 0.00E+00 6.12E-03 1.73E-07 1.53E-05 2.45E-15
Lung 15000 1.07E-01 2.96E+00 2.51E-08 3.59E-05 5.75E-15
Eyes 0 0.00E+00 1.66E-04 3.39E-08 5.42E-07 8.69E-17
Trachea 0 0.00E+00 1.48E-02 5.72E-07 7.24E-05 1.16E-14
Colon 2124 0.00E+00 2.70E-02 2.86E-08 3.58E-06 5.73E-16
Stomach 1400 5.00E-05 9.23E-02 1.27E-07 3.01E-05 4.83E-15
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Fig. 20.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within multiple organs after T plus 18 hours.
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The activity in the lung was reduced from 14.4 percent to 10.7 percent from time
T plus 12 hours to time T plus 18 hours. The majority of the activity is absorbed by the
body. The activity in the stomach remains at less than 0.01 percent. For Cs-137, the
most sensitive organs were the trachea followed by the lung, stomach and colon.
Compared to the Cs-137 dose at time T plus 12 hours, the lung dose was 3.59 x 10-5
MeV/g and the dose remained the same at 3.59 x 10-5 MeV/g for T plus 18 hours. The
stomach dose from Co-60 at T plus 12 hours was 3.11 x 10-5 MeV/g and at time T plus
18 hours the stomach dose was 3.01 x 10-5 MeV/g or roughly a ten percent decrease in
dose to the stomach.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, no bin had a
zero dose and 8 bins had relative errors exceeding 0.10. Figure 20.2 provides a
simulated 3-dimensional view of the human body with a color profile that shows the
organ dose for the single photon of Cs-137. The color bar units to the right of the
phantom are in MeV/organ weight in grams.
At T plus 18 hours, the most sensitive organ for a Co-60 shifted from the trachea
to the colon. For Cs-137 the most sensitive organ was the trachea. The colon received a
dose of 2.00 x 10-4 MeV/g from Co-60 and the trachea received a dose of 7.24 x 10-4
MeV/g from Cs-137. The change in Co-60 activity from T plus 12 hours to T plus 18
hours was enough to alter the most sensitive organ. There was not enough change in Cs-
137 activity to alter the most sensitive organ. For Cs-137, 10.7 percent of the activity
remains in the lung at T plus 18 hours while 14.4 percent of the activity remains in the
lung at T plus 12 hours. The activity in the stomach dropped from 0.012 percent to
0.005 percent at T plus 18 hours. The key difference is the change in activity present in
the colon. The relative majority of activity remains in the lung.
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Fig. 20.2. Three-dimensional human dose profile from a Cs-137 photon source located
within multiple organs after T plus 18 hours.
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Ir-192 organ dose profile
An Ir-192 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus 18 hours from exposure that
ranges from a high of 9.67 x 10-5 MeV/g for the colon and a low of 3.84 x 10-9 MeV/g
for the skin. This organ dose contribution is from the sum of two photons with energies
of 0.47 MeV and 0.32 MeV along with two electrons with maximum energies of 0.66
MeV and 0.54 MeV. All four emissions are produced with a yield of 26.2%, 22.4%,
10.1% and 6.7%, respectively. Table 20.3 provides the calculated dose conversions for
each of the selected organs at time (T) plus 18 hours from detonation.
Table 20.3. Organ doses for an Ir-192 volume source in multiple organs at time T plus
18 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose (Gy)
Skin 0 0.00E+00 2.13E-04 1.62E-10 3.83E-09 6.14E-19
Rib Bone Group 0 0.00E+00 3.39E-01 3.85E-07 1.03E-05 1.65E-15
Small Int 3499 2.55E-03 3.22E-01 1.49E-06 2.42E-05 3.88E-15
Gonads 0 0.00E+00 3.07E-04 7.84E-07 4.01E-07 6.43E-17
Rectum 0 0.00E+00 4.21E-03 1.28E-06 3.28E-06 5.25E-16
Thyroid 0 0.00E+00 3.94E-03 3.05E-06 9.84E-06 1.58E-15
Lung 15000 1.07E-01 1.81E+00 5.05E-07 2.20E-05 3.53E-15
Eyes 0 0.00E+00 9.70E-05 3.66E-07 3.17E-07 5.07E-17
Trachea 0 0.00E+00 9.36E-03 1.03E-05 4.59E-05 7.35E-15
Colon 2124 1.24E-01 7.28E-01 2.50E-06 9.67E-05 1.55E-14
Stomach 1400 0.00E+00 8.30E-02 3.23E-06 2.71E-05 4.34E-15
As expected, like the Ir-192 multiple source organs at time T plus 12 hours, the
majority of the activity remains in the lung but continues to pass through the stomach,
small intestine and colon. Of the 14.2 percent of activity that remained in the lung at
time T plus 12 hours, the lung retained 10.7 percent at time T plus 18 hours. The
activity in the stomach remained at essentially zero and the activity in the small intestine
was reduced from 4.6 percent to 0.3 percent. The most sensitive organs for Ir-192 at
time T plus 18 hours remained the colon followed by the trachea, stomach and small
intestine. The dose to the lung at time T plus 12 hours from Ir-192 was 2.63 x 10-5
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MeV/g and the lung dose at time T plus 18 hours was 2.20 x 10-5 MeV/g. The colon
dose at time T plus 12 hours from Ir-192 was 6.05 x 10-5 MeV/g and the colon dose at
time T plus 18 hours was 9.67 x 10-5 MeV/g. This produced an increase in the colon
dose by roughly 30 percent.
Statistical checks were performed on the Ir-192 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence photons passed and produced similar results. The 10 statistical checks for tally-
six dose photons passed and produced similar results as with Co-60. Of the 61 tally
bins, no bins had a zero dose and 6 bins had relative errors exceeding 0.10 for the 0.47
MeV photon. The second 0.32 MeV photon produced similar results
The tallies for the electron sources within the lung had to be evaluated in a
slightly different manner based on their inability to penetrate uniformly throughout the
phantom. Secondary emissions, such as bremsstrahlung and characteristics x rays were
the primary radiation source for organs outside of the lung. Three of the 10 statistical
checks did not pass. The relative error was 0.24, the VoV did not decrease at a rate
according to the inverse of the number of histories, and the pdf value was 0. This
reflects a large number of zero doses and slightly greater than zero doses based on the
electron source. Figures 20.3 and 20.4 provide a simulated 3-dimensional view of the
human body with a color profile that shows the organ dose for the 0.47 MeV photon of
Ir-192 and the 0.66 MeV electron of Ir-192, respectively. The color bar units to the right
of the phantom are in MeV/organ weight in grams.
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Fig. 20.3. Three-dimensional human dose profile from the 0.47 MeV Ir-192 photon
source located within multiple organs after T plus 18 hours.
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Fig. 20.4. Three-dimensional human dose profile from a 0.66 MeV Ir-192 beta source
located within multiple organs after T plus 18 hours.
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Sr-90 organ dose profile
A Sr-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus 18 hours that ranges from a high of
3.91 x 10-7 MeV/g for the colon and a low of 4.50 x 10-12 MeV/g for the skin. This
organ dose contribution is from a single beta emission with a maximum energy of 0.55
MeV. The beta emission is produced with a yield of about 100%. Table 20.4 provides
the calculated dose conversions for each of the selected organs that will be considered in
this problem.
Table 20.4. Organ doses from a Sr-90 volume source in multiple organs at time T plus
18 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose (Gy)
Skin 0 0.00E+00 2.50E-07 1.00E-13 4.50E-12 7.21E-22
Rib Bone Group 0 0.00E+00 1.55E-03 8.12E-10 4.72E-08 7.56E-18
Small Int 3499 7.00E-04 5.05E-04 1.34E-09 3.79E-08 6.08E-18
Gonads 0 0.00E+00 1.16E-07 1.00E-10 1.52E-10 2.44E-20
Rectum 0 0.00E+00 6.19E-06 8.83E-10 4.81E-09 7.71E-19
Thyroid 0 0.00E+00 9.62E-06 3.63E-09 2.40E-08 3.85E-18
Lung 15000 1.08E-01 1.27E-02 1.48E-09 1.54E-07 2.47E-17
Eyes 0 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0
Trachea 0 0.00E+00 2.50E-05 1.31E-08 1.22E-07 1.96E-17
Colon 2124 8.48E-02 2.94E-03 4.42E-09 3.91E-07 6.26E-17
Stomach 1400 0.00E+00 1.50E-04 2.71E-09 4.89E-08 7.83E-18
The most sensitive organ for a Sr-90 beta source at time T plus 18 hours
remained the colon. The trachea and lung followed the colon in sensitivity. The colon
retained 9.4 percent of the activity at T plus 12 hours and 8.5 percent at T plus 18 hours.
Of the 14.2 percent of activity that remained in the lung at T plus 12 hours, the lung
retained 10.8 percent at T plus 18 hours. Compared to the lung dose from Sr-90 at T
plus 12 hours which was 1.65 x 10-7 MeV/g, the lung dose at T plus 18 hours was 1.54 x
10-7 MeV/g.
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Statistical checks were performed on the Sr-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence missed six of the 10 checks. The relative error was 0.42, the VoV was 0.64 and
the rate did not decrease according to the inverse of the number of histories, the figure of
merit was not constant and the pdf value was 0. The 10 statistical checks for tally-six
dose passed. Of the 61 tally bins, 8 bins had a zero dose and 30 bins had relative errors
exceeding 0.10 for the 0.55 MeV beta emission. Figure 20.5 provides a simulated 3-
dimensional view of the human body with a color profile that shows the organ dose for
the beta emission of Sr-90. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
Y-90 organ dose profile
A Y-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus 18 hours that ranges from a high of
2.81 x 10-6 MeV/g for the colon and a low of 8.86 x 10-11 MeV/g for the skin. This organ
dose contribution is from a single beta emission with a maximum energy of 2.28 MeV.
The beta emission is produced with a yield of about 100%. Table 20.5 provides the
calculated dose conversions for each of the selected organs.
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Fig. 20.5. Three-dimensional human dose profile from a Sr-90 beta source located
within multiple organs after T plus 18 hours.
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Table 20.5. Organ doses from a Y-90 volume source in multiple organs at time T plus
18 hours.
Organs
No. of
Sources in
Organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)/his
Std
Deviation
Organ Dose
(MeV/g)/his
Organ
Dose (Gy)
Skin 0 0.00E+00 4.93E-06 7.44E-13 8.86E-11 1.42E-20
Rib Bone Group 0 0.00E+00 1.72E-02 3.14E-09 5.23E-07 8.37E-17
Small Int 3499 7.00E-04 7.29E-03 8.54E-09 5.47E-07 8.77E-17
Gonads 0 0.00E+00 3.36E-06 1.25E-09 4.40E-09 7.05E-19
Rectum 0 0.00E+00 1.04E-04 6.87E-09 8.09E-08 1.30E-17
Thyroid 0 0.00E+00 1.21E-04 1.80E-08 3.02E-07 4.84E-17
Lung 15000 1.08E-01 8.18E-02 5.16E-09 9.93E-07 1.59E-16
Eyes 0 0.00E+00 2.01E-06 2.87E-09 6.57E-09 1.05E-18
Trachea 0 0.00E+00 3.79E-04 7.01E-08 1.86E-06 2.97E-16
Colon 2124 8.48E-02 2.12E-02 1.88E-08 2.81E-06 4.5E-16
Stomach 1400 0.00E+00 2.26E-03 1.65E-08 7.38E-07 1.18E-16
As with Sr-90, the colon, trachea and lung received the highest dose from a
highly-energetic beta radiation source located in multiple organs at time T plus 18 hours.
Of the 14.2 percent of the activity that remained in the lung at T plus 12 hours, the lung
retained 10.8 percent at T plus 18 hours. The organ activity follows that of Sr-90.
Compared to the lung dose from Y-90 at T plus 12 hours which was 1.06 x 10-6 MeV/g,
the lung dose at T plus 18 hours was 9.93 x 10-7 MeV/g. The colon dose from Y-90 at T
plus 12 hours was 2.55 x 10-6 MeV/g and at the colon dose at T plus 18 hours was 2.81 x
10-6 MeV/g. This produced an increase in the colon dose by roughly 10 percent.
Statistical checks on the Y-90 dose output file were performed. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all but one check. The pdf was 0. The 10 statistical checks for tally-six
dose passed. Of the 61 tally bins, one bin had a zero dose and 24 bins had relative errors
exceeding 0.10 for the 2.28 MeV beta radiation. Figure 20.6 provides a simulated 3-
dimensional view of the human body with a color profile that shows the organ dose for
the beta radiation of Y-90. The color bar units to the right of the phantom are in
MeV/organ weight in grams.
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Fig. 20.6. Three-dimensional human dose profile from a Y-90 beta source located
within multiple organs after T plus 18 hours.
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Results from multi-organ lung, stomach, liver, small intestine and colon volume sources
after 18 hours
Figure 20.7 provides a graph of all of the potential sources distributed in multiple
organs after T plus 18 hours from exposure. Based upon the results of the observed
programs, 18 hours after inhalation, Co-60 remained the most limiting radionuclide. The
trachea, colon and stomach appeared to be the most sensitive organs based upon a single
radiation from a source distribution described above. Even though the trachea shows the
highest sensitivity, the dose is a little deceiving. The observed dose for the trachea is
based on the number of voxels which include the air encircled by the trachea. The actual
dose based on the weight of the organ is less than that for the stomach and small
intestine.
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Fig. 20.7. Summary graph of organ doses for the five potential multi-organ sources after
time T plus 18 hours.
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CHAPTER XXI
ESTIMATING ORGAN DOSE BASED ON VOLUME SOURCES IN THE LUNG,
STOMACH, SMALL INTESTINE AND COLON 24 HOURS AFTER A LUNG
INHALATION
Co-60 organ dose profile
A Co-60 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at time T plus 24 hours from exposure that
ranges from a high of 2.40 x 10-4 MeV/g for the colon and a low of 1.23 x 10-8 MeV/g
for the skin. This organ dose contribution is the sum of two photon emissions that occur
with a yield of about 100 percent. Table 21.1 provides the calculated dose conversions
for each of the selected organs at time (T) plus 24 hours from exposure.
Table 21.1. Organ doses a Co-60 volume source in multiple organs at time T plus 24
hours.
Organs
No. of
Sources in
organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)
Std
Deviation
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 0 0.00E+00 6.87E-04 2.96E-11 1.23E-08 1.98E-18
Rib Bone Group 0 0.00E+00 9.17E-01 8.62E-08 2.78E-05 4.46E-15
Small Int 3499 3.10E-02 7.86E-01 4.01E-07 5.90E-05 9.45E-15
Gonads 0 0.00E+00 1.29E-03 1.56E-07 1.69E-06 2.7E-16
Rectum 0 0.00E+00 1.26E-02 3.14E-07 9.80E-06 1.57E-15
Thyroid 0 0.00E+00 1.11E-02 8.72E-07 2.77E-05 4.43E-15
Lung 15000 2.68E-01 5.33E+00 1.68E-07 6.47E-05 1.04E-14
Eyes 0 0.00E+00 4.21E-04 2.09E-07 1.38E-06 2.2E-16
Trachea 0 0.00E+00 2.73E-02 2.98E-06 1.34E-04 2.14E-14
Colon 2124 2.60E-01 1.81E+00 7.71E-07 2.41E-04 3.86E-14
Stomach 1400 6.24E-03 2.74E-01 8.41E-07 8.95E-05 1.43E-14
As expected the activity in the lung was reduced from 31 percent to 26.8 percent
from time T plus 18 hours to time T plus 24 hours. Once again, the majority of the
activity remained in the lung at time T plus 24 hours. As with time T plus 18 hours, the
colon contained the second highest activity at T plus 24 hours. The activity in the colon
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increased from 22.7 percent to 26.0 percent. The activity of the small intestine
decreased from 4.6 percent to 3.1 percent. The activity in the stomach was further
reduced from 0.9 percent to 0.6 percent. For Co-60, the most sensitive organs remained
the colon followed closely by the trachea, stomach and lung. Compared to the lung dose
from Co-60 at time T plus 18 hours which was 6.79 x 10-5 MeV/g and the lung dose at
time T plus 18 hours was 6.47 x 10-5 MeV/g. The colon dose from Co-60 at T plus 18
hours was 9.53 x 10-5 MeV/g and at time T plus 24 hours the colon dose was 2.41 x 10-4
MeV/g or roughly a 20 percent increase in dose to the colon.
Statistical analysis of output file
The tally-four fluence analysis for each detector, setup as described in chapter
VII, provided a random behavior for the mean. The desired relative error should be less
than 0.10 and the observed relative error was 0.03. The desired and observed relative
errors decreased according to the inverse of the square root of the number of histories.
The desired variance of the variance should be less than 0.10 and the observed VoV was
0.00. The figure of merit value was constant and the behavior was random. The
probability density function (pdf) desired should be greater than three, the observed pdf
was 10. The tally-four fluence passed all 10 statistical checks. Out of 10 tally-four bins,
only one had a zero dose and no bins contained relative errors greater than 0.10. The
second 1.33 MeV photon simulation provided similar results.
The tally-six dose analysis for each material provided a random behavior for the
mean. The desired relative error should be less than 0.10 and the observed relative error
was 0.00 for the 1.17 MeV photon and 0.00 for the 1.33 MeV photon. The desired and
observed relative errors decreased according to the inverse of the square root of the
number of histories. The desired variance of the variance should be less than 0.10 and
the observed VoV was 0.00. The figure of merit value was constant and the behavior
was random. The desired probability density function (pdf) should be greater than 3.00
and the observed value was 10.0 for the 1.17 MeV photon and 8.10 for the 1.33 MeV
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photon. The tally-six dose passed all 10 statistical checks. Out of 61 tally-six bins, no
bin had a zero dose and only 5 bins contained relative errors greater than 0.10.
Figure 21.1 provides a simulated 3-dimensional view of the human body with a
color profile that shows the organ dose for the 1.33 MeV photon of Co-60. Each axis is
represented in the figure along with a color bar that indicates the organ dose in
MeV/organ in grams provided by the MCNPX output file. In the MCNPX output file,
the trachea received a slightly lesser dose than the lung based upon the number of voxels
versus the measured gram weight of the trachea. The phantom includes the airway as
part of the trachea.
Cs-137 organ dose profile
A Cs-137 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus 24 hours from exposure that
ranges from a high of 7.37 x 10-5 MeV/g for the trachea and a low of 3.41 x 10-9 MeV/g
for the skin. This organ dose contribution is from a 0.66 MeV photon emitted from Cs-
137 that occurs with a yield of about 86 percent. Table 21.2 provides the calculated dose
conversions to the selected organs at time (T) plus 24 hours from detonation.
Table 21.2. Organ doses for a Cs-137 volume source in multiple organs at time T plus
24 hours.
Organs
No. of
Sources in
organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)
Std
Deviation
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 0 0.00E+00 1.90E-04 4.09E-12 3.41E-09 5.46E-19
Rib Bone Group 0 0.00E+00 4.59E-01 1.39E-08 1.39E-05 2.23E-15
Small Int 3499 0.00E+00 4.21E-02 2.53E-08 3.16E-06 5.07E-16
Gonads 0 0.00E+00 4.65E-05 7.57E-09 6.08E-08 9.74E-18
Rectum 0 0.00E+00 2.64E-04 1.07E-08 2.05E-07 3.29E-17
Thyroid 0 0.00E+00 6.06E-03 1.71E-07 1.52E-05 2.43E-15
Lung 15000 8.03E-02 2.96E+00 2.52E-08 3.60E-05 5.76E-15
Eyes 0 0.00E+00 1.72E-04 3.59E-08 5.63E-07 9.01E-17
Trachea 0 0.00E+00 1.51E-02 5.75E-07 7.37E-05 1.18E-14
Colon 2124 0.00E+00 2.69E-02 2.89E-08 3.57E-06 5.71E-16
Stomach 1400 0.00E+00 9.36E-02 1.28E-07 3.06E-05 4.9E-15
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Fig. 21.1. Three-dimensional human dose profile from a 1.33 MeV photon source
located within multiple organs at time T plus 24 hours.
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As expected, the activity in the lung was reduced from 10.7 percent to 8.0
percent from time T plus 18 hours to time T plus 24 hours. The majority of the activity
is absorbed by the body. The activity in the stomach remained at less than 0.01 percent.
For Cs-137, the most sensitive organs were the trachea, followed by the lung and
stomach. Compared to the lung dose from Cs-137 at time T plus 18 hours which was
3.59 x 10-5 MeV/g, the lung dose essentially remained the same at 3.60 x 10-5 MeV/g for
T plus 24 hours. The stomach dose from Cs-137 at T plus 18 hours was 3.01 x 10-5
MeV/g and the stomach dose at time T plus 24 hours was 3.06 x 10-5 MeV/g or roughly a
five percent increase in dose to the stomach. The increase is well within the margin or
error for both the doses at T plus 18 and T plus 24 hours.
Statistical checks were performed on the Cs-137 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed and produced similar results. The 10 statistical checks for tally-six dose
passed and produced similar results as with Co-60. Of the 61 tally bins, no bin had a
zero dose and 8 bins had relative errors exceeding 0.10. Figure 21.2 provides a
simulated 3-dimensional view of the human body with a color profile that shows the
organ dose for the single photon of Cs-137. The color bar units to the right of the
phantom are in MeV/organ weight in grams.
At T plus 24 hours, the most sensitive organ for a Co-60 remained the colon. For
Cs-137 the most sensitive organ was the trachea. The Co-60 colon received a dose of
2.41 x 10-4 MeV/g and the Cs-137 trachea received a dose of 7.37 x 10-5 MeV/g. The
change in activity for Co-60 and Cs-137 from T plus 18 hours to T plus 24 hours was not
enough to alter the most sensitive organ. For Cs-137, 8.03 percent of the activity
remained in the lung at T plus 24 hours while 10.7 percent of the activity remained in the
lung at T plus 18 hours. The activity in the stomach dropped from 0.005 percent to 0.0
percent at T plus 24 hours. The relative majority of residual activity remained in the
lung.
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Fig. 21.2. Three-dimensional human dose profile from a Cs-137 photon source located
within multiple organs at time T plus 24 hours.
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Ir-192 organ dose profile
An Ir-192 source located within the lung, stomach, liver, small intestine and
colon would deliver a dose to the selected organs at T plus 24 hours from exposure that
ranges from a high of 1.03 x 10-4 MeV/g for the colon and a low of 3.82-9 MeV/g for the
skin. This organ dose contribution is from the sum of two photons with energies of 0.47
MeV and 0.32 MeV along with two electrons with maximum energies of 0.66 MeV and
0.54 MeV. All four emissions are produced with a yield of 26.2%, 22.4%, 10.1% and
6.7%, respectively. Table 21.3 provides the calculated dose conversions for each of the
selected organs at time (T) plus 24 hours from detonation.
Table 21.3. Organ doses for an Ir-192 volume source in multiple organs at time T plus
24 hours.
Organs
No. of
Sources in
organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)
Std
Deviation
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 0 0.00E+00 2.12E-04 1.64E-10 3.82E-09 6.11E-19
Rib Bone Group 0 0.00E+00 3.19E-01 3.74E-07 9.67E-06 1.55E-15
Small Int 3499 7.50E-04 3.28E-01 1.55E-06 2.46E-05 3.95E-15
Gonads 0 0.00E+00 3.38E-04 8.81E-07 4.42E-07 7.08E-17
Rectum 0 0.00E+00 4.44E-03 1.39E-06 3.46E-06 5.54E-16
Thyroid 0 0.00E+00 3.56E-03 2.84E-06 8.89E-06 1.42E-15
Lung 15000 7.90E-02 1.68E+00 4.88E-07 2.04E-05 3.27E-15
Eyes 0 0.00E+00 9.77E-05 2.47E-07 3.19E-07 5.11E-17
Trachea 0 0.00E+00 8.40E-03 9.70E-06 4.12E-05 6.59E-15
Colon 2124 1.09E-01 7.75E-01 2.20E-06 1.03E-04 1.65E-14
Stomach 1400 0.00E+00 7.94E-02 3.04E-06 2.59E-05 4.15E-15
As expected, like the Ir-192 multiple source organ at time T plus 18 hours, the
majority of the activity remained in the lung but continued to pass through the stomach,
small intestine and colon. Of the 10.7 percent of activity that remained in the lung at
time T plus 18 hours, the lung retained 7.9 percent at time T plus 24 hours. The activity
in the stomach remained at essentially zero and the activity in the small intestine was
reduced from 0.3 percent to 0.1 percent. The most sensitive organs for Ir-192 at time T
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plus 24 hours remained the colon followed by the trachea, stomach and small intestine.
The dose to the lung at time T plus 18 hours from Ir-192 was 2.20 x 10-5 MeV/g and the
lung dose at time T plus 24 hours was 2.04 x 10-5 MeV/g. The colon dose at time T plus
18 hours from Ir-192 was 9.67 x 10-5 MeV/g and the colon dose at time T plus 24 hours
was 1.03 x 10-4 MeV/g. This produced an increase in the colon dose by roughly 3
percent.
Statistical checks were performed on the Ir-192 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence photons passed and produced similar results. The 10 statistical checks for tally-
six dose photons passed and produced similar results as with Co-60. Of the 61 tally
bins, no bin had a zero dose and 5 bins had relative errors exceeding 0.10 for the 0.47
MeV photon. The second 0.32 MeV photon produced similar results.
The tallies for the electron sources within the lung had to be evaluated in a
slightly different manner based on their inability to penetrate uniformly throughout the
phantom. Secondary emissions, such as bremsstrahlung and characteristics x rays were
the primary radiation source for organs outside of the lung. Three of the 10 statistical
checks did not pass. The relative error was 0.31, the VoV was 0.28 and the pdf was 0.
This reflects a large number of zero doses and slightly greater than zero doses based on
the electron source. Figures 21.3 and 21.4 provide a simulated 3-dimensional view of
the human body with a color profile that shows the organ dose for the 0.47 MeV photon
of Ir-192 and the 0.66 MeV electron of Ir-192. The color bar units to the right of the
phantom are in MeV/organ weight in grams.
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Fig. 21.3. Three-dimensional human dose profile from the 0.47 MeV Ir-192 photon
source located within multiple organs at T plus24 hours.
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Fig. 21.4. Three-dimensional human dose profile from the 0.66 MeV Ir-192 electron
source located within multiple organs at T plus 24 hours.
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Sr-90 organ dose profile
A Sr-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus 24 hours from exposure that ranges
from a high of 4.31 x 10-7 MeV/g for the colon and a low of 4.32 x 10-12 MeV/g for the
skin. This organ dose contribution is from a single beta emission with a maximum
energy of 0.55 MeV. The beta emission is produced with a yield of about 100%. Table
21.4 provides the calculated dose conversions for each of the selected organs that will be
considered in this problem.
Table 21.4. Organ doses from a Sr-90 volume source in multiple organs at time T plus
24 hours.
Organs
No. of
Sources in
organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)
Std
Deviation
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 0 0.00E+00 2.41E-07 8.99E-14 4.32E-12 6.93E-22
Rib Bone Group 0 0.00E+00 1.50E-03 8.15E-10 4.55E-08 7.29E-18
Small Int 3499 0.00E+00 5.10E-04 1.27E-09 3.83E-08 6.14E-18
Gonads 0 0.00E+00 4.13E-07 3.90E-10 5.41E-10 8.66E-20
Rectum 0 0.00E+00 6.80E-06 1.08E-09 5.29E-09 8.48E-19
Thyroid 0 0.00E+00 1.05E-05 4.06E-09 2.63E-08 4.21E-18
Lung 15000 8.00E-02 1.16E-02 1.41E-09 1.41E-07 2.25E-17
Eyes 0 0.00E+00 1.07E-07 3.51E-10 3.51E-10 5.62E-20
Trachea 0 0.00E+00 2.79E-05 1.47E-08 1.37E-07 2.19E-17
Colon 2124 7.64E-02 3.24E-03 4.65E-09 4.31E-07 6.9E-17
Stomach 1400 0.00E+00 1.58E-04 2.86E-09 5.16E-08 8.26E-18
As expected, the most sensitive organ for a Sr-90 electron source at time T plus
24 hours remained the colon. The trachea and lung follow the colon in sensitivity. The
colon retained 8.5 percent of the activity at T plus 18 hours and 7.6 percent at T plus 24
hours. Of the 10.8 percent of activity that remained in the lung at T plus 18 hours, the
lung retained 8.0 percent at T plus 24 hours. Compared to the lung dose from Sr-90 at T
plus 18 hours which was 1.54 x 10-7 MeV/g, the lung dose at T plus 24 hours was 1.41 x
10-7 MeV/g.
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Statistical checks were performed on the Sr-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence missed two of the 10 checks. The relative error was 0.29 and the pdf was 0. The
10 statistical checks for tally-six dose passed. Of the 61 tally bins, 8 bins had a zero
dose and 31 bins had relative errors exceeding 0.10 for the 0.55 MeV beta emission.
Figure 21.5 provides a simulated 3-dimensional view of the human body with a color
profile that shows the organ dose for the beta radiation of Sr-90. The color bar units to
the right of the phantom are in MeV/organ weight in grams.
Y-90 organ dose profile
A Y-90 source located within the lung, stomach, liver, small intestine and colon
would deliver a dose to the selected organs at T plus 24 hours that ranges from a high of
3.13 x 10-6 MeV/g for the colon and a low of 8.8 x 10-11 MeV/g for the skin. This organ
dose contribution is from a single beta emission with a maximum energy of 2.28 MeV.
The beta emission is produced with a yield of about 100%. Table 21.5 provides the
calculated dose conversions for each of the selected organs that will be considered in this
problem.
Table 21.5. Organ doses from a Y-90 volume source in multiple organs at time T plus
24 hours.
Organs
No. of
Sources in
organ
Activity
normalized
to 1
MCNP Dose
(MeV/g)
Std
Deviation
Organ Dose
(MeV/g)
Organ
Dose (Gy)
Skin 0 0.00E+00 4.94E-06 7.54E-13 8.88E-11 1.42E-20
Rib Bone Group 0 0.00E+00 1.60E-02 3.01E-09 4.86E-07 7.78E-17
Small Int 3499 0.00E+00 7.57E-03 8.58E-09 5.68E-07 9.11E-17
Gonads 0 0.00E+00 4.55E-06 2.22E-09 5.95E-09 9.54E-19
Rectum 0 0.00E+00 1.06E-04 6.72E-09 8.26E-08 1.32E-17
Thyroid 0 0.00E+00 1.30E-04 1.98E-08 3.24E-07 5.2E-17
Lung 15000 8.00E-02 7.51E-02 4.92E-09 9.12E-07 1.46E-16
Eyes 0 0.00E+00 2.37E-06 3.97E-09 7.74E-09 1.24E-18
Trachea 0 0.00E+00 3.25E-04 6.27E-08 1.59E-06 2.55E-16
Colon 2124 7.64E-02 2.36E-02 1.97E-08 3.13E-06 5.02E-16
Stomach 1400 0.00E+00 2.21E-03 1.63E-08 7.21E-07 1.16E-16
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Fig. 21.5. Three-dimensional human dose profile from a Sr-90 beta source located
within multiple source organs at T plus 24 hours.
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As expected, following Sr-90, the colon, trachea and lung received the highest
dose from a highly-energetic beta particle source located in multiple organs at time T
plus 24 hours. Of the 10.8 percent of activity that remained in the lung at T plus 18
hours, the lung retained 8.0 percent of the activity at T plus 24 hours. The organ activity
follows that of Sr-90. Compared to the lung dose from Y-90 at T plus 18 hours which
was 9.93 x 10-7 MeV/g, the lung dose at T plus 24 hours was 9.12 x 10-7 MeV/g. The
colon dose from Y-90 at T plus 18 hours was 2.81 x 10-6 MeV/g and the colon dose at T
plus 24 hours was 3.13 x 10-6 MeV/g. This produced an increase in the colon dose by
roughly 10 percent.
Statistical checks were performed on the Y-90 dose output file. The same
warnings present with Co-60 were observed. The 10 statistical checks for tally-four
fluence passed all but two checks. The relative error was 0.11 and the pdf was 0. The
10 statistical checks for tally-six dose passed. Of the 61 tally bins, two bins had a zero
dose and 22 bins had relative errors exceeding 0.10 for the 2.28 MeV beta emission.
Figure 21.6 provides a simulated 3-dimensional view of the human body with a color
profile that shows the organ dose for the beta emission of Y-90. The color bar units to
the right of the phantom are in MeV/organ weight in grams.
247
Fig. 21.6. Three-dimensional human dose profile from a Y-90 beta source located
within multiple organs at time T plus 24 hours.
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Results from multi-organ lung, stomach, liver, small intestine and colon volume sources
after 24 hours
Figure 21.7 provides a graph of all of the potential sources distributed in multiple
organs and their organ doses after T plus 24 hours. Based upon the results of the
observed programs, 24 hours after inhalation, Co-60 remains the most limiting
radionuclide. The trachea, colon and stomach appeared to remain the most sensitive
organs based upon a single emission from a source distribution described above. Even
though the trachea shows the highest sensitivity, the dose is a little deceiving. The
observed dose for the trachea is based on the number of voxels which include the air
encircled by the trachea. The actual dose based on the weight of the organ is less than
that for the stomach and small intestine.
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Fig. 21.7. Summary graph of organ doses for the five potential multi-organ sources after
T plus 24 hours.
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CHAPTER XXII
DOSE TO MODEL CONFIRMATION USING EXPERIMENTAL TESTING OF
SCANDIUM-46 IN A RANDO MALE TORSO PHANTOM
Description of the RANDO phantom
The RAN100 phantom was selected as the experimental representation of the
human torso. There is no head, arms or legs associated with the model that was used in
this experiment. The phantom was constructed with a natural human skeleton cast inside
soft tissue-simulating material. The shape of the lungs follows the natural contours of
the rib cage. The material is removed representing the air space of the neck and stem
bronchi. The phantom is horizontally sliced in 2.54 cm sections. 3 cm x 3 cm hole grid
patterns are placed in each section to allow for a variety of TLD placements.
Experimental source and phantom arrangement
Based on the energy spectrum from the five radionuclides of concern, a
radionuclide with an activity of around 60 to 120 days and one that emitted a photon
energy of approximately 1 MeV was desired for testing the dose output from our
computational phantom. Sc-46 has a half-life of 83.79 days and produces a beta and two
gammas with a yield of approximately 100 percent. The average beta energy is 0.11
MeV and the two gamma energies are 1.12 MeV and 0.89 MeV respectively.
Approximately 48.92 mg of scandium chloride salt was irradiated in the NSC Triga
reactor for 2.15 hours at the A6 core position with an average thermal flux of 6.56 x 1012
neutrons/cm2-s. The above set up produced an activity of 3.687 uCi of Sc-46 on
31JAN08 at 1415. The activity was confirmed through a measurement by the gamma
spectrum analysis using a HPGe detector with the sample geometry of S48PS. The
S48PS refers to a point source (PS) that is on a stand (S) that is 48 inches from the
detector.
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The source was encapsulated in a glass vial and placed in section 17 of the
RANDO phantom. The source was centered approximately 15 cm from the chest wall at
the midline between the phantoms nipples. An MCNPX file was created with a single
Sc-46 source placement at position (16.44 29.70 136.98) which corresponds to the
experimental phantom source position. The same number of histories was simulated for
both photon energies as the other simulated sources. The dose and fluence were
measured from the 10 lung detector placements. Table 22.1 provides the calculated dose
conversions for each of the selected organs and the simulated detectors with point source
of Sc-46.
Table 22.1. Organs and detector doses from a Sc-46 point source position in lung.
Organs
MCNP Dose
(MeV/g-his)
Std
Deviation
En Dep
(MeV/his)
Organ Wt
(g)
Organ Dose
(MeV/g-his)
Organ Dose
(Gy/his)
Skin 5.00E-04 2.16E-11 2.54E-05 2830 8.99E-09 1.44E-18
Rib Bone Group 1.14E+00 7.64E-08 7.53E-02 2167 3.47E-05 5.57E-15
Small Int 8.43E-02 1.25E-07 4.05E-03 640 6.33E-06 1.01E-15
Gonads 1.33E-04 4.48E-08 6.45E-06 37.1 1.74E-07 2.78E-17
Rectum 6.29E-04 5.88E-08 3.08E-05 63 4.89E-07 7.83E-17
Thyroid 2.15E-02 1.06E-06 1.05E-03 19.6 5.37E-05 8.60E-15
Lung 8.20E+00 1.39E-07 9.94E-02 999 9.95E-05 1.59E-14
Eyes 5.78E-04 2.27E-07 2.83E-05 15 1.89E-06 3.03E-16
Trachea 1.21E-01 6.94E-06 5.93E-03 10 5.93E-04 9.50E-14
Colon 5.05E-02 1.35E-07 2.47E-03 369 6.71E-06 1.07E-15
Stomach 1.40E-01 4.76E-07 6.86E-03 150 4.58E-05 7.33E-15
UpRtFt Det 2.03E-03 7.78E-07 1.23E-07 4.91E-03 2.51E-05 4.02E-15
UpLtFt Det 1.54E-03 7.05E-07 9.34E-08 4.91E-03 1.90E-05 3.04E-15
CeFt Det 1.03E-03 4.89E-07 6.28E-08 4.91E-03 1.28E-05 2.05E-15
There are many portable instruments available for use in the civilian sector. The
Ludlum model 2350-1 Data Logger was chosen with a Model number 44-9 alpha, beta
and gamma probe along with a 44-2 NaI probe to verify real time exposure data from the
phantom. The detectors were calibrated using a Cs-137 check source. Lithium Iodide
TLD chips were selected and placed in various locations throughout the phantom to test
accumulated dose from the Sc-46 source over a period of one week.
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For the purpose of this experiment, out of the 10 possible detector positions, the
center chest position was chosen based on anatomical markers that are readily
identifiable. On standard man, the center of the sternum is between the nipples and
easily identifiable. However, care must be taken in recognizing that not everyone fits
the mold of standard man. Different body shapes must be taken into account before
emergency responders utilize a preset detector location. This may not be the best
location for barrel-chested men or women with large mammary glands.
Addipose or breast tissue will add internal shielding as well as increase the
distance from the lung source to the surface of the detector. This will reduce the dose
rate by the simple one over r squared rule and reduce the number of primary photons
reaching the detector. More importantly, this will provide a potential false negative
reading based on the calibration of the detector at a given distance of 15 cm. The top or
apex of the lung may prove to be a better location for performing lung surveys. The top
of the lung does not change appreciably with a change in adipose tissue for most people.
Mammary glands do not have a significant affect on this location for most people as
well.
Depending upon the size or sex of the individuals, the emergency responders
may choose the center back or apex of the back. This will significantly reduce the
distance between the detector and the lung and may provide enough dose-rate above
background to achieve good statistics. In either case, tables should be developed that
provide emergency response personnel with dose rate limits based on detector location.
44-9 Alpha, beta and gamma probe measurements
The Ludlum model 44-9 Alpha, Beta, Gamma detector was a GM pancake
detector that will detect alpha, beta and gamma radiation. The detector was energy
dependent and operated between 850 – 1000 volts. It has a thin mica window that was
protected by a stainless steel screen. The open area was 12 cm2 and the operating
voltage was 900 volts. The detector was calibrated with a 6 uCi Cs-137 source using a
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2π geometry. Based on the known activity, the number of photons passing through the
sensitive region of the detector would be approximately 1.11 x 105 photons/s. The
measured count rate for the detector using the known Cs-137 source was 206.67 cps.
Therefore, the overall efficiency of the detector for 0.66 MeV photons was 1.86 x 10-3.
The detector has an over-response to 1 MeV photons of approximately 1.3. Therefore,
an energy correction factor of 1.3 must be applied, which reduces the overall efficiency
to 1.43 x 10-3 if 1 MeV photons are measured.
The time adjusted activity of the Sc-46 source was 281.51 uCi based on the
known activity of 368.7 uCi 35 days prior to the measurement. When the Sc-46 source
was placed in section 17 of the RANDO phantom, the 44-9 detector probe measured
631.67 cps at 15 cm from the chest wall with the face of the probe perpendicular to the
direction of the photons and centered between the nipples. The calculated measurement
based on the MCNPX Sc-46 simulation, with the source in the above mentioned
position, provided a photon fluence of 2.82 x 10-2 photons/cm2 - decay. Since the
sensitive volume of the detector is 12 cm2, this would produce a fluence rate of 2.94 x
105 photons/s across the sensitive volume of the detector. Based on the calculated
efficiency, the simulated detector should measure a count rate of 420.68 cps. Since Sc-
46 emits 2 photons per decay, the actual measured count rate should be 841.36 cps. The
error between the measured count rate and the simulated count rate was 33.2 percent
which is within the acceptable error range of 25-50 percent.
44-2 NaI probe measurements
The Ludlum model 44-2 NaI gamma scintillator was capable of detecting low
levels of gamma radiation in the range of 60 keV – 1.25 MeV. The probe contained a
2.54 cm diameter x 2.54 cm thick NaI crystal coupled to a photomultiplier tube. The
detector was energy dependent and operated between 500 – 1200 volts. The operating
voltage was 850 volts. The detector was calibrated with a 6uCi Cs-137 source using a
2π geometry. When the Sc-46 source was placed in section 17 of the RANDO phantom,
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the 44-2 probe measured 8.0 mR/hr at 15 cm from the chest wall with the face of the
probe perpendicular to the direction of the photons and centered between the nipples.
Since the dose came from two photons averaging 1 MeV, an energy correction factor
based on the calibration of Cs-137 which has a 0.66 MeV photon must be applied. The
probe would under respond by 0.63 and therefore the actual dose to the detector volume
would be approximately 11.4 mR/hr.
The calculated measurement based on the MCNPX Sc-46 simulation with the
source in the above mentioned position provided a dose of 5.73 x 10-4 MeV/g from the
1.12 MeV and 4.62 x 10-4 MeV/g from the 0.89 MeV photon. The dose is in air was
based on a detector volume of 4.67 x 10-2 cm3 and a mass of 4.91 x 10-3 g. The density
for air was 1.3 x 10-3 g/cm3. The total dose to the air volume was 2.04 x 10-15 Gy. A
quick conversion shows that the two Sc-46 photons would deliver a dose to the air
volume of 2.04 x 10-15 rad/disintegration. The number of disintegrations for the given
source was 1.36 x 107 dps. Multiplying the disintegrations per second by the dose per
disintegrations and converting the answer to mrad/hr provides a dose rate of 10 mrad/hr.
The percent error between the measured dose rate and the simulated dose rate was
approximately 12.3 percent. This is within the acceptable error range of 25 – 50 percent.
Lithium fluoride TLD dose confirmation
The phantom dose was independently confirmed by using 18 lithium fluoride
TLD chips placed at defined locations on three different levels approximating the top,
middle and lower portions of the lung. Table 22.2 provides the distance from the source
and the dose rate of each TLD.
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Table 22.2. Position and dose rate for 18 LiF TLDs inside the RANDO phantom with
the Sc-46 source.
Phantom
Position Read. (μC) Dose(R)
Disctance
From Source
(cm)
Standard
Deviation Time (hr)
Dose
Rate
(mR/hr)
A1 113.5 2.37 15.1 0.001 168.00 14.14
A2 116.3 2.43 15.1 0.001 168.00 14.48
A3 80.16 1.68 15.1 0.001 168.00 9.98
A4 102.6 2.15 15.1 0.001 168.00 12.78
A5 618.7 12.95 7.1 0.001 168.00 77.06
A6 590.4 12.35 7.1 0.001 168.00 73.53
A7 334.5 7.00 9 0.001 168.00 41.66
A8 358.8 7.51 9 0.001 168.00 44.69
A9 163.8 3.43 12 0.001 168.00 20.40
A10 88.11 1.84 17.7 0.001 168.00 10.97
B1 83.93 1.76 17.7 0.001 168.00 10.45
B2 95.5 2.00 17.7 0.001 168.00 11.89
B3 96.79 2.03 17.7 0.001 168.00 12.05
B4 78.39 1.64 18.8 0.001 168.00 9.76
B5 86.8 1.82 18.8 0.001 168.00 10.81
B6 67.01 1.40 19.4 0.001 168.00 8.35
B7 12.68 0.27 control 0.001 168.00 1.58
B8 9.77 0.20 control 0.001 168.00 1.22
The TLDs that were placed 15 cm from the source provided a dose rate that ranged from
9.98 mrad/hr to 14.48 mR/hr. After subtracting the background average from the
controls, the dose rate ranged from 8.58 mrad/hr to 13.08 mrad/hr. The dose rate is
consistent with the energy corrected dose rate from the NaI probe at 11.4 mR/hr as well
as the simulated dose rate from the MCNPX program of 10.0mR/hr.
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CHAPTER XXIII
EVALUATION OF EMERGENCY RESPONSE GUIDELINES APPLICABLE TO A
RADIOLOGICAL DISPERSAL DEVICE
Particle dispersal in air
Sandia National Laboratories has run hundreds of explosive experiments with
various materials and device geometries in order to understand the aerosol physics of a
possible RDD (Harper 2006). Harper et al. related the aerosolization of the physical
forms of radioactive material and how they would respond under different conditions.
Table 2 of Harpers report provides the largest source that is potentially available for an
RDD. A Co-60 metal irradiator source would provide 1.11 X 107 GBq. A Cs-137 CsCl
salt irradiator source would provide 7.4 X 106 GBq. An Ir-192 metal irradiator source
would provide 3.7 X 104 GBq and a Sr-90/Y-90 ceramic thermal generator source would
provide 1.11 X 107 GBq (Harper 2006).
Table 3 of Harpers report provides a breakdown of selected dose limits,
significance of each limit and realistic RDD hazards for varying devices. Intermediate
and small sources provide no acute health effects. Doses of 1 Gy from 24 hours of
exposure to ground shine only occur from very large sources at a distance of
approximately 300 m from detonation. An inhalation dose of 2.7 Gy to the lung, based
on the 30-day committed dose, can occur up to 2 km from the blast if sophisticated
engineering is used with a very large source. The 50 year committed dose of 1 Sv from
lung inhalation can occur up to 7 km from a very large source with sophisticated
engineering (Harper 2006).
Dose comparison
In order to compare activity and dose based on one of the likely RDD events, a
few assumptions were made. The first assumption is that a uniform dispersal would
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occur. This is a worst case scenario that would require a sophisticated engineering
device. The second assumption is that the entire radiation source would be reduced to a
one μm AMAD. While this is unlikely without a sophisticated engineering device, it
was considered to be a worst case scenario. The third assumption is that the radiation
was considered airborne and easily re-suspended with the natural dust and debris that
accompany an explosive device. While external exposure and internal exposure must
be considered simultaneously when establishing control levels, the assumption that half
of the dose will come from internal exposure was considered to be a conservative
approach.
With the above assumptions, Table 23.1 provides an instantaneous activity for
each isotope that would deliver an immediate dose that corresponds to a 0.01 Gy limit to
the lung, stomach, small intestine and colon one hour after an inhalation exposure.
The activities can be adjusted based on the dose limit established. Dividing the
dose limit by time would create dose rate limits that can be used to establish triage action
levels as well as time limits for emergency response personnel. The dose rate can be
directly measured using either the GM pancake probe or the NaI probe described in
chapter XXI 21, with the appropriate correction factors applied.
Table 23.2 provides emergency responders with a Dose Rate for the GM pancake
probe and the NaI probe located at the center of the sternum. The dose rates provided in
Table 22.2 correspond to an activity from a source that would deliver a dose to the lung
within 24 hours. The dose rates are based on the dose rate per activity derived from the
experimental results from Sc-46. The ratio has been corrected for the gamma energy and
yield for each isotope.
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Table 23.1. Activities that correspond to preset organ dose limits for the five
radionuclides considered in this problem.
Organ Radionuclide
Acitivity
(GBq)
Dose Limit
(Gy)
Activity to reach
Dose Limit in 1
hour (GBq)
Acitivity in
mCi
Lung Co-60 5.37E+02 0.01 1.49E-01 4.03E+00
Stomach Co-60 4.40E+02 0.01 1.22E-01 3.30E+00
Small Intestine Co-60 3.23E+03 0.01 8.98E-01 2.43E+01
Colon Co-60 3.96E+03 0.01 1.10E+00 2.97E+01
Lung Cs-137 2.02E+03 0.01 5.61E-01 1.52E+01
Stomach Cs-137 5.79E+02 0.01 1.61E-01 4.35E+00
Small Intestine Cs-137 1.20E+04 0.01 3.34E+00 9.03E+01
Colon Cs-137 1.37E+04 0.01 3.81E+00 1.03E+02
Lung Ir-192 1.94E+03 0.01 5.40E-01 1.46E+01
Stomach Ir-192 5.43E+02 0.01 1.51E-01 4.07E+00
Small Intestine Ir-192 2.18E+03 0.01 6.05E-01 1.63E+01
Colon Ir-192 4.34E+03 0.01 1.21E+00 3.26E+01
Lung Sr-90 3.33E+05 0.01 9.25E+01 2.50E+03
Stomach Sr-90 1.41E+05 0.01 3.93E+01 1.06E+03
Small Intestine Sr-90 6.22E+05 0.01 1.73E+02 4.67E+03
Colon Sr-90 1.87E+06 0.01 5.20E+02 1.40E+04
Lung Y-90 5.10E+04 0.01 1.42E+01 3.83E+02
Stomach Y-90 1.67E+04 0.01 4.65E+00 1.26E+02
Small Intestine Y-90 6.85E+04 0.01 1.90E+01 5.14E+02
Colon Y-90 1.55E+05 0.01 4.31E+01 1.16E+03
In an emergency situation, there would be two preset levels for evaluating
contaminated injured personnel, 0.01 Gy over a 24 hour period of time which provides a
cut off for individuals who are either contaminated or non-contaminated and 1.0 Gy over
a 24 hour period of time which corresponds to emergency medical treatment for the
individual or no medical treatment based on the lung dose. The above two limits only
apply to individuals who were present within the affected zone. Direct medical
intervention should be reserved for any casualty that exceeds the 1.0 Gy exposure level.
While the 50 year committed effective dose equivalent would be much higher, the
aforementioned levels are for an acute dose scenario during an RDD emergency. Table
23.2 provides an accumulated activity for each of the five radionuclides considered in
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this problem based on the one hour, six hour, 12 hour, 18 hour and 24 hour snap shots
simulated in the multiple source organs.
Table 23.2. Lung activity limits to reach a dose limit of 0.01 Gy for the five
radionuclides in this problem.
Organ Radionuclide
Dose
Limit(Gy)/
24 hours
Activity
Limit(GBq)/24
hours
Acitivity in
mCi/24
hours
Lung Co-60 0.01 2.30E-03 6.23E-02
Cs-137 0.01 4.14E-03 1.12E-01
Ir-192 0.01 5.80E-03 1.57E-01
Sr-90 0.01 8.79E-01 2.38E+01
Y-90 0.01 1.36E-01 3.68E+00
Using this table, emergency responders can establish action levels based on the
two limits listed previously in this chapter by simply comparing the ratio of the dose
limit/24 hours divided by the activity limit per 24 hours.
Table 23.3 provides a real time detector response based on the above limits. The
dose rate is calculated using the calibration factor and probe setup based on the Sc-46
experimental data. Each probe was calibrated using Cs-137 and corrected for energy.
The probe was positioned centered on the sternum.
Table 23.3. Dose rate limits for GM pancake and NaI probes based on five radionuclides
within the Lung using a dose limit of 0.01 Gy.
Radionuclide
Acitivity in
mCi/24
hrs
Dose Rate
from GM
Pancake
Probe (cps)
Dose Rate
from NaI
Probe
(mR/hr)
Co-60 6.23E-02 3.18E+03 4.57E-02
Cs-137 1.12E-01 7.70E+03 1.49E-01
Ir-192 1.57E-01 1.44E+04 1.05E+00
Sr-90 2.38E+01 N/A 1.01E-03
Y-90 3.68E+00 N/A 1.56E-04
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Since Sr-90 and Y-90 are beta emitters, the dose rate for the GM pancake probe
was not applicable. The GM detector can be utilized to differentiate between beta and
gamma contamination on individuals using a combination of open and closed windows.
Nasal and mouth swabs can be obtained to indirectly assess the internal contamination if
a beta radionuclide has been identified. Once the radionuclide from the RDD has been
identified, indirect calculations based on ICRP 30 methodology can be used to assess
internal dose. The internal dose can then be indirectly measured using bioassay
techniques.
Table 23.4 provides the dose rate limits for medical intervention based on an
internal dose of 1 Gy delivered to the lungs over 24 hours. The dose rate limit is
provided for each of the five radionuclides. The same assumptions were applied as with
Table 23.3. The applied dose rates are above background rates and should be used with
a 95 percent confidence interval.
Table 23.4. Dose rate limits for GM pancake and NaI probes based on five radionuclides
within the lung using a dose limit of 1 Gy.
Radionuclide
Acitivity in
mCi/24
hrs
Dose Rate
from GM
Pancake
Probe (cps)
Dose Rate
from NaI
Probe
(mR/hr)
Co-60 6.23E+00 3.18E+05 4.57E+00
Cs-137 1.12E+01 7.70E+05 1.49E+01
Ir-192 1.57E+01 1.44E+06 1.05E+02
Sr-90 2.38E+03 N/A 1.01E-01
Y-90 368.079 N/A 1.56E-02
Every model contains known and unknown errors. Individual quantity errors
were provided in all of the computer simulation runs based on the MCNPX model.
While errors propagate throughout each system, care has been taken to minimize and test
the statistical reliability and predictability of the program. The most significant error is
associated with atomic cross-sections. Cross-sections are used in every interaction
calculation. This can easily lead to a 25 percent difference in organ or whole body dose
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between the program prediction of dose and the experimental measurement of dose used
to validate the program. Based on this reality, a safety margin should be built in to the
dose rate limit in order to better protect an individual from deterministic effects of
ionizing radiation associated with internal contamination. Emergency responders should
reduce the dose rate limit for their instruments by at least 25 percent. While this may
increase the number of individuals who are segregated into the categories of known
internal contamination, it should not significantly affect the limited medical resources
available for patient care. It will also ensure that someone who may be more susceptible
to radiation sickness will not be overlooked based on having a dose that is just under the
limits established by the emergency responders.
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CHAPTER XXIV
CONCLUSIONS AND FUTURE WORK
The action levels provided in chapter XXIII 23 are for a radiological dispersal
device and should not be used for other types of radiological events. Radiological events
such as Chernobyl, 3-mile Island, or nuclear weapons testing are outside of the scope of
this study. The organ and individual dose rate limits have been tailored specifically for
an RDD event using computer simulation and verification through experimental testing.
Based on the experimental testing and simulated modeling of the five radionuclides, real
time lung measurements using the instruments mentioned in chapter XXI 21 or
equivalent instrumentation, emergency responders can rapidly scan personnel and
segregate them according to the two action levels provided for potentially contaminated
individuals within the affected area. The initial segregation should be between injured
and non-injured personnel. All personnel should be medically treated without regard for
radioactive contamination. Once an individual is medically stable, care can be provided
on monitoring and decontaminating the individual followed by reducing or treating
internal radioactive contamination if necessary. All personnel who do not exhibit a
medical injury, should be monitored and decontaminated as rapidly as possible. Only
individuals who exceed action level two should receive medical care based on internal
contamination. The acceptance of scientifically based dose limits would aid in the triage
of injured personnel as well as possibly reassures the general public that they do not
have to overload the medical community if and when an event may occur.
The MAX phantom coupled with the MATLAB programs and the MCNPX
output code are flexible enough to accurately model acute organ doses resulting from a
RDD event. It can be tailored to fit different scenarios. It is designed to provide a rapid
estimate of organ dose based on the likely radioactive make-up of a RDD to assist
emergency response personnel in performing triage of potentially contaminated injured
people as well as establish scientifically based dose limits for emergency responders.
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Further refinement of the dose distribution to the skin would provide more
accurate dose modeling of the skin. Dr. Kemper and his group have just developed a
new MAX model that reduces the voxel size from 0.36 cm3 to 0.36 mm3 this will greatly
enhance the resolution between organ surfaces as well as assist in better defining
vascular organs. The lung simulation would greatly benefit from a different approach
that takes into consideration the truncated air passages and defines them separately from
the lung tissue.
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APPENDIX A
1tally 6 nps = 1000000
tally type 6 track length estimate of heating. units mev/gram
particle(s): photon
masses
cell: 1 2 3 5 6 7 8
5.08550E-02 4.69826E-02 6.06528E-05 4.84289E-02 6.57850E-02 6.01862E-02 4.89888E-02
cell: 9 11 12 14 15 16 18
4.94554E-02 4.89888E-02 4.94554E-02 4.89888E-02 4.89888E-02 4.89888E-02 4.80557E-02
cell: 22 24 25 26 27 31 32
4.43232E-02 6.06528E-05 4.66560E-02 4.99219E-02 4.89888E-02 4.94554E-02 4.80557E-02
cell: 33 34 35 36 37 38 39
4.89888E-02 4.85222E-02 4.89888E-02 6.20525E-02 4.89888E-02 4.89888E-02 4.89888E-02
cell: 40 41 42 43 44 45 46
4.85222E-02 6.81178E-02 6.81178E-02 6.81178E-02 6.81178E-02 6.20525E-02 6.20525E-02
cell: 47 48 49 50 55 60 70
6.20525E-02 6.20525E-02 6.20525E-02 6.20525E-02 4.89888E-02 4.89888E-02 5.50541E-02
cell: 71 76 77 79 81 90 95
7.83821E-02 7.51162E-02 4.85222E-02 4.85222E-02 7.83821E-02 1.21306E-02 4.89888E-02
cell: 98 99 102 106 110 116 119
4.66560E-02 4.85222E-02 7.51162E-02 4.89888E-02 4.89888E-02 4.89888E-02 4.89888E-02
cell: 121 125 140 150 160
4.94554E-02 7.83821E-02 4.89888E-02 4.89888E-02 4.89888E-02
Fig. A-1. MCNPX output file section on mass calculations for each material. Cell 90
corresponds to the lung with a value of 1.21 X 10-2g per voxel.
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Table A-1. Hand calculated volume of lung using a voxel size of 3.6mm x 3.6mm x
3.6mm.
IDMAX Organ/Tissue Nº of voxels Vol (cm3)
0 Air 4127281 192562.4223
1 Skin 122984 5737.941504
6 Ribs+clavicles+sternum+scapulae 32948 1537.221888
12 Liver 36743 1714.281408
14 Kidneys 6328 295.239168
18 Small intestine 20413 952.388928
34 Testes 709 33.079104
35 Prostate 438 20.435328
45 Leg bone right (superior 1) 4976 232.160256
60 Thyroid 405 18.89568
90 Lungs 87506 4082.679936
119 Eyes 309 14.416704
140 Trachea 1182 55.147392
150 Colon 12391 578.114496
160 Stomach 8165 380.94624
Voxel size: 3.6mmx 3.6mmx 3.6mm
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